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PREFACE 
Weight management is multifactorial. It is like peeling an onion. At the core it 
seems it is simple math: calories in versus calories burned equals pounds lost or 
gained. But it is all the other layers, the factors that influence the core that are unique 
and make all the difference, many of which are beyond our control. May this project lead 
to a better understanding of the chronic disease of obesity and result in a more 
knowledgeable, less biased, kinder hearted and healthier provider and patient 
population. May it also serve as a stimulus to finding a cure for this chronic, debilitating 
and often life-threatening disease.  
“The improvement of understanding is for two ends: first, our own increase of 
knowledge; secondly, to enable us to deliver that knowledge to others”. -John Locke 
“If you judge people you have no time to love them”- Mother Teresa 
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Abstract 
Obesity is a multifactorial, individualized, chronic disease that increases known risk 
factors for significant comorbidities and mortality. The primary purpose of this Evidence-
Based practice project was to improve indicators of obesity (weight, BMI) among 
patients served by a free medical clinic, using a tailored multicomponent intervention. 
The secondary purpose was to determine if the weight loss intervention was associated 
with a decrease in blood pressure and depression symptoms. The intervention was 
guided by the Health Promotion Model by Nola Pender. The Johns Hopkins Nursing 
Evidence Based Practice Model (JHNEBP) guided implementation of the project. A 
comprehensive literature review was completed in five databases, and strong evidence 
supported the tailored multicomponent intervention used in this project. Eligible 
participants (n=26) took part in the 3-month program. Written education materials were 
provided in English and Spanish, and an interpreter was used when appropriate. 
Weight, BMI, and BP were measured weekly, then at weeks 8 and 12. The PHQ-9 was 
measured at baseline and at week 12. Analysis: Continuous outcome variables and 
dichotomous data were analyzed using the nonparametric equivalent of the paired t-test 
– the Wilcoxon signed-rank test. A weight or BMI reduction of >3% from baseline is 
considered clinically significant. Weight significantly decreased from baseline (228.96 
lbs., SD = 57.16) to Week 4 (214.87 lbs., SD = 44.68, p = .026). Mean BMI also 
significantly decreased from baseline (39.87kg/m2, SD = 6.19) to week 4 (38.27 kg/m2, 
SD = 6.57, p= .028), and from baseline to week 12 (38.64 kg/m2, SD = 6.93, p=.023). 
Significantly more patients in the intervention group achieved at least 3% weight loss 
between baseline and Week 12, compared to those who did not receive the intervention 
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(27% vs 16%, p = .034). Depression improved significantly from baseline to Week 12 (p 
= .014). There were no significant differences in SBP or DBP. Conclusions: Based on 
these results, a tailored multicomponent weight loss program is effective at reducing 
weight, BMI, and depression in the primary care setting.   
Search words: obesity AND intervent* OR treat* AND “weight loss” OR BMI OR “waist 
circumference” OR “body fat” AND “primary care” OR “primary health care” OR “primary 
healthcare” 
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CHAPTER 1 
INTRODUCTION 
Background 
 In this chapter, the problem of obesity will be described in the global and national 
contexts, including its prevalence, pathophysiology, risk factors, clinical presentation, 
diagnostic findings, and available treatment options.  
Obesity, resulting from excess adiposity and subsequent chemical imbalances 
create the systemic chemical effect that increases overall health risk for comorbidities 
and mortality, including: depression, hypertension, elevated cholesterol and 
triglycerides, cardiovascular disease, cerebrovascular accident, liver and gallbladder 
diseases, reproductive diseases, type II diabetes, osteoarthritis, certain cancers and 
sleep apnea. Obesity can be prevented and or treated with existing, new and or 
evolving discoveries (Doig & Huether, 2014; Goettler, Grosse & Sonntag, 2017; Jensen  
et al., 2014; Kushner & Ryan, 2014; Triplett, Repas, & Alvarez, 2014).  
Prevalence 
Obesity is a global health threat. In 2016, as many as 1.9 billion adults 
throughout the world were overweight, of which 650 million adults were obese. 
Moreover, 340 million children were overweight or obese, and many of these acquire 
lifestyle patterns in childhood that will follow them into adulthood and increase their risk 
for lifelong obesity (WHO, 2018). 
Since 1975, the global prevalence of obesity has nearly tripled (WHO, 2018), 
which may be attributable to increased access to high-calorie food, less active lifestyles, 
more sedentary work, and automotive sources of transportation (Rolls et al.,2017). In 
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every global region, except for sub-Saharan Africa and Asia there are more people who 
are obese than underweight (WHO, 2018). Underserved and minority populations have 
a disproportionately higher incidence of obesity and suffer from proportional weight 
related comorbidities. Women of these communities are impacted at a higher degree. 
All women are at risk for obesity but minority and low-income women and persons living 
in certain rural and urban geographical regions are at a higher risk than those living in 
affluent regions (ACOG, 2014; Hageman et al., 2017; Katzmarzyk et al., 2018; Kozica et 
al., 2015) . “African American and Hispanic women are twice as likely as their white 
counterparts to be overweight or obese. Forty-two percent of women with incomes 
below 130% of the poverty level are obese” (ACOG, 2014). 
Patients with obesity can be found in every clinical practice in the world, but their 
disease is often left unaddressed and untreated (McLaughlin, Hamilton & Kipping, 2017; 
Pollak et al., 2016). This may be due in part to previously experienced and anticipated 
poor treatment from a provider who may have a preconceived bias or stigma regarding 
overweight obese patients. This may cause patients to avoid seeking treatment and or 
poor compliance (Phelan, et al., 2015). As much as 69% of overweight or obese female 
patients have reported a perceived healthcare provider obesity bias (Alberga  et al., 
2017). This may have a significant impact on population health, because of the 
increased risk of obesity-related comorbidity and mortality (Doig & Huether, 2014; Guan 
et al., 2016; Kroes et al., 2017; Kushner & Ryan, 2014; WHO, 2018), being overweight 
or obese is linked to more deaths globally than being underweight or starvation.   
In the United States, about two-thirds of the population is either overweight or 
obese, with approximately 35% of the adult population having a body mass index (BMI) 
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in obese range (Bomberg et al., 2017; Kroes, Osei-Assibey, Baker-Searle & Haung, 
2016; Kushner & Ryan, 2014). Obesity has an enormous impact on the national, and 
therefore global, economy. Medical care costs are estimated to be between $200 and 
$220 billion in the United States and approximately $2 trillion globally (Bomberg et al., 
2017). Furthermore, research shows that obesity in the workplace leads to decreased 
productivity and increased employee absenteeism (Bomberg et al., 2017; Goettler et al., 
2017).  
Obesity is preventable and treatable. Even a 5% to 10% reduction in body weight 
can significantly reduce the risk for obesity-related complications and improve quality of 
life (Bomberg et al., 2017; Kroes et al., 2016; Jensen et al., 2014; Kushner & Ryan, 
2014; WHO, 2018). Because of its high prevalence, lifelong chronicity, substantial 
clinical and economic consequences, and high potential to be prevented and treated, 
obesity management is justifiably considered a high priority in the primary care setting.  
Pathophysiology 
Obesity is defined as a body mass index (BMI) of greater than or equal to 
30kg/m2 and develops due to an imbalance between caloric intake and caloric 
expenditure in persons with a genetic predisposition. The genetic component can be 
related to either genotype or a genetic- environment interaction. It can be associated 
with either single or multiple genetic defect(s) such as: GWAS or FTO gene, leptin or 
melanocortin pathway defect, the congenital deficiency of proprotein convertase 
subtilisin/kexin type 1 gene (PCSK1), Down or Prader-Willi syndromes. It can also be 
related to endocrine disorders such as: Cushing’s disease, polycystic ovary syndrome, 
diabetes or hypothyroidism, as well as hypothalamic injury. The intricate 
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pathophysiology involves a multitude of interactions between hormones, cytokines and 
neurotransmitters. The adipocytes are the basis for adipose tissue. Alterations in 
adipocytes have a systemic effect on chemical balance. Adipocytes secrete multiple 
hormones, and cytokines called adipokines. These help to regulate satiety, metabolism, 
fat storage, insulin sensitivity, vascular homeostasis, immune response, female fertility, 
and energy metabolism (Doig & Huether, 2014; Perreault, 2019a; Triplett, et al., 2014). 
Obesity is often accompanied by frequent relapses and cyclical weight gain-
weight loss (Kushner & Ryan, 2014; Rodriguez-Cristobal, 2017; McLauglin et al., 2017). 
Obesity often has a cyclical nature with depression and or anxiety (Kushner & Ryan, 
2014; Ma et al., 2019; Rodriguez-Cristobal et al., 2017; Rolls et al., 2017) and relapses 
often coincide with exacerbations of weight-related comorbidities, such as: worsening 
joint pain, hypertension, increased HbA1c or elevated cholesterol levels. 
Risk factors 
Because of its impact over the lifespan, obesity is considered a chronic disease 
with myriad risk factors (Doig & Huether, 2014; Kushner & Ryan, 2014; McLaughlin et 
al., 2017) that can impact every person, at every age, and nearly every system of the 
human body. Excess adiposity and subsequent chemical imbalances create the 
systemic chemical effect that increases overall health risk for comorbidities and 
mortality, including: depression, hypertension, elevated cholesterol and triglycerides, 
cardiovascular disease, cerebrovascular accident, liver and gallbladder diseases, 
reproductive diseases, type II diabetes, osteoarthritis, certain cancers and sleep apnea 
(Doig & Huether, 2014; Kroes et al., 2016; McLaughlin et al., 2017; Tapsell et al, 2017).  
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Since the underlying mechanism involves a metabolic imbalance between 
calories consumed and calories expended (usually through exercise), it seems intuitive 
that a high-calorie diet and sedentary lifestyle are the two most important risk factors for 
developing obesity (Hartman et al., 2014; Kroes et al., 2016; Kushner & Ryan, 2014; 
Thabault et al., 2016). However, each of these is associated with unique risk factors that 
ultimately determine caloric balance. Calorie consumption depends on eating patterns, 
the types of foods consumed, the source of calories (i.e. macronutrients), the cultural 
meaning of food, ability to access and prepare foods, and emotional responses to food. 
Since calorie consumption is the net result of a person’s food choices, eating behaviors, 
personal beliefs and values, sociocultural context, and environmental characteristics, 
identifying and minimizing all risk factors for a high-calorie diet is virtually impossible.  
Likewise, a sedentary lifestyle is the result of both intrapersonal and 
interpersonal factors that determine whether or not someone will engage in physical 
activity. For example, the decision to start an exercise program at a local gym may 
depend on a person’s prior experience with that facility, their level of enjoyment 
engaging in a particular exercise, and the cost of gym membership. Other individual 
factors may include the availability of appropriate attire, transportation to the gym, and 
psychological comfort in a gym environment. Ultimately, these and many other factors 
will determine if a person starts the exercise program or not.  
However, starting the program does not guarantee that the person will actually 
go to the gym and exercise; the person must be willing to forego other competing 
demands for their time, energy, and attention so they can physically follow through with 
their exercise plan. Still others are unable to engage in physical activity due to chronic 
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or acute illnesses that limit mobility or endurance. Despite a nearly limitless array of 
physical activities with which to engage, research shows that only 23.2% of U.S. adults 
meet the minimum recommendations for exercise and aerobic activity established by 
the CDC (2017). Clearly, calorie expenditure relies on a complex interplay between 
innumerable factors that are difficult for individuals (and our population) to overcome.  
While it is relatively easy to think of obesity as an imbalance between calories 
consumed and calories expended, research suggests that genetic risk factors may also 
exist. Genotype and interaction of gene-environment are predisposing factors to 
obesity. Either single or multiple genetic defect(s) such as: leptin or melanocortin 
pathway defect, the congenital deficiency of proprotein convertase subtilisin/kexin type 
1 gene (PCSK1), Down or Prader-Willi syndromes or endocrine disorders such as 
Cushing’s disease, polycystic ovary syndrome, diabetes or hypothyroidism as well as 
hypothalamic injury may be instrumental in the development of obesity. 
Pathophysiology is intricate, involving delicate interactions between a multitude of 
hormones, cytokines and neurotransmitters producing interlocking systemic effect (Doig 
& Huether, 2014; Perrault, 2019a; Triplett et al., 2014).  
Additionally, certain medications can be instrumental in weight gain including 
some: antipsychotics, antidepressants, antiepileptics, antihyperglycemics, 
antihistamines, alpha-blockers, beta-blockers, hormones and glucocorticoids (Perreault, 
2019a; Perreault, 2019c) and are limitedly described in Table 1.1. As one intervention, a 
medication reconciliation and review will be completed, and whenever possible 
medication adjustments may be considered.   
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Table 1.1 
Medications associated with weight gain 
Medication class Some of the drugs in class Mechanism of action 
causing weight gain 
Antidepressants/antianxiety: 
selective serotonin re-
uptake inhibitors (SSRI); 
monoamine oxidase 
inhibitors (MOAI); tricyclic 
antidepressants (TCA) 
TCA: nortriptyline, 
amitriptyline; SSRI: 
paroxetine, citalopram, 
escitalopram; TCA: 
doxepin, imipramine and 
mirtazapine. 
SSRI:5-HT inhibition;  
MAO-I: increase 
concentrations of NE, 5-
HT, and DA in neuronal 
synapses; 
TCA: Neuronal receptor 
sensitivity change due to 
down-regulation of Beta       
-adrenergic and 5-HT 
receptors 
Antipsychotics thioridazine, olanzapine, 
risperidone, clozapine and 
quetiapine 
5-HT antagonism 
Neurologic and mood 
stabilizers 
lithium, carbamazepine, 
gabapentin and valproate 
Valproate component – 
MOA unknown 
Antiepileptic 
 
divalproex Divalproex 
sodium/Valproate 
component – MOA 
unknown 
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Antihyperglycemics 
 
insulin, sulfonylureas, 
thiazolidinedione, 
meglitinides 
Plasma insulin/glucose 
levels related to 
insulin/antihyperglycemic 
therapy 
Glucocorticoids prednisone Carbohydrate metabolism 
is increased at 
glucocorticoid receptor 
sites 
Antihistamines cyproheptadine Nonselective 5-HT 
receptor antagonist and 
anticholinergic drug 
decreases ACTH 
secretion- and increases 
anticholinergic effect 
Hormones progestins, 
medroxyprogesterone 
Alters insulin, glucose or 
glucagon release further 
altering carbohydrate 
metabolism  
Alpha-blockers terazosin Slows metabolism and 
relaxes smooth muscles 
Beta-blockers propranolol Beta-2 receptors are 
responsible for insulin 
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secretion and 
glycogenesis  
(Crismon, Argo & Buckley, 2014; Dietrich, Smith & Gums, 2014; Drayton & Pelic, 2014; 
Lee, 2014; Melton & Kirkwood, 2014; Perreault, 2019c; Saseen & MacLaughlin, 2014; 
Schrader & Ragucci, 2014; Teter, Kando & Wells, 2014; Triplitt, Repas & Alvarez, 2014) 
 
Clinical Presentation 
Patients with obesity may present to the primary care setting because they are 
concerned about their weight, due to a complication arising from their obesity (e.g. 
obstructive sleep apnea or low back pain), or for treatment of an unrelated problem (e.g. 
headache). They may report a recent weight gain, or they may share that they have 
struggled with being overweight since childhood. In any case, the patient should be 
weighed, and height measured so that their body mass index (BMI) can be calculated. A 
BMI greater than or equal to 30 kg/m2 indicates obesity.  
Beyond their BMI, the patient should be asked about their risk factors for obesity, 
how their weight affects their health and relationships, and if they feel motivated to lose 
weight. This conversation should be nonjudgmental, compassionate, and empathetic, 
but because of the clear health benefits of maintaining a normal BMI, it should not be 
avoided. The patient should also be asked about: readiness; current and previous 
attempts to lose weight, cultural and psychosocial barriers and motivators to weight 
loss, emotional health and well-being (Eaton et al., 2016; Kushner & Ryan, 2014; 
Samdal et al., 2017; Tapsell et al., 2017; Thabault et al., 2016).  
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A physical exam of a person with obesity may reveal the following: 
cardiovascular disease, jugular vein distention; reduced peripheral vascular circulation 
or varicosities; venous or lymph peripheral edema; pleural fluid retention and or 
dyspnea; hepatomegaly with possible ascites; Mallampati scores consistent with sleep 
apnea; inflammation; back or joint pain with decreased range of motion; polycystic 
ovaries; stress incontinence; hirsutism; rash and or cellulitis or carbuncles (Doig & 
Heuther, 2014). Because obesity and hypertension often occur together, a full set of 
vital signs including blood pressure should be evaluated. Additional clinical testing might 
include an evaluation of gait, cardiopulmonary fitness (e.g. 6-minute walk test), and 
anthropometric measurements (Kushner & Ryan, 2014; Tapsell et al, 2017).  
Diagnostic Testing 
Because obesity is strongly and almost universally associated with a number of 
chronic illnesses, it may be appropriate at their primary care visit to review fasting 
glucose or HbA1C and a fasting lipid panel that are consistent with current guidelines 
(Jensen et al., 2014; Kushner & Ryan, 2014; Tapsell et al, 2017; Uphold & Graham, 
2013).  Additionally, when possible, adults should have a complete blood count, liver 
function studies, a renal panel, and thyroid stimulating hormone, as well as an 
electrocardiogram based on patient risk. A referral to cardiology may be indicated if 
there is evidence of ischemic heart disease, which may warrant a cardiac stress test or 
heart catheterization. Evidence of obstructive sleep apnea should trigger a referral to a 
pulmonologist or sleep medicine specialist who can evaluate the patient’s need for 
continuous positive airway pressure (CPAP). Evidence of hepatic, renal or thyroid 
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disease as well as any disease not routinely addressed in primary care may necessitate 
a referral to a specialist as well (Uphold & Graham, 2013).   
Treatment Options 
Traditionally, obesity treatment has relied on delivering education to the patient 
about calorie restricted diets and exercise. In addition, treatment may focus on 
preventing or managing the long-term consequences of obesity, such as hypertension 
and type 2 diabetes mellitus. Medications, including those presented in Table 1.2 may 
also be used to reduce appetite and food cravings or decrease carbohydrate absorption 
from the gut.  
Table 1.2 
 Weight loss Pharmacotherapeutic Agents 
Drug Class Generic and Brand Name Mechanism of Action 
Gastrointestinal lipase 
inhibitor 
Orlistat/ Xenical or Alli Decreases fat absorption 
in the gut by inhibiting GI 
lipase 
Serotonin 2C Receptor 
Agonist 
Locaserin/ Belviq Appetite suppression 
through activation of 
serotonin receptor in 
hypothalamus 
Phentermine-Topiramate 
Combination 
Extended release 
Phentermine-Topiramate/ 
Bontril PDM or Bontril slow 
release 
Exact MOA unknown; May 
reduce appetite and 
increase satiety via 
multiple pathways 
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Noradrenergic Agents Phendimetrazine/ Bontril 
PDM or Bontrilslow 
release 
 
Phentermine/ Adipex-P or 
Suprenza 
 
Diethylpropion/ Tenuaate 
or Tenuate Dospan 
Exact MOA unknown; May 
reduce appetite and 
increase satiety via 
multiple pathways 
Serotonergic Agents-Off 
Label (not approved for 
obesity management by 
FDA) 
Fluoxetine Increased 5-HT levels, 
decreases appetite and 
disrupts hunger satiety 
  
Glucagon-like peptide-1 
receptor/ anti-diabetic- off 
label 
Liraglutide/ Victoza Increases insulin and 
decreases glucagon 
release 
Opiate agonist Naltrexone/ Vivitrol or 
Revia 
Effect not established for 
weight loss. Used in 
combination with 
bupropion 
A noradrenergic/ 
dopaminergic 
antidepressant 
Buproprion Action in cerebral reward 
–dopamine centers 
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(Curry et al., 2018; Sheehan, Chen, Yanovski & Calis, 2014; Tek, 2016) 
  
Finally, weight loss surgery has been an obesity management option for 
decades. Fairly recent improvements in surgical techniques, products, and 
interprofessional care coordination have resulted in dramatically beneficial outcomes for 
patients undergoing bariatric surgery (Jensen et al., 2014; Kushner & Ryan, 2014; 
Uphold & Graham, 2013; Welbourn et al., 2018).  
It is clear that one treatment option does not work, or is not appropriate, for every 
patient with obesity. Evidence shows that tailored multicomponent interventions are an 
effective way to promote weight loss, but this approach can be resource-intensive, 
particularly in underfunded primary care settings without access to weight loss 
specialists, dietitians, and other team members that focus on obesity management 
(Eaton et al., 2016; Cheatham et al., 2018; Kushner & Ryan, 2014). The aim of this 
project was to help patients and providers to overcome barriers that prevent weight loss 
in adults with obesity through the implementation of theory-driven and Evidence-Based 
weight loss interventions.  
Data from the Literature Supporting Need for the Project 
According to the WHO (2018), obesity is a global health threat. In the United 
States obesity prevalence has reached 35% of the adult population (Bomberg et al., 
2017; Kroes et al., 2016; Kushner & Ryan, 2014). It is a known fact that obesity related 
comorbidities can decrease physical well-being, functionality and quality of life, as well 
as lead to mortality (ADA, 2019b; American Heart Association, 2018; Kroes et al., 2016; 
Kushner & Ryan, 2014; Ma et al., 2019; Rodriguez-Cristobal et al., 2017; Tang et al., 
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2016; Thabault et al., 2016; Welbourn et al., 2018). There is much evidence available 
as to how to treat obesity, however used separately there has been little impact on this 
growing epidemic. Obesity is a multifactorial chronic disease that is often accompanied 
by weight-related comorbidities, thus no one treatment will work for each person. This 
EBP Project combines multiple interventions into a personalized program that 
addresses obesity on an individual level based upon EBP and the patient’s needs and 
preferences. The project provides a program and simply accessed tools that can be 
easily adopted into any primary care setting.  
Data from the Clinical Agency Supporting Need for the Project 
 The clinical site chosen for this EBP Project is a clinic located in a low-
socioeconomic urban neighborhood in North East Indiana. The clinic mission is based 
upon the Gospel of Matthew: 25. They provide medical, vison and dental care as well as 
some laboratory services to the underserved population, many of whom are minority, 
who are economically disadvantaged and have no insurance. The care is free and 
includes a limited range of free pharmaceuticals as well as refurbished glasses and 
hearing aids. Referrals to specialists are made based upon need and availability of 
service providers. The key stakeholders for this project included: physicians, nurse 
practitioners (NP), staff nurses (RN), administrative staff, and volunteers, as well as the 
patients. The medical clinic is primarily staffed six days a week by volunteers and 
students other than the Medical Director, two NPs, two RNs and a few administrative 
staff.  
 There is a great need for this EBP Project as currently the clinic does not have a 
weight management program, other than basic diet information and occasional 
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volunteer nutritional counseling from dieticians.  Based upon available resources at the 
clinical site, as well as project participant resources and capabilities, some potential 
interventions that may produce weight loss may not be a possibility, such as: certain 
laboratory studies, bariatric referral or the use of some pharmacotherapies.  
Comparison group: A retrospective electronic medical record (EMR) review was 
conducted prior to initiation of this DNP EBP Project. Patient records were accessed 
with the permission of administration and the Medical Director for the use in this project. 
Reviewed records had a baseline date of January 2019 and were included in the review 
if the patient had a follow up appointment between 3 to 5 months later and the patient 
was at least 18 years old, and had at least one BMI greater than or equal to 30 kg/m2 , 
had a weight and consistent height provided for each visit. Patients were excluded if 
they were under 18 years old, the height was incorrectly measured and varied between 
visits (eg.5’2” and the next visit 5’5”) or in between visits time was not within then the 3 
to 5 months. A total of 25 EMRs were included in this retrospective. There were seven 
males and 19 females. The mean age was 46.96 (13.82) years. The mean baseline 
weight was 235.10 (54.21) pounds (lbs.) and mean BMI was 38.61 kg/m2 (7.18).  At the 
3 to 5- month follow up the group mean was 235.86 (55.36, p=.558) lbs. and mean BMI 
was 38.59 kg/m2 (7.31, p=.914). There was no significant change in weight or BMI. 
Attainment of a 3% total body weight loss goal was achieved by only 16% of those in 
the comparison group.  
Purpose of the Evidence-Based Practice Project 
The purpose of this project was to improve selected obesity indicators, including 
weight, body mass index (BMI), waist circumference, and waist-to-hip ratio, through the 
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implementation of an Evidence-Based multicomponent intervention tailored to individual 
patient strengths, barriers, and resources. In addition, a secondary aim was to 
determine if the weight loss intervention resulted in improvement in health outcomes 
related to obesity, including BP, HbA1c, lipids, as well as depression and anxiety 
symptoms. The intervention components varied by patient, but in general, options 
included diet and exercise education, tracking of caloric intake and exercise, lifestyle 
and behavioral counseling, pharmacotherapies, and referrals for psychotherapies and 
or bariatric evaluation when appropriate.  
PICOT Question 
 Specifically, this project addressed the following two-part PICOT question.  
Will the use of an evidenced based protocol for the assessment and treatment of obese 
patients assist adult patients with obesity to achieve better weight loss outcomes over a 
three month period compared to usual care as measured by primary outcomes of a 
reduction in BMI, waist circumference and waist to-hip ratio. And will the implementation 
improve secondary outcomes measured of BP, HbA1c, total cholesterol, HDL, LDL, 
triglycerides and the PHQ-9 and the GAD-7 scores.  
Significance of the EBP Project 
 The importance of this EBP Project is represented in reduced weight-related 
health risk in a patient population with obesity. Obesity is a global health risk that has 
nearly tripled since 1975 (WHO, 2018). The risks associated with obesity and weight-
related comorbidities can be life threatening and impact quality of life for the obese 
population. The impact of obesity is seen in poorer health, increased exacerbations of 
diseases, decreased mobility, decreased quality of life, and decreased productivity and 
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financial resources (Bomberg et al., 2017; Kroes, Osei-Assibey, Baker-Searle & Haung, 
2016; Jensen et al., 2014; Kushner & Ryan, 2014; WHO, 2018).  
Addressing the clinical problem 
 Obesity is a significant risk factor for comorbidities and mortality in the general 
population however it disproportionally effects those of reduced socioeconomic standing 
and the underserved population. Those are the people who are served by this clinical 
site. Currently this clinical site does not have a set protocol in place to address the 
problem of obesity. This project addresses this issue of obesity and weight-related risks 
through a multicomponent individualized tailored weight loss intervention program that 
is sustainable and can be simply accessed and utilized within the clinic.  
How this project can improve patient outcomes 
This EBP Project can improve clinical outcomes by improving overall population 
BMI and health risk as evidenced by improved BMI, BP, HbA1c, total cholesterol, HDL, 
LDL, triglycerides and PHQ-9 and GAD-7 scores. By improving BMI, BP, HbA1c, total 
cholesterol, HDL, LDL, triglycerides cardiovascular risk as well as those associated with 
elevated blood glucose and diabetes are reduced (ADA, 2019b; American Heart 
Association, 2018; Doig & Heuther, 2014; Kushner & Ryan, 2014; Triplett et al., 2014). 
Reduced PHQ-9 and GAD-& scores indicated improved mental health and wellbeing 
and can be directly associated with weight loss and improved BMI (Batsis et al., 2018; 
Bomberg et al., 2017; Kushner & Ryan, 2014; Ma et al., 2019)  
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CHAPTER 2 
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE 
Theoretical Framework 
After a careful and thorough review of the health promotion and disease 
prevention literature, the Pender Health Promotion Model was chosen to assist with the 
development and implementation of an intervention that was used in this Evidence-
Based practice (EBP) project. In this section, a succinct description of the Pender 
Health Promotion Model (Pender, 1982; Pender 2011) and an overview of how this 
model applies to this EBP project will be provided.  
Overview of Theoretical Framework 
The Pender Health Promotion Model (HPM; Pender, 1982; Pender, 2011) was 
developed by Nola Pender PhD, RN, FAAN, a Professor Emerita at the University of 
Michigan and a Distinguished Professor at Loyola University in Chicago, Illinois. The 
HPM was developed as a complement to existing models of health protection. In this 
theory, Pender states that each person has a unique set of experiences, beliefs, and 
attitudes that affect their willingness and ability to change detrimental health behaviors, 
such as consuming an unhealthy diet and exercising infrequently. This model was first 
presented in nursing literature in 1982 and was revised in 1996. The initial purpose of 
the model was to “assist nurses in understanding the major determinants of health 
behaviors, as a basis for behavioral counseling to promote healthy lifestyles” (Pender, 
1982, p.2; Pender, 2011, p. 2). This model recognizes that a person’s context – their 
experiences, feelings, emotions, resources, social barriers, etc. – impacts their health 
behavior.  
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Assumptions of the HPM are that:  
• People attempt to create living environments in which they can live to 
their personal health potential. 
• People are self-aware, thoughtful and able to evaluate their own 
capabilities. 
• People strive for positive growth and an equilibrium between change 
and stability. 
• People desire to determine their own behavior. 
• People interact with and within their environment, both changing over 
time through this interaction. 
• Health care providers are part of the person’s interpersonal 
environment throughout their life, impacting the person’s choices. 
• Behavioral change is managed through self-determined change in the 
person-environment interaction (Pender, 1982; Pender, 2011). 
Health promotion behavior is defined as the “desired behavioral end point or 
outcome of health decision-making and preparation for action” (Pender, 2011, p.6). 
Using the HPM the healthcare provider, working in a collaborative relationship with the 
patient, can assess and intervene to assist with behavioral and lifestyle changes to 
promote health. Assessment includes prior behaviors and attempts to change behavior, 
personal influences, barriers and benefits, self-efficacy and enjoyment of activities, 
social norms and social support, role models within the social network, influences, 
commitment to change, and competing demands or barriers to success. Based on their 
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assessment findings, the nurse intervenes to support the behavior change through 
education, role-playing, problem-solving, and removal of perceived barriers to change.  
In the model Pender theorizes that motivation is modified by specific behavioral 
variables and that the individuals’ behavior and outcome is determined by two 
interrelated paradigms: Individual Characteristics and Experiences, and Behavior 
Specific Cognitions and Affect. Examples of Individual Characteristics and Experiences 
that may impact the individual’s ability and desire to engage in health behavior change 
include whether or not they had previously attempted similar behaviors as well as 
biological, psychosocial or sociocultural factors supporting or preventing the 
intervention, such as: the individuals’ perceived self-efficacy, perceived benefit and 
barriers, interpersonal relationships, options and demand characteristics. All of these 
directly influence the individual’s commitment to the plan of action and health promoting 
behavioral changes and can be interrupted or curtailed by immediate competing 
demands or preferences.  
This model is applicable to this project as it provides a frame from which to 
develop motivational strategies to encourage weight loss in project participants. This 
model accepts that each person is an individual in which motivation to lose weight is 
heavily influenced by the life experiences specific to that person and to prior weight loss 
behaviors. Therefore, the ideal weight loss intervention will vary from one person to 
another based on whether and how they have tried to lose weight in the past, their 
perceived facilitators and barriers to weight loss, current lifestyle patterns, and 
comorbidities. Therefore, the use of a multicomponent, individualized approach to 
treatment may theoretically promote weight loss better than a more generalized (“one-
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size-fits-all”) approach. For example: some patients may prefer walking over group 
aerobic activities or use of the My Fitness Pal phone app instead of a paper journal to 
track caloric intake and exercise, or face-to face counseling rather than simple written 
instructions. If the patient’s preferences are not consistent with the recommended 
weight loss interventions, the HPM predicts that these interventions will not be as 
effective as they could be if they were more consistent with the patient’s preferences. 
Besides matching interventions to the patient’s preferences, perceived barriers 
and facilitators, and immediate competing demands, the HPM promotes patient self-
efficacy and autonomy. By individualizing the weight loss intervention and allowing the 
patient choices, consequently giving them ownership of their treatment and goals, self-
efficacy and autonomy are increased. When the person feels that they have the ability 
within themselves to lose weight, the HPM model predicts that they are more likely to 
change their weight-loss behaviors.  
In summary, the Pender HPM describes and explains which intrapersonal, 
interpersonal, and environmental factors ultimately predict a person’s ability to adopt 
health behaviors that result in weight loss. These predictive factors, which are unique to 
each person, serve as opportunities for the advanced practice nurse to design a weight 
loss management plan that are likely to result in weight loss success.  
Evidence-Based Practice Model: Purpose and Overview 
The model selected to guide this EBP project was the Johns Hopkins Nursing 
Evidence-Based Practice (JHNEBP) Model. In this section, the JHNEBP Model and how 
it applied to this EBP project will be described.  
Purpose of EBP Model 
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Like other models that have been used to guide EBP projects, the purpose of the 
JHNEBP Model is to provide direction to project leaders in integrating Evidence-Based 
interventions to solve real-world clinical problems (Dang & Dearholt, 2017). Using a 
multi-step and highly detailed approach to EBP adoption, the model supports the use of 
EBP as a core competency in nursing practice. Permission to use this model was 
obtained June 15, 2018 (Appendix B), from Johns Hopkins Medicine (2017).  
Overview of EBP Model 
The JHNEBP model is a three-step method that starts with Inquiry: the 
recognition and acknowledgement that a fixable problem exists in the health care 
environment. Inquiry involves critical thinking to identify the scope of the problem and to 
thoroughly assess the complete situation within the clinical setting, including the 
context, background, stakeholders and environment. Context refers to the 
circumstances in which the problem exists. Background refers to the events or situation 
that lead up to the problem. Discovering the background of a problem may lead to 
identification of gaps in what is known or done and what is unknown or not done. 
Stakeholders include all persons or entities that are affected by or have an interest in 
the problem. These can include: the patient, care giver, health care provider and or 
community. A stakeholder can also be a third party or parties such as insurance or 
government agencies. Environment refers to the surroundings or area in which the 
problem exists, such as: a clinic, hospital or the community.  
After the context, background, stakeholders, and environment are explored, the 
EBP Project Leader begins a three-part group of activities that consists of: 1) Forming a 
practice question (P), 2) Discovering best available evidence (E), and 3) Translation of 
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this evidence into the practice setting (T) (JHNEBP, 2017). The practice question 
guided the design of the EBP project and clarified which evidence to seek; therefore, it 
needed to be relevant, precise, accurate and provide clarity.  
Based on the practice question, evidence was obtained and evaluated for: study 
design/level, study quality, consistency and applicability. In this project, if the evidence 
was level III, IV or V or of low quality it was not used as it did not offer the high level of 
evidentiary support needed to provide EBP.  
Translation refers to converting the best available evidence into a useful and 
meaningful form that also incorporates professional experience and patient preferences 
(Dang & Deartholt, 2017). This can be difficult because even the highest level and 
quality of evidence may be met with translational incompatibilities with reality. 
Translation may require modification, education, development of a skill set, 
collaboration and a timeline compatible with the EBP intervention or practice 
improvement (Dang & Dearholt, 2017). If translation is initially unsuccessful, the EBP 
project team might return to the practice question or evidence steps to seek alternative 
approaches to use in translation. The “best practice” emerges when the translation step 
has been successfully completed, which then results in practice improvements that 
could focus on clinical, learning, or operational changes within the health care 
environment (Dang & Dearholt, 2017). The JHNEBP Model is pictorially depicted below 
(Figure 1.1) and demonstrates the cyclical quality that allows for change, further inquiry, 
evidence and translation in practice and learning.  
Figure 1.1 
The Johns Hopkins Nursing Evidence-Based Practice Model (2017) 
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_____________________________________________________________________ 
 
(The Johns Hopkins Nursing Evidence-Based Practice Model, 2017). 
Model and tools used with permission from Johns Hopkins Hospital and The 
Johns Hopkins University (Appendix B).  
______________________________________________________________________ 
Application of EBP Model to DNP Project 
This EBP project was concentrated on improving obesity-related patient 
outcomes at a free clinic in an underserved community in Northeast Indiana. Weight 
management had been identified by the practice as one of the challenges faced by the 
patient population at this site. Current interventions being utilized have not produced 
significant weight loss, improvement in comorbidities, health promotion or risk reduction. 
The uncertainty of how best to promote weight loss in this population served as the 
genesis for this project. Research shows that obesity is a multifactorial chronic disease 
that is exquisitely difficult to manage in the primary care setting (Bomberg et al. 2017; 
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Kushner & Ryan, 2014; Thabault, Burke & Ades, 2016). Moreover, the factors that 
cause obesity in one person may not be the same as those that cause obesity in 
another person; a “silver bullet” approach to obesity management is therefore unlikely to 
be effective.  
Because this project deals with a complex clinical problem that exists within a 
multifaceted system consisting of the person, their primary care provider, and unique 
environmental nuances from one person to the next, it may take several attempts to 
arrive at the “best practice” for patients (Eaton et al., 2017; Hartman et al., 2014; 
Kushner et al., 2014). With its cyclical approach to identifying best practices, the 
JHNEBP Model is congruent with finding a solution to the problem of obesity. This 
section will describe how each of the steps of the JHNEBP Model will be used in the 
current EBP project. 
 Inquiry. The first step in the JHNEBP Model is to inquire about the clinical 
problem, gaining all pertinent information. In this project, the clinical problem is weight 
management among the patient population who have obesity defined as a BMI of > 30. 
Many of these patients have significant health risk and weight related comorbidities 
including hypertension, Diabetes Mellitus type II (DMII), hyperlipidemia, depression and 
or anxiety.  
Initial inquiry took the form of anecdotal observations made by the EBP Project 
Leader and a meeting with key stakeholders at the Matthew 25 Health and Dental 
Clinic. During the observations and meetings, it was noted that a high proportion of 
adult clinic patients were obese, no protocol was in place to address obesity at this 
clinic, the dietician services were provided by volunteers and only available a few times 
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a month, weight loss educational resources were very limited and staff was only able to  
provide limited education and coaching for weight loss. Based on these initial findings, a 
retrospective electronic medical record (EMR) review was conducted prior to initiation of 
this DNP EBP Project. With permission from the Medical Director and administration, 
patient records were accessed for the use in this project. Reviewed records had a 
baseline date of January 2019 and were included in the review if the patient had a 
follow up appointment between 3 to 5 months later. Inclusion criteria included patients 
who were at least 18 years old, had at least one BMI greater than or equal to 30 kg/m2, 
and had a weight and consistent height provided for each visit. Patients were excluded 
if they were under 18 years old, the height was incorrectly measured or varied between 
visits (eg.5’2” and the next visit 5’5”) or did not have recorded visits 3 to 5 months from 
baseline. A total of 25 EMRs were included in this retrospective. Demographics included 
seven males and 19 females, a mean age of 46.96 (13.82) years. The mean baseline 
weight was 235.10 (54.21) pounds (lbs.) and mean BMI was 38.61 kg/m2 (7.18).  The 3 
to 5-month follow up group mean was 235.86 lbs. (55.36, p=.558) and mean BMI was 
38.59 kg/m2 (7.31, p=.914). There was no significant change in weight or BMI. 
Attainment of a 3% total body weight loss goal was achieved by only 16% of those in 
the comparison group.  
Based on the observations at this clinic it was clear that obesity affected a near-
majority of adult clinic patients, obese patients were generally open to assistance with 
weight loss, and that the clinic staff could do more to facilitate and promote weight loss 
in this population.  
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Practice Question. After confirming with clinic staff that they would like to learn 
more about how to help patients with obesity manage their weight, an EBP project 
question was developed using the PICOT criteria. First, clinic staff wished to focus on 
weight management in the adult population, regardless of age, sex, race, ethnicity, 
comorbidities, or socioeconomic characteristics. Second, clinic staff were open to a 
variety of interventions that focused on lifestyle changes, the use of medications, and 
referrals to other team members (e.g. behavioral health, dietician). However, because of 
the type of patient population, referral to bariatric specialist could not be a consideration. 
They were agreeable to reasonable modifications in their workflow but hiring additional 
staff to support the intervention was not going to be an option. Therefore, the 
intervention had to be something that the current staff mix at the clinic could implement 
within their collective scopes of practice. Third, the comparison group would need to be 
a retrospective sample who received routine education and follow-up about obesity, as 
described above. Fourth, the outcomes for this project needed to include BMI (and 
therefore weight), but clinic staff were also interested in other health-related secondary 
outcomes such as blood pressure, glycosylated hemoglobin, and symptoms related to 
anxiety and depression. Finally, the time frame for the project was restricted to 6 
months (September 2019 to March 2020) with targeted changes in the primary outcome 
expected within 3 months of starting the intervention.  
These suggestions from the clinic were used to form the initial PICOT Practice 
Question for the JHNEBP Model: Primarily, will obese adult patients participating in a 
multicomponent tailored weight loss intervention achieve greater reductions in weight, 
BMI, and waist circumference, than those receiving the current standard of care over a 
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three month period? In addition, clinic staff expressed a strong desire to manage 
obesity-related comorbidities as part of the project. Therefore, the effect of this 
multicomponent tailored intervention on blood pressure, glycosylated hemoglobin, 
anxiety symptoms, and depression symptoms was explored over a three-month period.  
 Evidence. To determine which intervention(s) to implement, the literature about 
obesity and weight management in primary care was thoroughly reviewed using the 
strategy and methods described in the section entitled, “Literature Search”. Sources 
were appraised using the JHNEBP Appraisal System (Dang & Dearholt, 2017), which 
provided a tool to evaluate the quality and strength of evidence. Intervention(s) with the 
strongest supporting evidence, and that were also feasible within the clinical site, were 
implemented in this EBP project as part of a tailored multicomponent weight loss 
program  
Evidence applicable to this EBP Project encompassed multicomponent 
interventions. According to the evidence, including that provided by the US Preventive 
Task Force (LeBlanc et al., 2018) effective weight loss intervention should consist of a   
multicomponent approach that addresses diet, aerobic and resistance exercise, lifestyle 
modifications, and behavioral counseling. General principles that should underpin all 
weight loss recommendations include: 
• Diet – Lean protein, low-fat dairy, unsaturated fats, whole grains, colorful 
fruits and vegetables, leafy greens. Overall calorie reduction is 
emphasized. 
• Exercise – Aerobic exercise (at least 150 minutes per week of moderate-
intensity exercise over at least 4 or 5 days). Resistance exercise (at least 
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2 days per week of moderate-intensity resistance exercise using 
machines, free weights, or resistance bands).  
• Lifestyle Modification - Making healthy food choices, eating at meal-time 
and enjoying healthy snacks, limiting alcohol consumption and empty 
calories, setting achievable goals and tracking progress through 
journaling, logs or food and activity tracking technology. Practicing healthy 
sleep and hygiene habits in order to promote a well-rested state to reduce 
food cravings.  
• Behavioral Counseling - Assist with the patient’s development of a 
sense of self-efficacy and autonomy through motivational counseling in 
which the patient makes choices, sets and achieves goals. Assessment 
for and treatment of depression and anxiety, with referral to psychiatry if 
needed. Use of antidepressant/ antianxiety medications if warranted 
(Batsis et al., 2016; Beeken et al., 2017; Curry et al., 2018; Eaton et al., 
2016; Grossman et al., 2017; Hageman et al., 2017; Hartman et al., 2014; 
Kozica et al., 2015; Kroes, Osei-Assibey, Baker-Searle & Huang, 2016; 
Jensen et al., 2014; Kushner & Ryan, 2014; Samdal et al., 2017) 
• Additional interventions supported in the literature include use of 
motivational interviewing (Rodrguez-Cristobal  et al., 2017; Szczekala, 
Wiktor, Kanadys & Wiktor, 2018; Thabault  et al., 2016; Welbourn  et al., 
2018), written education tools (Beeken  et al., 2017; Thabault  et al., 
2016), phone counseling (Harrigan  et al., 2016; Hartman  et al., 2014), 
electronic media or internet based intervention (Beeken  et al., 2017; 
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Hageman  et al., 2017) and or activity tracking technology such as a FitBit 
® Garmin® or AppleWatch ® or use of an app such as MyFitnessPal® 
(Cheatham, Stull, Fantigrassi & Motel, 2017; Tang, Abraham, Greaves & 
Nikolaou, 2016).  
Translation. Translation of evidence can be a challenge because a given 
Evidence-Based practice may not be feasible within a particular clinic context or 
circumstance. Therefore, careful attention was paid to determining, along with input 
from clinic staff and patients, which EBP interventions are feasible for this project. This 
was completed via meetings with clinic staff and the EBP Project Leader, as well as 
during clinic appointments with patients, in which feasibility of the interventions was 
determined and an action plan was formulated. Further translation included 
implementation of the action plan and evaluation of outcomes as well as determining 
any future steps such as: modification to the individual weight loss intervention plan(s) 
and or modification(s) to the implementation of the weight loss intervention plan within 
the clinical setting (Dang & Dearholt, 2017). Additionally, results of this project will be 
disseminated through a published EBP Project Report and as a poster and podium 
presentation at a regional or national nursing conference.  
Best Practice. According to Dang and Dearholt (2017), it may take several 
iterations of the P-E-T process to get it right. After the Practice-Evidence-Translation 
process successfully identified a version of the Evidence-Based intervention(s) that 
works best at the clinical site, this was referred to as the best practice for weight 
management in adult patients with obesity who seek care at this clinical site. The best 
practice that results intentionally included multiple potential interventions that could be 
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implemented for a patient, based on their unique circumstances, abilities, resources, 
and perceived barriers to weight management. 
Practice Improvements. The most important clinical practice improvements resulting 
from this project included a standardized process for identifying, teaching, and 
supporting adult patients with obesity, which had to date been a significant challenge for 
clinical staff. Additional clinical practice improvements included: easily accessible 
standardized web-based assessment tools and better implementation of obesity 
assessment and treatment protocols. Improvements in learning included easily 
accessible standardized web-based educational materials for patients and staff. 
Operational improvements included the development or revision of clinic policies and 
procedures regarding obesity management, improved patient satisfaction with clinical 
care, and improvement in objective measures of care quality related to chronic disease 
management.  
Strengths and Limitations of EBP Model for DNP Project 
The JHNEBP Model has been used to guide numerous EBP projects in nursing 
since its inception, and it has several important strengths compared to other EBP 
translation models for this particular EBP project. First, the model assumes that nursing 
is a science and a profession. Some other models, such as the Iowa Model for 
Evidence-Based Practice and the Stetler Model do this as well, but many, including the 
Rogers’ Model of the Diffusion of Innovations and the Kotter and Cohen’s Model of 
Change do not (Dang, Melnyk & Fineout-Overholt et al., 2015; Melnyk & Fineout-
Overholt, 2015). This is an important strength for this project because the JHNEBP 
Model focuses on collecting evidence to answer the inquiry and questions as well as 
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support interventions. All of the interventions that had the potential to be utilized within 
this EBP project had science and evidentiary support that they were effective.  
The JHNEBP Model is further strengthened by the precision and usefulness of its 
overall structure, which consists of 19 unique steps that served as guideposts for the 
EBP Project Leader and team. This ensures a systematic approach to solving problems 
in the clinical setting, particularly for novice EBP project leaders. Moreover, clinical sites 
that are not experienced with the EBP project “process” can use the steps of the 
JHNEBP Model to increase staff engagement and anticipate process barriers so that 
the clinic could sustain the practice changes after the project ended.  
A third major strength was the longevity of the Johns Hopkins Nursing Evidence 
Appraisal Tool, which has been extensively revised, used, and published over the past 
decade. Having a rich history of guiding EBP projects in nursing, this tool has 
demonstrated its utility and effectiveness at distinguishing between high-quality and low-
quality evidence.  
For this particular project, which focused on obesity management, being able to 
identify the best available evidence was paramount for two important reasons: First, 
weight loss is remarkably difficult, largely due to patient nonadherence to a 
recommended weight loss regimen (Eaton et al., 2016; McLaughlin et al., 2017; 
Perreault, 2019b). Therefore, clinicians who prescribe weight management interventions 
must be able to defend the components of their weight loss prescription using sound 
evidence that patients can trust. Second, primary care providers report that obesity 
management is extremely challenging (Eaton et al., 2016; Hageman et al., 2017, 
Kushner & Ryan, 2014; McLaughlin, 2017; Pollak et al., 2016). A variety of fad diets, 
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weight loss supplements, and other “lose weight quick” schemes are promoted through 
social media outlets and other sources of consumer information. These approaches to 
weight loss are difficult to maintain due to high cost, being over-restrictive, or being 
ineffective, and this can lead to patients feeling dissatisfied with the weight loss 
experience. Adopting Evidence-Based weight loss practices in the primary care setting 
may help clinicians to feel better prepared to teach patients which weight loss strategies 
are effective and which ones are not.  
 Limitations of the model  
 The Iowa Model of EBP to Promote Quality Care provides guidance for clinicians 
when making practice decisions that affect patient outcomes. This model encourages 
the identification of ‘triggers’ - practice questions stemming from clinical problems or 
new knowledge. These triggers initiate change originating at the top level and will 
potentiate systematic research and team forming. This model has specified decision 
points at which further investigation and evaluation may take place that is again 
potentiated from the top level down (Dang, Melnyk & Fineout-Overholt et al., 2015). The 
team aspect of this model would be beneficial when promoting practice change.  
 The Stetler Model initiated the term evidence in1976 and has since expanded the 
term to substantiating evidence. This model utilizes a five-step approach to acquire and 
utilize research to facilitate EBP. The steps consist of preparation, validation, 
comparative evaluation and decision making, translation and application and a final 
evaluation. One progresses through the steps by completing the associated tasks and 
moving on to the next level. The user does not return to the beginning of the process, 
should a change be needed but rather continues to move forward. This is unlike the 
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JHNEBP model in which the user may progress in a circular pattern in which further 
investigation and potential research may provide an alternative approach should 
evaluation show that a change in plan is required. This is a weakness of the Stetler 
Model as this model considers evidence in a use /do not use format in either informal or 
formal interventions or protocols in a rigid path that does not provide for alterations. This 
model can be utilized by the individual practitioner unlike the Iowa model (Dang, Melnyk 
& Fineout-Overholt et al., 2015).  
 In summary, the JHNEBP Model provided a cyclical step approach to EBP that 
included inquiry, development of a practice question, research and finding evidence, 
translation of evidence into practice, best practices, and finally practice improvements. 
This process was developed specifically for nursing and allows the novice researcher to 
utilize its cyclical approach and path to the EBP implementation process that can be 
altered as new information or questions arise, utilizing evidence obtained from scientific 
inquiry to promote best practice.  
Literature Search 
Sources Examined for Relevant Evidence 
 An extensive and comprehensive literature review was completed in order to 
support inquiry and to determine best practice for this EBP project. This included a 
search of five databases in addition to citation chasing. Evidence was sought out using 
CINAHL, MedLine via EBSCO, Joanna Briggs (JBI), PubMed and the Cochrane Library. 
In addition, citation chasing was utilized to discover relevant evidence from articles that 
were found in the online databases listed above. The CINAHL, MedLine via EBSCO, 
and PubMed databases were selected due to their extensive volume of health-related 
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research articles and rapid access to high levels of evidence. The Joanna Briggs 
Institute database and the Cochrane Library were selected due to the evidence 
summaries and systematic reviews accessible through these resources. The expertise 
of a health resources librarian was sought to further strengthen the literature review for 
this EBP project.  
The literature search had several criteria for inclusion: articles published within 
five years, adult population, English language, human subjects, study tested an 
intervention to treat obesity in a primary care setting, and evidence was level I or II and 
of high or good quality. Articles were excluded if: study focused on weight loss for a 
condition other than obesity (e.g. type 2 diabetes mellitus, polycystic ovarian syndrome); 
the target population included children, pregnant women, or neonates; or the main 
intervention tested was irrelevant to the primary care setting (e.g. bariatric surgery). 
Results of the literature search are summarized in Tables 2.1 and 2.2. 
Table 2.1 
Literature Search Summary 
______________________________________________________________________ 
Database Key search words or phrases 
 
Limiters 
 
 
CINAHL 
 
obesity  
 
AND intervent* OR treat*  
 
AND “weight loss” OR BMI OR “waist 
circumference” OR “body fat”  
 
AND “primary care” OR “primary 
health care” OR “primary healthcare” 
 
 
01/01/2016-06/30/2019; 
scholarly peer-reviewed; 
English language, human, 
and Adult >19 years 
 
Boolean phrase 
 
Cochrane 
library 
obesity 
intervent* 
“weight loss” 
01/01/2016-06/30/2019 
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JBI obesity 2016-2019 
 
MedLine via 
EBSCO 
obesity  
 
AND intervent* OR treat*  
 
AND “weight loss” OR BMI OR “waist 
circumference” OR “body fat”  
 
AND “primary care” OR “primary 
health care” OR “primary healthcare” 
 
01/01/2016-06/30/2019; 
scholarly peer-reviewed; 
English language, human, 
and  
Adult >19years 
 
Boolean phrase 
 
PubMed obesity AND intervent* OR treat* 
AND “weight loss” OR BMI OR “waist 
circumference” OR “body fat” AND 
“primary care” OR “primary health 
care” OR “primary healthcare”  
01/01/2016-06/30/2019; 
English language, human, 
and Adult >19years 
 
 
______________________________________________________________________ 
Table 2.2 
Evidence Search Table 
______________________________________________________________________ 
       Database             Yielded            Duplicates            Reviewed            Accepted 
   
CINAHL 
 
52 42 12 2 
Cochrane 
 
12 3 2 6 
JBI 
 
26 0 1 0 
MEDLINE via 
EBSCO 
 
156 139 34 5 
PubMED 
 
311 147 47 1 
Citation 
chased 
4 0 4 2 
 
Total 561 331 100 16 
 
 
Evidence Appraisal 
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 Evidence was appraised for strength and quality using the JHNEBP Evidence 
Appraisal Tools (Appendix C) (Dang & Dearholt, 2017; Johns Hopkins Medicine, 2017).  
Levels of Evidence 
 The level of evidence for a source was determined by the study design that was 
used in that source. For example, Level I evidence consists only of meta-analyses, 
systematic reviews, and randomized controlled trials. Level II evidence consists of 
quasi-experimental designs (e.g. cohort, case-control). Level III evidence consists of 
nonexperimental designs (e.g. descriptive, qualitative). Level IV evidence consists of 
methodically developed guidelines from nationally known experts based upon research 
or expert panel consensus. Finally, Level V evidence consists of a synopsis of 
published literature without methodically appraisal of evidence. A summary of the 
appraisal criteria is provided in Table 2.3. Evidence at Levels I through II were used in 
this EBP project.  
Appraisal of Relevant Evidence 
The Johns Hopkins Nursing Research Evidence Appraisal Tool (Appendix C) 
was also used with permission (Appendix B) to evaluate the quality of each source. 
Once the level of evidence was determined as level I, II or III, the quality was rated as 
high, good or low: 
• High quality evidence was consistent, had results that were transferable, 
with an adequate study design, sample size, a sufficient control, and was 
able to provide conclusions. They contained fully inclusive literature review 
with references to scientific evidence and provided recommendations that 
were consistent with their findings.  
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• Good quality evidence that was consistent with results, an adequate 
sample size, use of a control, conclusions that were well defined and fairly 
decisive, recommendations based upon a relatively inclusive literature 
review with mention to some scientific data.  
Low quality evidence had samples that were insufficient in size, provided minimal 
evidence with inconclusive results that provided little or no conclusions based upon the 
work (Dang & Dearholt, 2017; Johns Hopkins Medicine, 2017). A PDF copy of the 
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool is 
found in appendix C.  
The level of chosen evidence are described in Table 2.3.  
Table 2.3 
Levels of Evidence 
______________________________________________________________________     
             Level                        Included                      Quality                      Design 
I 11 High SR (1) 
SR with MA (2) 
RCT (8) 
I 1 Good RCT (1) 
II 3 High SR (2) 
Quasi-exp. (1) 
II 1 Good SR (1) 
______________________________________________________________________ 
The evaluated works were of either level I or level II and of good or high quality. There 
were eleven sources that were level I and high quality (3 systematic reviews, 8 
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randomized controlled trials), one randomized controlled trial that was level I and good 
quality and two systematic reviews that were level II and high quality. 
Levels of Evidence 
Level I evidence. A systematic review (SR) completed by Batsis and colleagues 
(2016) looks at obesity interventions that can be used with older adults in the clinical 
setting. This systematic review of 6 online databases included randomized controlled 
trials published between January 2005 and October 2015. Interventions focused on 
behavior changes that lasted at least six months. Control groups varied but included 
routine care from a health care practitioner/physician, usual care, no exercise, and or 
use of a technological device. Primary outcomes measured were quality of life, weight 
loss, and physical activity. Weight loss was included as a component of each RCT.  
The range of weight loss was 0.5 to 10.7kg (0.1 to 9.3% of baseline body 
weight). The greatest weight loss was obtained from programs with both a diet 
intervention and an exercise intervention, rather than exercise alone. Combined diet 
and exercise also significantly improved quality of life and physical function. This study 
provides evidence that supports the use of obesity interventions, including diet and 
exercise, to reduce weight, improve physical function, and improve quality of life in the 
geriatric population.  
Beeken and colleagues (2017) presented evidence from a two-arm, multi-site, 
randomized controlled trial (RCT) that tested the effect of a self-guided “Ten Top Tips” 
(10TT) leaflet about weight loss, a logbook for documenting weight loss behaviors, and 
an initial consultation with a nurse, on weight, BMI, total cholesterol, blood glucose, and 
self-reported weight loss behavior, compared to usual primary care. At three months, 
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patients in the intervention group lost significantly more weight than the control group 
(mean difference = -0.87 kg, 95% CI -1.47, -0.27, p = .004). This weight loss was 
maintained over 24 months, but it was not significantly different than the group that 
received usual care. Furthermore, Beeken and colleagues (2017) reported statistically 
significant reductions in waist circumference, BMI, and systolic blood pressure, and 
statistically significant increases in self-reported weight loss behavior, at 3 months after 
the intervention, but there was no change in total cholesterol or blood glucose.  
Based on these findings, authors reported that the 10TT leaflet was effective for 
short term weight loss, reduction in systolic blood pressure, and increased use of weight 
loss habits in the primary care setting. It was found to be a low-cost option to use in 
primary care, with an average cost around $32 per intervention (leaflet, logbook, and 
nurse consultation) This report provides support for the use of written behavioral change 
and education materials as a weight loss intervention that could be incorporated into a   
multicomponent weight loss intervention and this EBP Project.  
Limitations of the study included use of literature as old as 2005; some studies 
reviewed focused on diet only or lacked an exercise component, studies did not focus 
interventions in primary care; pharmacological and surgical therapy were omitted from 
the study. A quality rating of high was applied to this report due to clear statement of 
purpose, comprehensive and reproducible strategies; use of Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) criteria to reduce bias and 
increase transparency; use of empirical evidence; use of pilot study to provide 
consistency; details of studies and consistent result interpretation and generalizability.  
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Eaton and colleagues (2016) conducted a RCT over 24 months within a 
socioeconomically disadvantaged community in Rhode Island. The purpose was to test 
a tailored lifestyle intervention addressing obesity within the obese population in primary 
care with the goal of assisting weight loss and increase physical activity. Participants 
who were referred through primary care were randomized into one of two groups: 
enhanced intervention (EI) (n=106) or standard intervention (SI) (n=105). All participants 
received three face-to-face weight loss meetings. The EI group was also provided 
individualized telephone counseling and tailored printed and electronic media tools that 
focused on diet and exercise. The interventions were tapered after the first year of study 
participation. Anthropometric measurements and resting heart rate and blood pressure 
were obtained at baseline and at 6, 12, 18, and 24 months. The 7-day Physical Activity 
Recall Questionnaire and a ten-minute treadmill were used to assess participants’ 
perception of moderate physical activity.  
Results generally showed weight loss was greater in the EI group versus the SI 
group at 6 months (37.2% and 12.9% respectively; p<.01) and at 12 months (47.8% and 
11.6% respectively; p<.01), but not at 18 months (31.4% and 26.7% respectively; p=.64) 
or at 24 months (33.3% and 24.6% respectively; p=.39). The EI group reported a 
significant increase in the number of minutes in which they engaged in physical activity 
at 6, 12, 18, and 24 months (95.7, 126.1, 103.6, and 101.3 respectively versus 67.9, 
73.7, 63.3 and 75.0 respectively; p = .10, .002, .02, and .12 respectively).   
This RCT (Eaton et al., 2016) is of high quality due to its strengths of 
consistency, translation and generalizable results, and definitive conclusions. Methods, 
study design and interventions are clearly defined and address the purpose of 
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evaluating a tailored intervention to promote weight loss and increase activity in the 
obese population. Statistical analysis was completed using ANOVA. Prior to the study, 
needed sample size was determined with 104 participants needed (  =0.05) for each 
arm. This study provided results that were encouraging but it also had limitations 
including: only one geographic area; participants from related practice may have biased 
results; mainly female participants; use of self-reporting that may have skewed 
reliability; multiple modes of intervention delivery- DVD, printed materials and 
telephone; and attenuation of participants. The results provided support for the use of a 
tailored lifestyle intervention including face-to-face, telephone and or electronic media 
interventions for the treatment of obesity.  
Hageman and colleagues (2017) completed a three phase, 30 month long RCT 
with the primary objective of comparing three weight loss interventions: web-based only 
(WO), web-based with peer-led discussion (WD), and web-based with professional 
email counseling (WE). Secondary goals included: improvements in healthy eating, 
activity, blood pressure and lipids. The study focused upon women living in a rural 
community. Phase I lasted from baseline to six months and included guided weight loss 
using one of the experimental treatments (WO, WD, or WE). In Phase I, all subjects had 
access to web-based diet and exercise recommendations, a weight loss plan, a diet and 
exercise log book, a pedometer, weekly goal-setting sessions, and weekly feedback. In 
addition, the WD group had access to a peer discussion board and the WE group had 
access to the peer discussion board, professional email counseling, feedback about 
their discussion board postings from a member of the research team, and scheduled 
reminders about their weight loss program. Phase II lasted from 6 to 18 months. During 
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this phase, all participants completed weekly weight logs, tracked diet and exercise, and 
received online feedback. In addition, the WD group had biweekly peer-led online 
discussions for the first 12 months. Phase III lasted from 18 to 30 months. During this 
phase, all subjects were encouraged to continue tracking diet and exercise, set goals, 
and receive online feedback. In addition, the WD group had access to the peer 
discussion board, but there was less input from the research team than before. The WE 
group continued to have email consultation available, but only at the participant’s 
request.  
Results showed that there was statistically significant weight loss in the WO, WD, 
and WE treatment groups at 6 months (5.1 kg, 4.1 kg, and 6 kg, respectively). However, 
this weight loss was not sustained beyond 6 months, and participants regained 
approximately half of the weight lost by 30 months. There were no differences in weight 
loss between groups, suggesting that the discussion boards and email coaching did not 
significantly impact weight loss more than the web resources alone. There was no 
significant improvement in secondary outcomes (waist circumference, daily caloric 
intake, minutes of moderate intensity activity, blood pressure, total cholesterol, HDL, 
LDL, triglycerides, and fasting glucose).  
This study suggests that the use of web-based resources, with or without 
supplemental interventions, can facilitate short-term weight loss in women with obesity. 
However, this weight loss may not be sustainable beyond 6 months, and there was no 
clinically or statistically significant improvement in obesity-related clinical outcomes. 
Strengths of this study that led to the high quality rating included: design -three arm trial 
of web-based interventions and web-based interventions with enhancements with 
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adequate control; sufficient sample with a large cohort of participants-n=301; three 
phase time table of 30 months; use of EBP and standardized methods with established 
validity such as- Actigraph Accelerometer to track activity and the 1998 Block Health 
Habit and History Questionnaire to assess behavioral measures; conclusions based 
upon results that countered expected outcomes; clear, consistent and generalizable 
results. Though conclusions were based on results of the study and statistical data was 
presented, one of the limitations of the study was the absence of methods of analysis. 
Other limitations included: a sample of primarily female women of high socioeconomic 
background; unknown reason for missing data/observations; nonsignificant weight loss 
data for participants who did and did not complete program at 18 months; contamination 
and sharing data between group members living in same region; and varying level of 
engagement in program.  
Harrigan and colleagues (2016) conducted a six month long, three-arm RCT at 
Yale University. The study compared the effects of in-person counseling, telephone 
counseling, or usual care on the following variables: BMI, body fat percentage, lean 
body mass, bone mineral density, waist and hip circumferences, physical activity, 
dietary intake, and obesity-related biomarkers (C-reactive protein, insulin, leptin, 
adiponetcim, interleukin-6, tumor necrosis factor alpha, and blood glucose). Subjects 
received individualized weight loss counseling in a graduated fashion (weekly for 1 
month, then every 2 weeks for 2 months, then monthly for 3 months). Dietary 
counseling focused mainly on calorie reduction through reduced fat intake, a plant-
based diet, and mindful eating practices. Physical activity counseling focused on home-
based moderate-intensity activity for at least 150 minutes per week and reducing 
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sedentary activity. Usual care consisted of a brochure about nutrition and physical 
activity, along with a two-session weight management program if desired.  
At six months, subjects in either of the experimental treatment groups had 
statistically significant reductions in weight, waist circumference, hip circumference, 
dietary intake from fat, and C-reactive protein, and statistically significant increases in 
physical activity, fiber intake, and servings of fruit and vegetables per day, compared to 
subjects in the usual care group. Weight loss was 6.4% in the in-person counseling 
group (p=.004), 5.4% in the telephone-counseling group (p=.009) and 2.0% in the usual 
care group (p=.46). There was no statistically significant change in percent body fat, 
lean body mass, bone mineral density, sugar intake, or concentrations in insulin, blood 
glucose, leptin, adiponectin, IL-6, or TNF-α in any group. These results suggest that 
either in-person or telephone-based counseling sessions are more effective than printed 
weight-loss information alone for managing obesity. This RCT’s purpose was to 
examine the effect of in-person versus telephone counseling versus usual care for the 
treatment of overweight/obesity in a female population having survived breast cancer 
(Harrigan et al., 2016). Strengths of this study that determined the high quality rating 
included: use of a design phase estimated sample size of 30 to provide a 93% power to 
detect 3.5kg in weight change between control and intervention groups; use of 
Permuted block randomization; use of SAS (9.3) PROC MI for data computations -
statistical significance set at p<.05 using two-sided tests; population sample and 
methods consistent with the purpose and clearly stated including a control group; 
interventions adapted from the Diabetes Prevention Program and 2010 US Dietary 
Guidelines using the American Cancer Society nutrition and physical activity guidelines; 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
 
46 
 
and weight loss counseling performed by registered dieticians with specialty 
certification. Limitations of the study were: a 15% attrition rate; lower compliance rate 
among telephone counseling group; use of self-reporting of activity and use of a 
pedometer which may affect accuracy; lack of diversity in population studied may affect 
generalizability; possible recruitment bias.   
Kozica and colleagues (2016) conducted a two-arm RCT in 42 rural and 
socioeconomically disadvantaged Victorian communities in Australia, between 2012 and 
2013. The aim of the trial was to evaluate the Healthy Lifestyle Program for women 
(HeLP-her) program, which focused on making small sustainable lifestyle and 
behavioral changes. There were two arms of the trial: the control group consisted of 20 
towns (n=301) and the intervention group consisted of 21 towns (n=348). Both groups 
received a face-to-face education session focused on national obesity management 
guidelines. The intervention group also received a program manual, telephone 
coaching, and text messages to strengthen program content and accountability. The 
primary outcomes were weight and BMI, which were measured at baseline and at the 
end of 1 year.  
Results indicated that subjects in the HeLP-her intervention group lost 0.92 kg 
more than subjects in the control group (95% CI -1.67, -0.16) in 1 year. There was high 
participant satisfaction with the program, particularly with regards to coaching by either 
face-to-face or text messaging, compared to telephone coaching or use of a program 
manual. These results suggest that a weight loss program focused on small sustainable 
lifestyle changes can result in weight loss over a 1-year period.  
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This high quality RCT utilized a mixed methods approach in this large scale 
obesity prevention trial that targeted a population at risk (Kozica  et al., 2015). This 
mixed methods approach consisted of qualitative data use and analysis as well as 
quantitative data collection methods including: questionnaires, tools and checklists to 
increase generalizability. In order to close knowledge gaps the study chose a variety of 
interventions and delivery modes. Limitations of the study included: lack of independent 
oversight of checklists that were conducted by research staff; lack of evaluation of 
fidelity of motivational interviewing; lack of data collection of delivery modes for lifestyle 
modification. Using multiple interventions such as: education, goal setting, behavioral 
self-management, action planning, addressing barriers, problem solving and relapse 
prevention skills, this report addresses the purpose and proposed interventions of this 
EBP Project. 
Ma and colleagues (2019) completed a twelve-month long RCT in California. The 
purpose was to evaluate the effect of concurrent treatment for obesity and depression 
on weight loss. All participants of the control group and the intervention group received 
usual care from their physician as well as information about obesity and depression 
management and wireless physical activity tracking technology (i.e. a pedometer). 
Subjects in the intervention group also received a 12-month intervention that included a 
behavioral weight loss counseling intervention, problem-solving therapy, and 
antidepressant medications, if indicated. The primary outcomes for this study were BMI 
and severity of depression symptoms, which was measured using the Depression 
Symptom Checklist (SCL-20). 
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After 12 months, the BMI of subjects in the intervention group decreased by 0.7 
kg/m2, compared to no change in the control group (95% CI -1.1, -0.2; p = .01). In 
addition, depression severity improved significantly in the intervention group compared 
to the control group (95% CI -0.4, 0; p = .01). These findings suggest that a 
multicomponent care intervention that focuses on both obesity management and 
depression management may lead to improvements in both. The purpose of this high 
quality RCT was to test the hypothesis that integrated collaborative intervention would 
improve depression and obesity over a 12 month time frame as compared to usual care 
(Ma et al., 2019). Strengths included: closing the knowledge gap by becoming the first 
and largest RCT of its kind; findings were based on results of the study and were 
generalizable; sufficient sample size and timeframe; use of a control group; use of 
validated testing methods-SCL-20 depression symptom checklist; statistical analysis 
completed using linear mixed-effects models to a 95% CI, p-values obtained from 
general least square models adjusted for baseline value of outcome, and randomization 
of covariates. Limitations of the study were identified, addressed and included: omission 
of a formal literature review; limited geographical region in Northern California; 
homogeneous high socioeconomic sample; missing data (2% of weight, 9% of SCL-20 
at 6 and 12 months); BMI data included from EMR or self–report; drop out data may 
have skewed results; continuity of care from other clinical sites would not have been 
captured in data. The results support the use of behavioral interventions including 
problem solving, and goal setting to promote modest weight loss and lends support to 
this EBP Project.  
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Rodriguez-Cristobal and colleagues (2017) conducted a 24 month long, 
multicenter, cluster RCT between 2008 and 2010. The purpose of which was to 
discover whether motivational interventions combined with current practice resulted in 
greater weight loss than usual care for the treatment of obesity. Both groups had visits 
with their primary care provider every three months, received basic weight loss advice 
about diet and exercise, caloric reduction (1200 to 1500 kcal per day), and an exercise 
plan. In addition, subjects in the intervention group received a motivation intervention 
consisting of graduated visits with trained nurses every 15 days during weeks 1 to 12 
followed by monthly sessions during weeks 13 to 32.  
Subjects in the intervention group lost 1.5 kg more than those in the control 
group (p = .02). Moreover, more subjects in the intervention group achieved a 5% loss 
in body weight than in the control group after 2 years (26% vs 18.1%, respectively; p = 
.04), but not after 1 year (22.6% vs 16.6%, respectively; p = .09). Authors also 
examined changes in cardiovascular risk factors (cholesterol, triglycerides, HDL, LDL, 
apolipoproteins A and B, and blood pressure). Subjects in the intervention group had 
significantly lower triglycerides (125.9 ± 65.1 vs 135.4 ± 65.6, respectively; p = .0001), 
APOA (p = .04) and APOA:APOB ratio (p = .0003) than those in the control group after 
2 years. Changes in total cholesterol, HDL, LDL, APOB, and blood pressure were not 
statistically significant between groups after 1 year or 2 years. These results suggest 
that motivational counseling, in addition to lifestyle modifications, may result in greater 
weight loss and reduced cardiovascular risk than lifestyle modifications alone. These 
results are applicable to this EBP Project.  
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This RCT is of high quality due to its strengths consisting of: randomized design 
and intervention provision via primary care therapists, accustomed to the treatment of 
overweight and obese patients; dietetic non-pharmacological approach; consistent, 
generalizable results; conclusions based on results; sufficient sample size, n=864; 
sufficient time frame of 32 months. Limitations of the study included: no formal literature 
review; high attrition rate of 52.25 % completed the final visit-reasons not investigated; 
missing data not analyzed.  
Rolls and associates (2017) tested the efficacy of a behavioral weight reduction 
program with the inclusion of two portion control strategies versus standard education 
within a RCT conducted over a twelve month period. The trial included women aged 20 
to 65 years, with a BMI of > 25 (n=186). All participants completed the Eating Attitudes 
Test (EAT) and the Beck Depression Inventory (BDI). Participants were placed in either 
the control group or one of two intervention groups. Subjects in the control group 
received usual care including advice to eat less and make healthy food choices. 
Subjects in one intervention group were instructed to choose foods based on energy 
density (ED) in order to promote healthy, satisfying foods while limiting portion size of 
high ED foods. Participants in this group were provided a food scale and food 
measuring tools as well as illustrated pictorial examples of healthy meal components 
and portions sizes. Subjects in the other intervention group were instructed to use pre-
portioned foods in an effort to learn portion control and healthy eating choices. 
Pedometers were also provided to both intervention groups.  
All three treatment arms resulted in weight loss from baseline after 3, 6, 9, and 
12 months, although the pre-portioned group lost more weight within 3 months than the 
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standard advice group and the portion-selection group (5.1 kg vs 3.7 kg vs 3.8 kg, 
respectively; p <.05 for pre-portion group vs other groups). However, the pre-portioned 
group also regained weight faster than the other two groups (p = .0005 for pre-portion 
group vs other groups), and all subjects regained at least some weight from their nadir 
at approximately 6 months. Weight regain seemed to be attenuated by a higher level of 
dietary restraint (i.e. more able to control dietary intake) and adherence to self-
monitoring. Regardless of treatment arm, cardiovascular risk factors improved 
significantly in all subjects from baseline to 12 months (blood pressure, waist 
circumference, glucose, insulin, insulin resistance, total cholesterol, HDL, and 
triglycerides), as did most indicators of reported food consumption (food weight per day, 
energy density, calories from beverages, calories from food, fruit intake, grain intake, 
protein intake, dairy intake, fats and oils intake, and pre-portioned foods intake). These 
results suggest that pre-portioned foods may increase the rate of weight loss over the 
short-term, but that weight regain after 3 months is likely.  
This piece had several strengths. First, they used a sufficient sample of 186 
participants determined using mixed effects model that determined 80% power would 
be achieved by a sample of 180. Secondly, there was random assignment of 
participants. Thirdly, participants met with registered dieticians and trained 
interventionists who used standardized instruction manuals to insure fidelity. 
Interventions for the control group included: following healthy dietary guidelines; limiting 
caloric intake; meal planning. The second intervention group were taught to choose high 
density energy foods and to control portion size. The third intervention group were 
instructed to use pre-portioned foods. Primary outcome measured was the trajectory of 
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weight change over time using random coefficient model and intended–to-treat model. 
Secondary outcomes measured included: cardiometabolic factors, dietary intake, 
questionnaire responses and pedometer readings. These were analyzed by linear 
mixed effects model with categorical fixed factors. Lack of sample diversity may limit 
generalizability and continued use of pre-portioned foods and food measuring tools may 
not be sustainable. In total the results from this good quality RCT provide support for the 
use of a healthy nutritional plan based upon guidelines like those from Dietary 
Guidelines for Americans-2010, utilize portion control along with increase physical 
activity and behavioral modification can assist with weight loss.  
 Samdal and associated (2017) performed a systematic review and meta-
regression analyses on literature about behavioral change techniques for weight loss 
published between January 2007 and April 2013. Interventions included cognitive or 
behavioral change strategies (eg. motivational counseling); simple education strategies 
were excluded. Outcomes measured were behavioral change technique to promote 
goal setting, self-monitoring, problem solving, feedback, social support, for physical 
activity and healthy eating (Samdal et al., 2017).  
The authors found that, among 35 trials reporting effect of behavior change 
technique related to increased physical activity, there were 30 reports of short term (ST) 
effect (0.36; [0.24, 0.47] 95%CI), 17 reports of long term (LT) effect (0.25 [0.13, 0.38] 
95%CI), and 47 reports of both ST and LT effect (0.31[0.23, 0.40] 95%CI). The effect of 
behavioral change techniques on diet was found in 20 reports of ST effect (0.41 [0.20, 
0.62] 95%CI),15 reports of LT (0.19 [0.07, 0.31] 95%CI), and 35 reports of ST and LT 
effect (0.29 [0.16, 0.42] 95%CI). BCT effect on physical activity and diet in combination 
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was found in 50 ST reports (0.37 [0.26, 0.48] 95%CI), 32 LT reports (0.24 [0.15, 0.33] 
95%CI), 82 ST and LT reports. The pooled size effect of ST and LT studies were 0.19 to 
0.41 with a 95% CI. The CI’s had analogous effect for physical activity and diet, 
however LT (0.24) showed a lesser result than ST (0.37) despite 95% CIs that 
coincided (0.15 -0.33 and 0.26- 0.48, respectively). There was high heterogeneity 
among ST reports (I 2 =71%, p<.0001) and lesser heterogeneity among LT reports (I 2 
=59%, p<.0001). 
The main results determined in the ST and LT, that behavioral interventions for 
diet and physical activity had a small effect however, consistency among studies was 
high mainly for ST. LT effect was associated with interventions such as motivational 
interviewing, that highlight patient-centered and autonomy facilitating communication. 
The results champion the use of self-monitoring, goal setting, in conjunction with 
person-centered and autonomy enhancing behavioral counseling. This systematic 
review supports the use of a behavioral intervention by the NP in primary care as part of 
a   multicomponent weight loss intervention.  
 Strengths of this high quality systematic review and meta-regression analysis 
were: the inclusion of 46 RCTs and 2 cluster RCT with a pooled sample of 11,183 
providing a sufficient sample for the analysis; study bias was addressed and analyzed 
for each of the RCTs; most studies reported analysis of intention-to-treat using baseline 
carried forward or random imputation. Attrition bias was found to be higher in long term 
due to drop out. This analysis was limited to a 12-month time frame, ending in 2014. 
Some individual study characteristics were limited and lacking in refinement. The results 
showed that the use of BCT had positive outcomes in the domains of goal setting, 
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barrier identification, problem solving as well as obesity risk and biomarker reduction. 
Additionally, person-centered methods such as motivational interviewing that support 
individual autonomy provided long term effect. These results support the use of BCT, 
goal setting and self-monitoring for the treatment of adult obesity.  
Tang and partners (2016) completed a SR of RCTs. The purpose was to 
determine the effectiveness of self-directed interventions for weight loss through focus 
on interventions that did not require ongoing professional interaction beyond an initial 
consultation (Tang et al., 2016). Articles published through July 2014 were reviewed. 
Interventions included those that: target diet and or physical activity; are self-directed 
with limited face-to-face professional contact to < one 90 minute instructional session; 
have at least one interactive intervention; or have at least one self-regulatory element 
such as goal setting or diary of thoughts and or behaviors. Outcomes measured: 
effectiveness of self-directed internet-based interventions; effectiveness of change 
technique (eg. goal setting, self-monitoring, feedback, behavioral instruction, social 
support) inclusion on self-directed interventions; changes in weight, BMI, waist 
circumference.  
Results of this meta-analysis showed that participants using self-directed 
interventions had greater weight loss than those who received minimal or no 
intervention (mean difference = -1.56 kg; 95% CI -2.25, -0.86). The mean individual 
weight loss in the intervention group (IG), who would have received any of the 
interventions listed above, ranged from 0.6 to 5.3 kg. Compared to no intervention, self-
directed interventions produced significantly greater reduction in BMI (mean difference = 
-0.41kg/m2; 95% CI -0.70, 0.11) and waist circumference (mean difference= -2.37cm; 
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95% CI -4.12, -0.61). Self-directed interventions included with in this study were 
predominately internet based (18 out of 25, 72%). Studies employing change 
techniques interventions such as: goal setting, self-monitoring, behavior skills were not 
found to be significantly more helpful than those who did not (p=.48, p=.35, p=.26 
respectively). However those that employed feedback and social support were found to 
be successful (p<.0001, p=.001 respectively). Participants in the internet-based 
intervention group experienced greater weight loss and BMI reduction than the control 
group (mean difference = -1.72 kg; 95% CI -2.60, -0.84; -0.47kg/m2; 95% CI -0.81, -
0.41 respectively). The intervention group also experienced greater waist circumference 
loss than control group (mean difference = -2.69 cm; 95% CI -5.01, -0.37).  
This study had many strengths and limitations. First it was the first to focus 
exclusively on self-directed weight loss measures, many of them internet based. This 
provided for specific intervention analysis; however, it was limited by a small sample 
size, thus reducing the power to determine effect on a heterogeneous sample and 
provide long term conclusions. There was a wide variation found for time of follow up 
when meta-analytic calculations were performed that may have resulted from diverse 
populations. Additionally, many trials utilized methods that could have biased 
interpretation. Targeted study outcomes included physical activity and or diet; self-
direction with no more than initial professional intervention or face-to-face contact; at 
least one interactive component (eg. entering personal data); at least one self-
regulatory element (eg. diary, goalsetting or review).  
The results suggest that self-directed weight loss interventions can provide a 
mechanism for modest short-term weight loss, but these would need to be 
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supplemented with additional interventions including community resources and clinical 
services to achieve long-term significant weight loss. This article is applicable to this 
EBP project as part of a   multicomponent weight loss intervention.  
Tapsell and colleagues (2017) conducted a single blind controlled trial with the 
object of determining the effectiveness of interdisciplinary treatment versus usual care 
for the treatment of overweight and obese adults. Participants were randomly assigned 
to either the control group, an interdisciplinary intervention group, or an interdisciplinary 
intervention group with a supply of 30 grams of walnuts per day. Interventions included: 
seven clinical counseling sessions that included: diet, exercise and behavioral coaching 
from professional nurse and interdisciplinary team based upon the Australian Guide to 
Healthy Eating (AGHE); walnuts; quarterly support telephone calls, measures of blood 
pressure, anthropometric and biomarkers (eg. lipid panel, fasting blood glucose and 
HbA1c); assessment with the International Physical Activity Questionnaire (IPAQ), 
Physical and Mental Health 12 Item Short Form Health Survey (SF-12) and the 
Acceptance and Action Questionnaire for Weight loss (AAQ-W). Outcomes measured 
included: weight loss from baseline and at 12 months; change in blood pressure; fasting 
blood glucose and lipids; changes in diet and exercise; psychological measures (AAQ-
W, DASS-21, QoL SF-12) (Tapsell et al., 2017). Individual outcomes measured not 
stated. 
Primary results indicated that both intervention groups had greater weight loss 
than the control group at 3 months and at 6 months. Post hoc analysis indicated that at 
3 months the intervention group, and the intervention plus walnut group had a greater 
weight loss than the control group (-1.2kg, p=.045; -1.3kg, p=.025). At six months the 
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intervention plus walnuts group had a greater weight loss than the control (-2.1kg, 
p=.010). The difference between control and intervention plus walnut group was -2.2kg 
p=.056 (95% CI). The 12 month adjusted weight change showed an effect significance 
of p=.056, consistent with the difference in weight between the intervention plus walnuts 
group and the control group of -2.2kg (95%CI -4.6 to0.1kg, p=.068) versus the 
intervention group and the control group was -1.9kg (95%CI -4.5 to 0.7kg, p=.228) and 
the intervention and the intervention plus walnuts groups -0.3kg (95% CI-2.8 to 2.2kg, 
p=1.00). Achievement of 5% weight loss at twelve months (p=.091) among the control 
group was 20%, among the intervention plus walnuts group it was 33% and among the 
intervention group it was 38%.  
Secondary results indicated that blood pressure tended to be lower among all 
groups, the difference was not statistically significant (p=.441). Fasting blood glucose 
was significantly lower at 3 (p=.040), 6 (p<.001) and 12 months (p=.003), compared to 
baseline. While the intervention group plus walnuts measurement of HbA1C at twelve 
months remained unchanged from baseline at 5.1 (4.9-5.4; p=.031), it was lower than 
baseline for the control and intervention groups 5.2 and 5.1 (5.0-5.4, 4.9-5.4 
respectively; p=.031). Lipid panels improved across the board at 3 months. Total 
cholesterol (mmol/L) for control, intervention and intervention plus walnut groups 
showed lower scores 5.2, 5.0, and 4.8 (4.4-5.6, 4.4-5.5, and 4.3-5.6 respectively; 
p=0.193), this trend continued for the control group at 12 months but not for the 
intervention or intervention plus walnut groups. Low density lipids (mmol/L) were also 
lower at three months (p<.001; < .031) and at six months (p=.020, p=.034). At 12months 
HDL rose above baseline (p< .021). Group effect showed better total cholesterol means 
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for the intervention plus walnut groups versus intervention or control groups (p=.037 and 
p=.001 respectively).  
 Self-reported caloric and total fat intake were lower than baseline for all groups 
at three months (p<.001) and at twelve months (p=.020). Physical activity was higher 
than at baseline at all time measures (p<.001). The findings indicated that 
interdisciplinary collaboration and intervention with an individualized approach provided 
greater results than usual care. The collaborative and individualized method of the 
intervention is applicable to the primary care setting and specifically to the   
multicomponent approach of this EBP Project.  
This study had several strengths and limitations. Strengths included: its 
applicability and generalizability within primary care. Secondly, analysis was conducted 
using intention-to-treat instead of compliance-based method. Thirdly, possible 
confounding variables were controlled. This study addressed gaps in current research 
and is transferrable. However, the sample size was small and limited to one clinical 
setting in which there was a language barrier, thus limiting access to potential at risk 
participants. Between group reporting inaccuracies may skew dietary results. Results of 
the study indicated that there is benefit from looking beyond dietary restriction. 
Behavioral and psychological factors have a role in weight loss and attrition and regular 
patient-clinician interaction (eg. 4 visits within 3 months) seems to provide positive 
effect. Primary care is a suitable atmosphere within which obesity and weight loss as 
well as weight related risk prevention can be addressed.  
In summary, Level I evidence supports the use of primary care interventions that 
focus on diet, exercise, self-monitoring of food intake and physical activity, and 
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concurrent management of depression as strategies to manage obesity, control 
depression symptoms, and reduce cardiovascular risk.  
Level II: Cheatham and colleagues (2018) conducted a systematic review using 
Preferred Reporting items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines. with the purpose of appraising current evidence related to the efficacy of 
wearable activity tracking technology (eg. Fitbit) as part of a comprehensive weight loss 
program (Cheatham et al., 2018). A search of five databases was conducted through 
December of 2016. Authors found 7184 citations and 25 relevant sources, of which 21 
scored 6 or higher (7)/10, and 4 scored a 5/10 using the Physiotherapy Evidence 
Database (PEDro) scale indicating moderate to high quality evidence.  
Interventions included in the review: behavioral and nutrition counseling; self-
monitoring of diet and activity (eg.website or Smartphone); self-monitoring through 
journaling; and use of an activity tracker. Outcomes measured included: BMI, waist 
circumference, body composition, physical activity, dietary changes/ caloric intake, 
blood pressure and heart rate. Strengths of the study were use of consistent research 
technique using PRISMA guidelines and PEDro evidence appraisal. The study filled a 
gap in current research. Limitations of the study were, primarily female participants, 
diversity in type of studies reviewed and no consistent type of activity tracking, and the 
limited age groups studied. Authors found that there was evidence to support the use of 
activity trackers as part of a comprehensive weight loss program. These devices, which 
included: pedometers, websites, Fitbit, Smartphone and accelerometer, electronic arm 
band, activity tracker with Bluetooth, and paper journal, provided statistically significant 
short-term weight loss that was superior to weight loss in programs without activity 
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trackers. Results suggest that an activity tracker used as part of a multicomponent 
intervention may provide positive short term weight loss. These findings provide support 
for the use of activity tracking technology (eg. pedometer, Fitbit, Smartphone 
applications) as part of a   multicomponent weight loss intervention program and this 
EBP Project.  
Kroes, Osei-Assibey and Baker-Searle (2016) conducted a systematic review the 
objective of which was to evaluate evidence concerning the impact of weight/BMI 
change on health-related quality of life (HRQoL) in obese adults. This was done through 
various weight loss interventions (Kroes et al., 2016). These interventions included: 
lifestyle modification and behavioral counseling; dietary and exercise coaching and 
education; pharmacotherapies, bariatric intervention; and some measure of health- 
related quality of life (HRQoL) (eg. SF-36, IWQOL-Lite). Outcomes measured included 
changes in weight, BMI, body composition, and HRQoL. HRQoL was measured with 
either the Short Form Health Survey (SF-36) tool or the Impact of Weight on Quality of 
Life (IWQOL-Lite) tool. Results of the pharmaceutical weight loss study using pooled 
data, at 52 weeks indicated the mean weight loss was 2.7% from baseline; 34.9% of 
participants lost 0.4 % to 9% of baseline. Weight gain was seen in 26.2% of 
participants. Changing weight correlated with SF-36 scores (0.2 for weight loss of 0-
4.9% to 2.8 for weight loss > 10 % from baseline). Lifestyle modification included diet, 
exercise and behavioral interventions resulted in weight loss that ranged from 3% to 
10% from baseline. Multiple studies (n=6) utilized the SF-36 tool to measure HRQoL. 
Results showed that regardless of lifestyle intervention, weight loss was associated with 
better HRQoL scores (increase of 0.64 in SF-36 for every 5kg weight loss). Weight loss 
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and improved physical abilities produced improvement in HRQoL scores as measured 
with the SF-36 (mean change 1.65).  
This study had many strengths. First a comprehensive search was conducted in 
four databases according to PRISMA guidelines identifying 6793 citations of which 32 
were included. Analysis of evidence was completed via standard methods. Conclusions 
drawn indicate that BMI > 25 typically coincide with decreased HRQoL. Significant 
weight loss following bariatric surgery may improve HRQoL. Non-bariatric studies that 
provided a weight loss of > 5 % also resulted in improved HRQoL though specific cause 
remains unidentified. Both SF-36 and IWQOL-Lite scores that were improved but were 
generally related to physical rather than mental HRQoL. Conclusions indicated that 
people with obesity have poorer health and thus HRQoL and even a weight loss of 5% 
of total baseline can reduce health risk, improve health and HRQoL.  
This systematic review was given a Level II high quality rating because of the 
inclusion of RCT and quasi-experimental studies and consistent results. It provides 
support for the use of an individualized multicomponent weight loss interventions 
including those specific to this EBP Project (eg.lifestyle modifications, and 
pharmaceuticals) for weight loss to improve all aspects of HRQoL in people with obesity 
and within this EBP Project.  
Thabault, Burke and Ades (2016) conducted a quasi-experimental study with the 
purpose of evaluating an intensive behavioral treatment program to manage obesity 
with the adult primary care population, specifically led by nurse practitioners (NPs). 
Multicomponent interventions included: use of the 5A’s framework (ask, assess, advise, 
agree, and assist); obesity screening and nutritional assessment; motivational 
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interviewing; and weight loss education that included a 500-1000kcal reduction with a 
goal of a 1-2 pound /week loss and increased physical activity; along with an 
introductory packet that included benefits of a healthy lifestyle and weight, dietary and 
activity journal, pedometer, questionnaire addressing goals and readiness to change 
and nutritional assessment. Outcome variables include weight loss; patient-provider 
satisfaction, feasibility; and acceptability. 
Data were collected at baseline and at 4 and 12 weeks. Baseline means for 
weight, BMI, SBP and DBP were: 229, 37.4, 129 and 71 respectively. After 4 weeks, 
mean weight decreased by 6.6 lbs (p < .05), and after 12 weeks, mean weight 
decreased by 10.77 lbs (p < .05). Changes in blood pressure were not statistically 
significant at either time point. The authors also evaluated the extent to which patients 
were satisfied with components of the weight loss program. In general, patients reported 
that scheduling was easy, consistent appointments with a nurse practitioner increased 
their own accountability to adhere to the program, that providers offered adequate 
support, and that use of the weight loss tools was feasible.  
Strengths of the study were: used of validated questionnaires, data analysis 
using SPSS and Excel XLSTAT Version 2013.5.3, the NP leadership, focus in primary 
care, and generalizability of the study. Limitations included: short duration, the study 
participants were referrals rather than a random sampling, and lack of further evaluation 
of biometric risk markers. Results indicated that a NP-led multicomponent intervention 
that focused on nutritional assessment, weight loss education, and motivational 
interviewing was satisfactory to patients and resulted in significant weight loss. This 
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study provided level II high quality support for this EBP project due to study design and 
consistent content and generalizable results.  
Welbourn and colleagues (2018) completed a systematic review to appraise 
current evidence regarding weight loss interventions used in primary and specialty care 
areas, in order to create a tiered model for these interventions centered on obesity 
severity. Based on 50 pieces of evidence, including published guidelines, systematic 
reviews and RCTs published between 2011 and 2016, the authors recommended a 
four-tier model for weight loss. Tier I interventions focus on obesity screening using 
standard anthropometric measurements (e.g. weight, BMI) and counseling about diet, 
exercise, and lifestyle changes. Tier II interventions included those in Tier I, with the 
addition of pharmacotherapies to facilitate weight loss. Tier III included interventions in 
Tiers I and II, as well as referral to a multidisciplinary team and a weight loss specialist. 
Finally, Tier IV included interventions from Tiers I through III, as well as referral to a 
bariatric physician specialist.  
Strengths of this research was the use of 50 works of evidence including recently 
published guidelines and policy documents, systematic reviews and RCTs obtained 
from six electronic databases; use of a NICE accredited process endorsed by 22 UK 
societies and nine Royal Colleges addressing obesity. Limitations were not addressed 
within the article but included: a UK rather than US specific perspective and guidance; 
need for translation into US insurance based medical care climate that is not National 
Health Service.  
In summary, Level II evidence from this literature review further support the use 
of weight loss interventions that focus on patient education, motivational interviewing, 
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and self-monitoring of diet and exercise. Moreover, Level II evidence suggests that 
multicomponent interventions based on characteristics that are unique to patients, 
including their resources, barriers, and preferences, can effectively lead to weight loss 
and provide support for this EBP Project.  
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Table 2. 4 
Appraisal of Evidence 
Citation 
(APA) 
Purpose Design Sample Measurement/ 
Outcomes 
Results/  
Findings 
Level/ 
Quality 
 
Batsis, J. A., 
Gill, L. E., 
Masutani, R. 
K., Adachi-
Mejia, A. M., 
Blunt, H. B., 
Bagley, P. J., 
Lopez-
Jimenez, F. & 
Bartels, S. J., 
(2016). Weight 
loss in older 
adults with 
obesity: A 
systematic 
review of 
randomized 
controlled trials 
since 2005. 
Journal of the 
American 
Geriatrics 
Society, 65(2) 
257-268. 
To identify 
obesity 
interventions 
that can direct 
clinical 
recommendatio
ns among the 
geriatric 
population. 
Systematic 
review  
 
Interventions 
included: 
Behavioral, 
diet and 
exercise 
counseling 
including 
500-
1000kcal 
deficit; 
meeting with 
diet or 
exercise 
physiologist 
or 
specialists; 
group 
meetings; 
pedometer 
use and log 
or diary; 
vitamin 
supplements  
The target 
population is 
community-
dwelling 
older adults 
with obesity.  
 
A thorough 
systematic 
literature 
search was 
performed 
and found  
5,741 
citations 
published 
2006 
forward; 19 
sources 
were used in 
the final 
review.  
 
Inclusion 
criteria:beha
vioral weight 
Outcomes measured: 
Weight (kg) was 
measured at intervals 
from 6 to 18 months. 
 
Physical function was 
measured using 
physical performance 
testing, the 6MWT, 
the Western Ontario 
McMaster Arthritis 
Index, and Functional 
Status Questionnaire 
at intervals from 6 to 
18 months.  
 
Quality of life was 
measured using the 
SF-36 at intervals 
from 6 to 18 months.  
Weight loss in the 
intervention groups 
ranged from 0.5 kg 
to 10.7 kg (0.1%-
9.3% of body 
weight). (p<.01) 
 
Dietary interventions 
produced a larger 
weight loss than 
exercise alone. 
(p=.52 to p=.001) 
 
Exercise increased 
physical function but 
not weight loss. 
(p=.02)  
 
A combination of 
diet and exercise 
interventions 
provided the best 
improvement in 
physical function 
and QoL (p=.03) 
(Batsis et al., 2016) 
Level 
I 
Qualit
y High 
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loss not 
involving 
pharmacolog
ical or 
surgical 
intervention. 
Exclusion 
criteria: 
pharmacolog
ical or 
surgical 
intervention 
and mitigated loss of 
muscle and bone 
mass seen in the 
studies with diet 
only interventions.  
 
Beeken, R. J., 
Leurent, B., 
Vickerstaff, V., 
Wilson, R., 
Croker, H., 
Morris, S., 
Omar, R. Z., 
Nazareth, I., & 
Wardle, J. 
(2017). A brief 
intervention for 
weight control 
based on 
habit- 
formation 
theory 
delivered 
through 
primary care: 
results from a 
randomized 
To test the 
hypothesis that 
ten top tips 
(10TT) can 
produce 
significantly 
better weight 
loss than usual 
care over a 3 
month period.  
RCT 
 
Intervention 
group 
received a 
leaflet about 
weight loss, 
a log book, 
and baseline 
consultation 
with a nurse.  
 
Control 
group 
received 
usual care 
from within 
their primary 
care setting, 
but may 
have 
The sample 
included 537 
primary care 
patients with 
obesity.  
 
Inclusion 
criteria: 
obsess 
adults that 
were able to 
provide 
consent. 
Exclusion 
criteria: 
active 
psychotic 
illness, 
pregnant or 
terminally ill. 
 
Weight (kg) was 
measured at baseline 
and at 3, 6, 12, and 
18 months.  
 
Secondary outcomes 
included BMI, waist 
circumference, blood 
glucose, and blood 
pressure. These 
were measured at 3, 
6, 12, and 18 
months. 
  
Weight loss in the 
intervention group 
was greater than 
weight loss in the 
control group at 3 
months (1.68 kg vs 
0.84 kg, 
respectively; p = 
.004).  
 
Weight loss was 
sustained in the 
intervention group 
for up to 24 months.  
 
Mean Glucose 
(HbA1c) (mmol l -1 ) 
at baseline was 5.9 
(SD -2.4) CG, 5.8 
(SD -2.1)_ IG; 3 
months the IG had a 
Level 
I  
Qualit
y High 
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controlled trial. 
International 
Journal of 
Obesity,41(2) 
264-254.  
included 
outside 
resources 
such as 
Weight 
Watchers ®.  
  mean glucose of 5.3 
versus 6.0 in the 
CG. A change of 
0.06 (SD -2.85) in 
the control group 
and 0 (SD -1.79) in 
the intervention 
group.  
 
SBP was lower in 
the intervention 
group by 2.98 
mmHg (95% CI -
5.73, -0.23).  
 
The 10TT leaflet 
intervention was 
effective for short-
term weight loss, 
glucose control, and 
BP control. 
  
Cheatham, S. 
W., Stull, K. R., 
Fantigrassi, M., 
& Motel, I. 
(2018). The 
efficacy of 
wearable 
activity tracing 
technology as 
part of a weight 
loss program: 
The purpose 
was to appraise 
current evidence 
related to the 
efficacy of 
wearable activity 
tracking 
technology as 
part of a 
comprehensive 
weight loss 
Systematic 
Review  
 
Of the 25 
studies, 
various 
controls and 
interventions 
were 
applied. 
Among them 
N=7184; 
n=25 that 
met inclusion 
criteria and 
no exclusion 
criteria.Inclu
sion criteria 
included: 
Controlled 
clinical trials, 
peer 
A systematic review 
conducted based 
upon PRISMA 
guidelines of 
databases through 
December of 2016. 
Databases included: 
PubMed, CINAHL, 
SportDiscus, 
Proquest and Google 
Scholar as well as 
Results of outcomes 
measured among 
studies included (p-
value range):  
Weight loss 
(p<.001-.05, 
p=.0004 to.9) 
BMI (p<.01 to.03) 
Decreased BP 
(p=.25, or p<.05) 
Level 
II 
Qualit
y High 
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a systematic 
review. The 
Journal of 
Sports 
Medicine and 
Physical 
Fitness, 
58(4)534-548.  
program. Three 
clinical 
questions were 
addressed: 1. 
“Are activity 
trackers 
effective as a 
single 
intervention or 
part of a 
comprehensive 
weight loss 
program? . . . 2. 
Does the use of 
activity trackers 
improve 
adherence to 
weight loss 
programs? . . . 
3. Are weight 
loss programs 
using activity 
trackers more 
effective among 
certain age 
groups or 
sex?”(Cheatham 
et al., 2018) 
the control 
groups 
received: 
Hypocaloric 
diet, 
pedometer, 
usual 
national 
guidelines 
diet and 
exercise 
advice and 
education, 
weigh in and 
journal use 
 
Interventions 
included: 
behavioral 
and nutrition 
counseling; 
self-
monitoring of 
diet and 
activity 
(eg.website 
or 
Smartphone)
; self-
monitoring 
through 
journaling; 
and use of 
reviewed, 
and 
comparison 
of portable 
activity 
tracking 
devices. 
 
Exclusion 
criteria: non-
English, no 
use or no 
measuremen
t of activity 
tracking 
device, or 
special 
populations, 
or case 
report, 
series, 
commentarie
s or 
dissertations
.  
citation chasing. 
Relevant studies 
were graded using 
the PEDro scale. 21 
studies scored > 6 
and 4 studies scored 
> 5. All subjects had 
a BMI of > 25kg/m2 , 
the majority being 
female. 
 
Outcomes measured: 
weight, BMI, waist 
circumference, body 
composition, physical 
activity, dietary 
changes/ caloric 
intake, blood 
pressure and heart 
rate 
 
Increase physical 
activity (p=.04 to 
.003, p<.001) 
Decreased % body 
fat (p=.008 to .9) 
Increased weight 
control behaviors 
(p=.003) 
Decreased kcal 
intake (p<.001) 
Decreased fat intake 
(p<.001) 
Decreased waist 
circumference 
(p<.05 to p<.0004) 
 
A total of 25 articles 
were reviewed and 
each piece of 
evidence was 
individually 
scrutinized and 
analyzed however a 
meta- analysis was 
not performed. 
Based upon 
individual works, this 
systematic review 
findings suggest that 
activity trackers 
used as part of a 
multi-modal 
intervention weight 
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an activity 
tracker.  
loss program 
provide short term 
results over 
standard care. 
Consistent research 
findings indicate that 
multi-modal 
interventions in 
general provided the 
best weight loss 
outcomes. In every 
article the 
intervention group 
had a significantly 
greater weight loss 
than the control 
group and or an 
increase in physical 
activity was found.  
Eaton, C. B., 
Hartman, S. J., 
Perzanowski, 
E., Pan, G., 
Roberts, M. B., 
Risica, P. M., 
Gans, K. m., 
Jakicic, J. m. & 
Marcus, B. H. 
(2016). A 
randomized 
clinical trial of a 
tailored 
lifestyle 
The aim of the 
study was to 
test a tailored 
lifestyle 
intervention to 
improve activity 
and achieve 
weight loss in an 
obese primary 
care population.  
RCT 
 
Standard 
care for both 
groups IG 
and CG 
included: 3 
face-to-face 
meetings 
with lifestyle 
counseling, 
and 
pamphlets .  
Intervention 
(IG) n=105, 
control (CG) 
n=106.  
 The sample 
was 79% 
women, 16% 
minorities, 
with a mean 
age 48.6 
years, and 
mean BMI 
37.8 kg/m2, 
Outcomes measured 
included: weight loss, 
and physical activity 
(walking) . 
Results: Percentage 
of sample that had 
5% loss of body 
weight from of 
baseline was 
greater in IG than 
CG (p<0.001). At 6 
months the IG 
37.2% and CG 
12.9%; at 12 months 
CG 26.7%; and at 
18 months IG 31.4% 
and CG 26.7% and 
at 24 months IG 
Level 
I  
Qualit
y High 
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intervention for 
obese, 
sedentary, 
primary care 
patients. 
Annals of 
Family 
Medicine, 
14(4) 311-319. 
IG also 
received 
phone call 
counseling , 
weekly 
mailings 
focused on 
diet, 
exercise and 
behavioral / 
lifestyle 
interventions 
and DVDs.  
 
who were 
sedentary.  
Inclusion: 
adult18 to 80 
years, BMI 
>, sedentary, 
English 
literate and 
able 
toprovide 
consent. 
Exclusion 
criteria: 
family 
member 
enrolled in 
the study, 
health 
condition 
making 
participation 
unsafe.  
33.3% and CG 
24.6% had a 5% 
reduction in weight.  
Activity increased 
significantly more 
among the IG than 
the CG (p=0.04). 
The mean difference 
in physical activity 
minutes among the 
groups: at 6 months 
IG 95.7 and CG 
68.3; at 12 months 
IG 126.1 and CG 
73.7; at 18 months 
IG 103.7 and CG 
63.7 and at 24 
months IG 101.3, 
CG 75.4 (Eaton et 
al., 2016).  
Conclusions indicate 
that a tailored 
lifestyle intervention 
in obese sedentary 
populations was an 
effective tool to 
promote weight loss 
and increased 
activity with optimal 
effect at 12 months.  
Hageman, P. 
A., Pullen, C. 
H., Hertzog, 
“This trial 
compared the 
effectiveness of 
RCT 
Interventions
: all groups 
n=301 
women with 
BMI of 28-
Outcomes measured:  
 
Mean body weight 
per group at 
Level 
I 
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M., Pozehl, B., 
Eisenhauer, C. 
& Boeckner, L. 
S. (2017). 
Web-based 
interventions 
alone or 
supplemented 
with peer-led 
support or 
professional 
email 
counseling for 
weight loss 
and weight 
maintenance in 
women from 
rural 
communities: 
Results of a 
clinical trial. 
Hindawi, 
Journal of 
Obesity, 2017, 
1-21. Retrieved 
from: 
https://www.nc
bi.nlm.nih.gov/
pmc 
/articles/ 
PMC539 
6444/pdf/ 
a web-based 
only (WO) 
intervention with 
web-based 
supplemented 
by peer-led 
discussion (WD) 
or professional 
email 
counseling (WE) 
across 3 phases 
to achieve 
weight loss and 
weight 
maintenance in 
women from 
underserved 
rural 
communities”   
(Hageman et al., 
2017). 
including the 
control group 
(WO) had 
web-based 
interventions 
with identical 
content that 
included diet 
and exercise 
plans, 
behavioral 
change 
plans, based 
upon 2010 
Dietary 
Guidelines 
for 
Americans 
and 2008 
Physical 
Activity 
Guidelines 
for 
Americans 
and Healthy 
People 
2010. One 
intervention 
group also 
received 
supplementa
l peer led 
counseling 
45kg/m2 
ages 40-69 
years, were 
randomly 
assigned to 
1 of 3 
groups:  
Web-based 
only/control 
(WO) n=101; 
Web-based 
and peer led 
discussion 
(WD) n=100; 
Web-based 
and 
professional 
email 
counseling 
(WE) n=100 
Inclusion: 
rural living, 
female, BMI 
28-45kg/m2, 
not on 
medications 
that affected 
weight, 
English 
literate, able 
to use 
telephone 
and 
Primary: body weight 
and waist 
circumference 
 
Secondary: 
attainment of 
specified weight loss, 
eating and activity 
targets 
baseline, 6, 18 and 
30 months: 
WO: 93.6 (SD 13.7), 
88.0 (14.6), 88.9 
(14.8), 89.4 (14.0) 
respectively. 
WD: 94.5 (12.9), 
89.4 (13.9), 89.6 
(13.6), 90.4 (13.3) 
respectively. 
WE: 93.3 (12.6), 
87.2 (13.5), 88.3 
(15.5), 89.5 (16.7) 
respectively.  
At the 6 month 
mark, the mean 
weight loss was: 
WO 5.1 (SD6.0) kg 
WD 4.1 (5.6)kg 
WE 6.0 (6.3) kg with 
42%, 38% and 51 % 
meeting the > 5% 
total body weight 
loss.  
Body weight kg: 
Comparison at 6, 18 
and 30 months: pb, 
mean difference 
(SD) 
“WOvsWD: p=.138, 
0.9 (-0.8 to 2.7); 
p=.360, 0.2(-1.1 to 
Qualit
y High 
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JOBE2017-
1602627.pdf 
(WD) and 
the second 
intervention 
group 
received 
professional 
email 
counseling 
(WE). 
computer, 
internet and 
DVD access, 
able to drive.  
Exclusion: 
diabetes 
type I or II 
with insulin 
use, 10% or 
greater 
weight loss 
in past 6 
months, 
current 
enrollment in 
weight loss 
program or 
research 
study, 
physical or 
mental 
restrictions.  
1.6); p=.268, -0.4(-
1.8 to 0.9). 
WO vs WE: p=.188, 
-0.8 (-2.5 to 0.9), 
p=.411, -0.2 (-1.5 to 
1.2), p=.444, -0.19-
1.4 to 1.2). 
WD vs WE: p=.047, 
-1.7 (-3.4 to 0.0), 
p=0.563, -0.4 (-1.7 
to 1.0), p=.632, 0.3 
(-1.0 to 1.7). 
Waist 
circumference: 
at 6, 18 and 30 
months: pb, mean 
difference (SD) 
WO vs WD: p=.070, 
1.6 (-0.5 to 3.7). 
p=.497, -0.01 (-1.5 
to 1.4), p=.479, -
0.04 (-1.5 to 1.4). 
WO vs WE: p=.461, 
0.1 (-2.0 to 2.2), 
p=.441, -0.1 (-1.5 to 
1.3), p=.463, -0.1 
(1.5 to 1.3). WD vs 
WE: p=.164, -1.5 (-
3.5 to 0.6), p=.891, -
0.1 (-1.6 to 1.4), 
p=.970, -0.03 (-1.5 
to 1.4)” 
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(Hageman et al., 
2017) 
Results showed that 
the web-based 
intervention had 
short term effect for 
weight loss in this 
rural population. 
However at 30 
months weight 
regain by as much 
as 50% was found 
within the population 
studied.  
Harrigan, M., 
Cartmel, B., 
Loftfield, E., 
Sanft, T., 
Chagpar, A. B., 
Zhou, Y., 
Playdon, M., 
Li, F. & Irwin, 
M. L. (2016). 
Randomized 
trial comparing 
telephone 
versus in-
person weight 
loss counseling 
on body 
composition 
and circulating 
biomarkers in 
The purpose 
was to examine 
the effect of in-
person versus 
phone based 
weight loss 
counseling 
versus usual 
care on body 
composition, 
physical activity, 
diet and 
biomarkers at 6 
months.  
RCT 
 
Control: 
usual care: 
diet and 
exercise 
advice 
based upon 
US dietary 
guidelines 
and the 
LEAN book.  
 
Interventions
: 
In-person 
and phone 
counseling 
included 11, 
Female 
breast 
cancer 
survivors 
with BMI 
>25kg/m2, 
ages 59 + 
7.5 years. 
n=33 in-
person 
counseling 
group (IP), 
n=34 
telephone 
counseling 
group (TC) 
and n=33 
usual care 
group (UC).  
Biomarkers and 
height and weight, 
waist circumference, 
activity and diet were 
measured at baseline 
and at 6 months.  
Results indicated 
that at 6 months the 
mean weight loss 
was IP 
6.4%,(p=0.004,) TC 
5.4%(p=0.009) and 
UC 2.0% (p=0.46).  
C-reactive protein 
reduced 30% IP & 
TC; versus 1% UC 
(p=0.05).  
Both IP and TC 
were effective 
weight loss 
strategies that had 
positive effects on 
C-reactive protein 
level reduction.  
Level 
I 
Qualit
y High 
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women treated 
for breast 
cancer: the 
lifestyle, 
exercise and 
nutrition 
(LEAN) study. 
Journal of 
Clinical 
Oncology, 
34(7)669-676.  
30 minute 
sessions 
over 6 
months that 
focused on 
diet and 
exercise 
advice 
based upon 
US dietary 
guidelines.  
and 
behavioral 
therapy.  
Inclusion: 
Breast 
cancer 
survivors Dx 
within 5 
years, stage 
0-3, BMI.>25 
kg/m2, 
completed 
chemotherap
y or radiation 
at least 3 
months prior, 
physically 
capable, 
English 
literate and 
agree to 
random 
assignment. 
Exclusion: 
pregnancy, 
CVA or MI in 
past 6 
months, or 
uncontrolled 
mental 
illness.  
Kozica, S.L., 
Lombard, C. 
B., Ilic, D., Ng, 
S., Harrison, C. 
L. & Teede, H. 
The aim of the 
study was to 
“conduct a 
process 
evaluation within 
RCT 
 
Control: 
The CG 
received 
N=649; 
Control 
group (CG) 
n=301; 
intervention 
The HeLP-her Rural 
program took place in 
Australia and New 
Zealand beginning in 
Results on Likert 1-5 
+SD indicated that 
face-to-face delivery 
methods to be the 
most desired by 
Level 
I 
Qualit
y High 
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J. (2015). 
Acceptability of 
delivery modes 
for lifestyle 
advice in a 
large scale 
randomized 
controlled 
obesity 
prevention trial. 
BMC Public 
Health, 
15(9)699-712. 
doi:10.1186/s1
2889-015-
1995-8 
the context of a 
large-scale rural 
obesity 
prevention 
program 
measuring 
implementation 
fidelity, dose 
delivered, 
context, reach 
and 
acceptability of 
diverse delivery 
modes” (Kozica 
et al., 2015) 
standard 
care-group 
education 
from 
National 
Guidelines.  
Intervention: 
low intensity 
lifestyle 
intervention 
that 
included: 
simple 
lifestyle 
advice via 
face-to-face 
group 
session, 
pone 
coaching, 
text 
messages, 
and an 
interactive 
manual.  
 
group (IG) 
n=348; 
females, 
aged 39.6+ 
6 years, BMI 
28.8 
+6.9kg/m2, 
from low 
socioecono
mic rural 
communities
.  
The 
intervention 
group was 
sub divided 
into clusters 
of n=15 
allowing for 
attrition.  
 
Inclusion: 
female, aged 
18-50 years, 
living in one 
of 41 
selected 
towns. No 
exclusion 
criteria 
stated.  
2012 and lasting 12 
months.  
At 1 year, CG n=233, 
IG n=259 
Data collection 
included: interviews, 
checklists and 
questionnaires that 
were analyzed using 
chi-square and t-
tests.  
Outcomes measured: 
Acceptability of mode 
for lifestyle advice: 
face-to-face, text 
messaging, 
telephone coaching, 
program manual.  
participants, with at 
least one session 
being the key to 
success.  
Group education 
sessions was the 
most highly valued 
component of the 
interventions. 
Lifestyle advise 
delivered through a   
multicomponent 
program was 
recommended to 
optimize 
acceptability and 
effect.  
Quantitative results 
at 12 months 
(n=190): 
Group sessions 
were preferred over 
telephone coaching 
(p<.00) or program 
manual (p<.00). text 
messaging scored 
slightly higher than 
phone coaching 
(p<.00) and program 
manual (p<.000; 
phone coaching 
scores were lower 
than all interventions 
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except program 
manual (p=.63). No 
statistical difference 
between group 
sessions and text 
messages (p=.13). 
 
 
 
Kroes, M., 
Osei-Assibey, 
G., Baker-
Searle, R. & 
Huang, J. 
(2016). Impact 
of weight 
change on 
quality of life in 
adults with 
overweight 
/obesity in the 
United States: 
a systematic 
review. Current 
Medical 
Research and 
Opinion, 
32(3)485-508.  
The objective of 
this study was to 
“review 
published 
evidence on the 
impact of 
weight/BMI 
change on 
health-related 
quality of life 
(HRQoL) in 
adults from the 
US with 
overweight/obes
ity” (Kroes et al., 
2016) 
Systematic 
review (SR) 
 
Of the 
studies 
included  
Interventions 
comprised:  
the SF-36 or 
the IWQOL 
Lite to 
measure 
HRQoL,  
lifestyle 
approaches: 
diet, 
exercise, 
counseling,  
pharmaceuti
cal 
therapies, or  
bariatric 
surgery 
N=6793 
titles were 
identified of 
which 32 
meet 
inclusion 
criteria and 
did not meet 
one or more 
exclusion 
criteria. 
Upon further 
review n=20 
provided 
adequate 
data and 
were 
included in 
the SR.  
Inclusion:  
Englishlangu
age, 
published 
2008 
This SR was 
conducted using 
PRISMA guidelines.  
A comprehensive 
data base search of 
MEDLINE, Embase, 
Econ Lit and the 
Cochrane Library. 
Inclusion criteria 
included: studies in 
US, adults, BMI >25, 
with > 1 year follow 
up quantified weight 
change and 
measurement of 
HRQoL.  
Studies design and 
outcomes were 
heterogeneous, with 
HRQoL.  
Outcomes 
measurement 
obtained via  
Results indicated 
that that 
pharmacotherapies 
and lifestyle 
intervention, 5%-
10% weight loss 
was achieved 
HRQoL also 
improved; lifestyle 
interventions 
coincided with SF-
36 scores PCSW 
increased by 0.64 
for every loss of 5kg 
(p<.001) 
.Pharmaceutical 
studies weight loss 
coincided with minor 
changes in SF-36 
scores (0.2 to 2.8).  
Bariatric surgery 
offered the greatest 
weight loss, > 20%, 
and improved 
Level 
II 
Qualit
y High 
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forward, 
adult 
population, 
overweight/o
bese, follow-
up 1 year or 
greater, 
change in 
HRQoL 
measure 
(SF-36 and 
or IWQOL-
Lite). 
Exclusion: 
Comorbitiy 
focus, not 
obesity 
related.  
the Short form 36 
(SF-36) or the 
IWQOL Lite. 
Improved HRQoL 
was seen in studies 
in which weight-loss 
was obtained.  
 
HRQoL scores. 
Studies reporting 
SF-36 post bariatric 
surgery: p<.008 
week 92, and at 2 
years p<.02 from 
baseline, IWQOL-
Lite scores from 
baseline reported 
significant 
improvements, 
specifically physical 
function and self-
esteem both 
(p<.001). 
Conclusion: there 
was an association 
between 
overweight/obesity 
and lower HRQoL 
scores; 
corresponding 
amount of weight 
loss and increased 
HRQoL was found 
among evidence 
reviewed. 
 
  
Ma, J., 
Goldman-
Rosas, L., Lv, 
N., Xiao, L., 
The objective is 
to “test the 
hypothesis that 
an integrated 
RCT 
Usual care 
group (UC) 
n=205 as 
N=409, 
adults, BMI 
> 30 (>27 for 
Asian 
The study: Research 
Aimed at Improving 
Both Mood and 
Findings provided 
statistically 
significant results at 
12 months.  
Level 
I 
Qualit
y High 
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Snowden, M. 
B., Venditti, E. 
M., Lewis, M. 
A., Goldhaber-
Fiebert, J. D. & 
Lavori, P. W. 
(2019). 
Effective of 
integrated 
behavioral 
weight loss 
treatment and 
problem-
solving therapy 
on body mass 
index and 
depressive 
symptoms 
among patients 
with obesity 
and 
depression: 
The RAINBOW 
randomized 
clinical trial. 
Journal of the 
American 
Medical 
Association 
(JAMA), 321(9) 
869-879. 
collaborative 
care intervention 
would 
significantly 
improve both 
obesity and 
depression at 12 
months 
compared with 
usual care” (Ma 
et al, 2019.) 
 
 
 
well as 
intervention 
group (IG) 
n=204 
received 
medical care 
from 
personal 
physicians, 
including 
information 
on weight 
management 
and mental 
health 
services and 
wellness 
programs 
routinely 
available in 
their primary 
care office. 
The UC 
group also 
received an 
activity 
tracker.  
 
The IG 
received the 
same initial 
information 
as UC but 
adults), and 
PHQ-9 score 
> 10, 
primary care 
patients in 
Northern 
California,  
study dates: 
9/30/2014-
01/12/2017, 
with 12- 
month follow 
up by 
01/17/2018.  
Inclusion: 
adult, obese, 
depressive 
symptoms 
(PHQ-9 
score > 10), 
English 
literate. 
Exclusion: 
plan to 
relocate, 
serious 
comorbiditie
s 
(undefined), 
pregnancy,  
Weight (RAINBOW) 
integrated  
Behavioral weight 
loss treatment and 
problem-solving 
therapy with 
antidepressant 
pharmacotherapies.  
Outcomes measure 
weight loss/BMI, 
PHQ-9, GAD-7 and 
SCL-20 scores. t-test 
analysis or x2 test 
analysis for 
unadjusted 
bivariables and Wald 
asymptomatic 95% 
CI for unadjusted 
proportions.  
 
Intervention group 
(IG) versus usual 
care (UC): 
Weight loss/BMI 
reduction: mean 
baseline to 12 
months: 36.7 (SD 
6.9) to 35,9 (SD 7.1) 
between group 
mean -0.7 (95% CI, 
-1.1 to -0.2) p=0.01.  
Depressive 
symptoms:  
SCL20: IG mean 
score reduced from 
1.5 (SD 0.5) to 1.1 
(SD 1.0) 
IG -0.3 versus UC 
1.5 (SD 0.6) to 1.4 
(SD 1.3) between 
group scores mean 
difference , -0.2 
(95% CI, -0.4 to 0) 
p=0.01. SCL 20 
scores improved by 
at least 50% at 6 
months (31% IG 
versus 16% UC) full 
depression 
remission 
SCL<0.50(IG 18% 
versus UC 6%) 
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also 
received 
multimedia 
lifestyle and 
self-care 
materials as 
well as 
health 
coaching 
from 
dieticians on 
a weekly 
basis, as 
well as 
psychiatry 
and primary 
care 
providers 
routinely.  
 
In between group 
GAD-7 scores: -1.2 
(95% CI, -1.2 to -
0.3) at 6 months; -
1.5 (95% CI, -2.4 to 
-0.5) at 12 months.  
Conclusions indicate 
by study results: 
Among adults with 
obesity and 
depression a 
collaborative 
intervention 
approach to 
treatment that 
included behavioral 
weight loss 
treatment and 
problem-solving 
therapies, as well as 
antidepressant 
pharmacotherapies 
as needed provided 
significantly greater 
results in weight 
loss and reduction 
depressive 
symptoms than 
usual care.  
Rodriguez-
Cristobal, J. J., 
Alonso-
Villaveerde, C., 
The aim of the 
study was “to 
investigate 
whether a 
RCT 
 
The 
intervention 
N=864, 
overweight/o
bese 
patients 
Outcomes measured: 
Weight, cholesterol, 
triglycerides, HDL, 
LDL, apolipoproteins 
Results: Weight loss 
kg mean at 1 year: 
CG, 1.3 kg, (0.1 
SE)59.3% were at 
Level 
I 
Qualit
y High 
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Panisello, J. 
M., Trave’-
Mercade, P., 
Rodriguez-
Corte’s, F., 
Marsal, J. R. & 
Pena, E. 
(2017). 
Effectiveness 
of a 
motivational 
intervention on 
overweight/obe
se patients in 
primary 
healthcare: a 
cluster 
randomized 
trial. BMC 
Family 
Practice, 18:74 
(2017) 1-8. doi: 
10.1186/s1287
5-017-0644-y  
 
motivational 
intervention 
together with 
current clinical 
practice, was 
more efficient 
than traditional 
intervention in 
the treatment of 
overweight and 
obesity and 
whether this 
intervention 
reduces 
cardiovascular 
risk factors 
associated with 
overweight and 
obesity” 
(Rodriguez-
Cristobal et al., 
2017).  
group (IG) 
received 32 
group based 
sessions 
(every 15 
days and 
then monthly 
for weeks 13 
through 32) 
of 
motivational 
intervention 
along with 
standard 
1200-
1500kcal/da
y diet and 
exercise 
education/co
unseling, 
anthropomet
ric 
measures, 
blood tests: 
triglycerides, 
APOA1 
APOB-100, 
HDL and 
LDL 
cholesterol .  
 
The control 
group (CG) 
ages 30-70 
years with 
BMI >25, 
from a 
multicenter 
were 
randomly 
assigned to 
either the 
intervention 
group (IG) or 
the control 
group (CG) 
n=446, . 
Inclusion:  
Aged 30-70 
years, 
overweight 
or obese, 
any gender, 
registered 
medical 
history or 
new 
diagnosis.  
Exclusion 
criteria not 
defined.  
A and B, and blood 
pressure 
  
or below baseline, 
and mean 50/16.6% 
had lost > 5%. IG 
1.8 kg,(0.4 SE) 
95%CI, -
0.47;1.36(p=.33) 
61.8% were at or 
below baseline and 
mean 64/22.6% had 
lost > 5%.  
Weight loss kg 
mean at 2 year: CG, 
1.0 kg, (0.4SE) 
55.8% were at or 
below baseline, and 
mean 36/18.1% had 
lost > 5%. IG 2.5 kg, 
(0.5SE) 95%CI0.31; 
2.74 (p=.01)65.5% 
were at or below 
baseline, and mean 
64/26.9% had lost > 
5%.  
The study showed 
that the combination 
of usual care 
combined with 
professional group 
based motivational 
interventions 
significantly 
increased 
maintenance and 
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n=446, who 
received 
standard 
care with 
visits every 3 
months: 
standard 
1200-
1500kcal/da
y diet and 
exercise 
education/co
unseling 
based on 
national 
guidelines, 
anthropomet
ric 
measures, 
blood tests: 
triglycerides, 
APOA1 
APOB-100, 
HDL and 
LDL 
cholesterol.  
 
weight loss. Also, a 
focus on 
psychological 
aspects of patient 
health may 
contribute to long 
term weight loss 
success.  
Rolls, B. J. 
James, B. L. & 
Sanchez, C. E. 
(2017). Does 
the 
incorporation of 
The purpose of 
the research 
was to test 
whether the 
efficacy of a 
behavioral 
RCT 
 
All three 
groups were 
given equally 
intensive 
N=186 
overweight 
(19%) or 
obese 
(81%) 
women. 
Participants were 
randomly assigned to 
either the control 
group/standard advice 
(SAG); the portion 
selection group (PSG) 
Results: weight loss 
for PPG was higher 
than other groups 
(P=0.021) however 
this group later 
regained more 
Level 
I 
Qualit
y 
Good 
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portion-control 
strategies in a 
behavioral 
program 
improve weight 
loss in a 1-year 
randomized 
controlled 
trial?. 
International 
Journal of 
Obesity, 
41(3)434-442.  
 
weight loss 
program would 
be improved by 
incorporating 
either one of 
two portion 
control 
strategies: 
prepackaged 
meals or portion 
selection versus 
standard advice  
behavioral 
program/ 
counseling.  
 
The SAG/ 
control group 
were 
instructed to 
eat less food 
and make 
healthy food 
choices.  
The PSG 
were 
instructed to 
choose 
portions 
based on 
energy 
density and 
food 
measuremen
t tools/scale. 
The PPG 
were 
instructed to 
build meals 
around pre-
portioned 
foods using 
food 
vouchers for 
purchase. 
Inclusion:  
Female, 
aged 20-65 
years, BMI 
28-45 
kg/m2, 
Exclusion: 
BO > 
160/100mm
Hg, 
reported 
weight 
change 
>4.5kg in 
past 3 
months, 
medically 
unstable, 
limited 
physical 
activity 
tolerance, 
current 
special diet 
or weight 
loss 
program 
enrollment, 
pregnant or 
lactating, 
scores of 
>19 on 
Eatin 
or the Pre-portioned 
foods group (PPG). 
Outcomes measures 
were assessed at 12 
months for 151 
participants (81%).  
Weight change/ 
trajectory,  
Secondary outcomes: 
dietary consumption 
questionnaire 
responses and 
pedometer readings.  
cardiometabolic 
factors: blood 
pressure, waist 
circumference, 
glucose, insulin, 
insulin resistance, 
total cholesterol, HDL, 
and triglycerides 
 
 
weight (P=0.0005). 
Thus resulting in 
insignificant weight 
loss across groups 
at 6 months (mean + 
se 5.2 +0.4kg) or 12 
months (4.5 + 
0.5kg). After 1-year 
weight loss mean 
was 6% of baseline. 
Secondary 
outcomes: 
SBP(p=.0061), DBP 
(p=.0003), Waist 
circumference 
(p<.0001), Glucose 
(p=.0015), Insulin 
(p<.0001), insulin 
resistance 
(p<.0001), 
Total cholesterol 
(p=.0007, HDL 
(p=.0001), LDL 
(p=12), Triglycerides 
(p=.0032) 
Conclusions: 
Though early weight 
loss was found 
using pre-packaged 
or portion 
controlled/selection 
foods, this did not 
last. The use of pre-
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Attitudes 
Test, or >25 
on Becks 
Depression 
Inventory.  
packaged or portion 
controlled/selection 
foods did not lead to 
greater long term 
weight loss versus 
standard advice.  
Samdal, G. B., 
Eide, G. E., 
Barth, T., 
Williams, G. & 
Meland, E. 
(2017). 
Effective 
behaviour 
change 
techniques for 
physical activity 
and healthy 
eating in 
overweight and 
obese adults: 
systematic 
review and 
meta-
regression 
analysis. 
International 
Journal of 
Behavioral 
Nutrition and 
Physical 
Activity, 
14(1)42-56. 
The aim of the 
SR to “explain 
heterogeneity in 
results of 
interventions to 
promote 
physical activity 
and healthy 
eating for 
overweight and 
obese adults, by 
exploring the 
differential effect 
of behavior 
change 
techniques 
(BCTs) and 
other 
intervention 
characteristics” 
(Samdal et al., 
2017) 
SR with 
meta-
regression 
analysis 
 
Interventions
: 
Behavioral 
change 
techniques: 
Motivational 
interviewing 
and self- 
determinatio
n theory 
(SDT), 
Acceptance 
and 
commitment 
theory 
(ACT), 
Change 
theory/techni
que (CT), 
Health at 
Every Size 
(HAES), 
N=6283 
articles; 584 
titles 
showed 
relevance 
after initial 
screening.      
Abstract 
screening 
for inclusion 
exclusion 
criteria 
produced 
n=48 
studies that 
provided 
evidentiary 
support and 
were 
relevant to 
this project. 
These 48 
articles 
contained 
82 outcome 
reports and 
a pooled 
SR using PRISMA of 
RCT > 12 weeks 
duration; January 
2007 to October 2014; 
adult populations- 
mean age 40 years; 
Mean BMI >30.  
Primary outcomes 
measured: healthy 
diet and physical 
activity.  
 
IBM SSPS statistics 
were used to 
complete meta-
analysis.  
Physical activity 
(PA) was addressed 
in 35 trials (30 
ST,0.36 effect size 
(ES) 95% CI; 17 LT, 
0.25 ES 95%CI; and 
47 both ST and LT, 
0.31 ES 95%CI). 
Diet was addressed 
in 26 trials (20 
ST,0.41 ES 95%CI; 
15 LT, 0.19 ES 
95%CI; and 35 ST 
and LT, 0.29 ES 
95%CI). PA and diet 
were both 
addressed in 61 
trials (50 ST, 0.37 
ES 95%CI;32 LT, 
0.24 ES 95%CI; and 
82 both ST and LT, 
no data).  
Level 
I 
Qualit
y High 
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mindfulness, 
other 
For  
Diet and 
physical 
activity,  
goal setting, 
self -
monitoring, 
feedback, 
social 
support,  
population 
of 11,183 
participants.  
Intervention
s were 
either short-
term (ST) < 
6 months or 
long-term 
(LT) > 12 
months.  
Inclusion:  
Behavioral 
change 
intervention, 
cognitive 
behavioral 
strategies 
or 
intervention.  
Exclusion: 
Did not 
include 
Behavioral 
change 
intervention, 
cognitive 
behavioral 
strategies 
or 
intervention.  
For physical 
activity and 
ST Meta-regression 
data: Goal setting: b 
0.480; 95% CI 
0.257-0.705 
p<0.001. Feedback 
behaviour: b 0.219, 
95% CI -0.040, 
0.479 p=0.096. Self- 
monitoring behavior: 
b 0.398, 95% CI 
0.164, 0.632, 
p=0.001.LT meta-
regression data: 
Goal setting: b 
0.228 ; 95% CI 
0.056, 0.327 
p=0.057. Self- 
monitoring behavior: 
b 0.184, 95% CI 
0.009, 0.360, 
p=0.040. Feedback: 
b 0.249, 95%CI 
0.085, 0.412, p= 
0.004  
 
Conclusions that 
there are both 
similarities and 
differences in BCTs 
the are effective to 
promote healthy 
eating and 
increased activity 
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healthy 
eating 
improveme
nt 
 
and maintenance. 
The results support 
goal setting, self-
monitoring and 
behavioral/person-
centered 
counseling/motivatio
nal interviewing that 
support autonomy.  
Tang, J. C. H., 
Abraham, C., 
Greaves, C. J. 
& Nikolaou, V. 
(2016). Self-
directed 
interventions to 
promote weight 
loss: a 
systematic 
review and 
meta-analysis. 
Health 
Psychology 
Review, 10(3) 
358-372. 
 
The focus of this 
study was on 
interventions 
that did not 
involve on going 
professional 
interaction/ 
contact, other 
than an 
introductory 
face-to-face 
session.  
Research 
questions 
included: “1. 
How effective 
are self-directed 
interventions . . . 
to promote 
short, medium 
and long-term 
weight loss in 
adults? 2. Are 
particular 
Systematic 
review and 
meta-
analysis 
 
Interventions
: 
target diet 
and or 
physical 
activity; self-
directed with 
limited face-
to-face 
professional 
contact to < 
one 90- 
minute 
instructional 
session; had 
at least one 
interactive 
intervention; 
or had at 
N= 5226 
from 
database 
search and 
N=3 from 
other 
sources. 
After 
removal of 
duplications 
n= 3884;  
Of these 
n=27 RCTs 
that met 
inclusion 
and did not 
meet one or 
more 
exclusion 
criteria and 
were 
included in 
the 
Articles included were 
published prior to July 
2014, study data of 
RCTs of self-directed 
weight loss or weight 
control interventions 
Database search: 
MEDLINE, Embase, 
PsychINFO, CINAHL, 
the Cochrane Library. 
Outcomes measured: 
effectiveness of self-
directed internet-
based interventions; 
effectiveness of 
change technique 
inclusion (eg. goal 
setting, self-
monitoring, feedback, 
behavioral instruction) 
on self-directed 
interventions; 
changes in weight, 
Results: people who 
utilized self-directed 
(mostly internet 
based) interventions 
lost a greater 
amount of weight 
than those who 
received minimal or 
no intervention/ 
treatment; Self-
monitoring: (MD= -
1.56kg, CI -2.25, -
0.86) (SMD = - 0.41, 
95% CI – 0.60, -
0.23, l2=79% ; p=< 
0.00001). The mean 
weight loss among 
the intervention 
group ranged 
between 0.6 to 5.3 
kg.  
Change techniques: 
Goal setting: was 
not significantly 
Level 
I 
Qualit
y High 
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modes of 
delivery of self-
directed weight 
loss 
interventions 
more or less 
effective? 3. Do 
particular 
frequently 
employed 
change 
techniques 
enhance 
effectiveness?” 
(Tang et al., 
2016) 
least one 
self-
regulatory 
element 
such as goal 
setting or 
diary of 
thoughts and 
or behaviors.  
 
 
 
quantitative 
synthesis.  
Inclusion:  
RCTs 
published in 
English 
prior to 
August 
2014, self-
directed 
weight loss, 
weight 
control 
intervention
s.  
Exclusion 
criteria not 
stated.  
BMI, waist 
circumference 
 
difference between 
groups IG CG.  
 
Conclusions 
indicated that self-
monitoring and self-
directed including 
on-line formats 
could be used to 
assist with weight 
loss generating 
modest but 
significant effect.  
Tapsell, L. C., 
Lonergan, M., 
Batterham, M. 
J., Neale, E. P., 
Martin, A., 
Thorne, R. . . 
.Peoples, G. 
(2017). Effect 
of 
interdisciplinary 
care on weight 
loss: a 
randomized 
controlled trial. 
BMJ Open, 
The objective 
was “ to 
determine 
effectiveness of 
a novel 
interdisciplinary 
treatment 
compared with 
usual care on 
weight loss in 
overweight and 
obese 
volunteers” 
(Tapsell et al., 
2017). 
Single 
blinded RCT  
 
Participants 
were 
randomized 
into one of 
the three 
groups: CG, 
IG or IWG. 
The CG 
received the 
usual care. 
The all were 
provided 
Initial 
sample: 
Control 
group/usual 
care (CG) 
n=126; 
Intervention 
group (IG) 
n=125 and 
intervention 
plus 
walnuts 
(IWG) 
n=126. 
Inclusion:  
.  
Outcomes measured: 
weight loss from 
baseline and at 12 
months; change in 
blood pressure; 
fasting blood glucose 
and lipids; changes in 
diet and exercise; 
psychological 
measures (AAQ-W, 
DASS-21, QoL SF-12) 
 
Results: 
At the 3 month 
mark, there was a 
significantly greater 
weight loss in the IG 
and IWG than Cg: (-
1.2 kg, p=0.045, I ; -
1.3kg , p=0.025 
IWG) and at 6 
months for IWG (-
2.1 kg, p=0.010). At 
12 months the 
weight change 
adjusted for 
baseline weight 
Level 
I 
Qualit
y High 
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2017 (7) 
e014533. 
doi:10.1136/bm
jopen-2016-
014533 
 
standard 
weight loss 
materials 
including 
healthy diet 
and exercise 
as well as 
nurse lead 
weight loss 
advice. The 
IG also 
received 
interdisciplin
ary advice 
from 
dietician, 
and 
psychologist. 
IWG 
received 
interdisciplin
ary advice 
and food 
supplement 
of 30g of 
walnuts daily 
Resident of 
the Illawarra 
region, 
aged 25-54 
years, BMI 
25-40kg/m2, 
English 
literate. 
Exclusion:  
Not English 
literate, 
severe 
medical 
condition or 
terminal 
condition-
life 
expectancy 
<1year, 
illegal drug 
use, 
alcoholism/r
egular 
alcohol use 
.50g/day, 
other major 
impediment
s  
 
showed effect of 
p=0.056 reflective of 
CG- IWG difference 
of -2.2kg (95% CI -
4.6 to 1,0kg, 
p=0.068) compared 
to CG -IG: -1.9kg 
(95%CI -4.5 to 
0.7kg, p=0.228) and 
difference between 
IG and IWG: -0.3kg 
(95% CI -2.8 to 2.2 
kg, p=1.00) 
Conclusions 
indicated that the 
intervention sample 
achieved 
significantly greater 
weight loss 
outcomes than the 
control/ usual care. 
Interdisciplinary 
interventions 
produced more 
clinically significant 
outcomes that were 
better sustained.  
Thabault, P. J., 
Burke, P., J., & 
Ades, p. A. 
(2016). 
The purpose of 
the study was to 
“ evaluate a 
nurse 
Quasi-
experi-
mental study 
 
Convenienc
e sample 
n=38 
Inclusion: 
  
Outcomes measured: 
weight loss; patient-
provider satisfaction, 
Weight, BMI and BP 
were assessed at 
initial visit and 4 and 
12 weeks. Initial 
Level 
II 
Qualit
y High 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
 
88 
 
Intensive 
behavioral 
treatment 
weight loss 
program in an 
adult primary 
care practice. 
Journal of the 
American 
Association of 
Nurse 
Practitioners, 
28 (2016) 249-
257.  
 
practitioner lead 
intensive 
behavioral 
treatment (IBT) 
program for 
obesity 
implemented in 
an adult primary 
care practice” 
(Thabault et al., 
2016). 
No control 
group.  
Intervention: 
5A’s 
framework 
(ask, assess, 
advise, 
agree, and 
assist); 
obesity 
screening 
and 
nutritional 
assessment; 
motivational 
interviewing; 
and weight 
loss 
education 
(500-
1000kcal 
reduction 
with a goal 
of a 1-2 
pound /week 
loss and 
increased 
physical 
activity); 
introductory 
packet 
(education-
benefits of a 
Aged 18 
years or 
older, 
primary 
care 
patients of a 
patient-
centered 
medical 
home 
practice in 
New 
England, 
Medicare, 
Medicaid, or 
commercial 
insurance.  
Exclusion 
criteria not 
identified.  
feasibility; and 
acceptability 
mean/SD were: 
weight 229/36, 
(males: 252/35; 
females: 215/29) 
BMI 37.4/4.6 
(males: 36.8/3.7; 
females: 37.9/5.1) 
,SBP 129/14, DBP 
71/13; At 4 weeks: 
weight 223/34, BMI 
36.3/4.4, SBP 
128/9, DBP 73/10; 
At 12 weeks: weight 
219/34, BMI 36.3/ 
4.4, SBP 131/15, 
DBP 73/12. Using 
paired t-test after 4 
visits weight loss 
was significant  
(6.6lbs, p<0.05); for 
males (8.9lbs 
p<0.05); for females 
(5.2lbs p<0.05). At 
12 weeks the mean 
weight loss was: 
males 11.73 lbs 
(p<0.05) and 
females 10.16lbs 
(p<0.05).  
Patient satisfaction 
was measured with 
a Likert scale 
questionnaire that 
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healthy 
lifestyle and 
weight, 
dietary and 
activity 
journal, 
pedometer, 
questionnair
e addressing 
goals and 
readiness to 
change and 
nutritional 
assessment) 
initial and 13 
follow up 
weight loss 
counseling 
sessions, 
anthropomet
ric 
measures,  
 
achieved a 75% 
response rate that 
indicated favorability 
in all categories: 
appointments, 
weight loss 
counseling and 
tools. 
Conclusions 
indicated that NP 
led IBT programs 
were an effective 
means for adults in 
primary care to 
achieve weight loss 
and was well 
received by the 
patient population.  
Welbourn, R., 
Hopkins, J., 
Dixon, J. B., 
Finer, N., 
Hughes, C., 
Viner, R. & 
Wass, J. 
(2018). 
Commissioning 
guidance for 
A SR of current 
evidence for 
commissioning 
primary/second
ary weight 
assessment and 
management for 
patients with 
severe or 
complex 
SR 
 
References 
included 
pathways, 
protocols 
and 
infrastructure 
for pediatric 
to adult 
A total of  
2,560 
references 
were 
identified 
from 6 
databases, 
of which 
n=50 were 
Outcomes included: 
weight loss pre and 
post intervention, 
quality of life, 
psychological health 
(depression, anxiety 
and self-esteem), 
mobility, social 
function and diabetes. 
The results provided 
4 tiers of guidance 
for the following 
health domains: 
general 
practitioners/primary 
care actions 
recommended: 
anthropometric body 
measurements, 
Level 
II 
Qualit
y 
Good 
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weight 
assessment 
and 
management in 
adults and 
children with 
severe 
complex 
obesity. 
Obesity 
Reviews: An 
Official Journal 
of The 
International 
Association for 
the Study of 
Obesity, 
19(1)14-27. 
 
obesity. The 
purpose of the 
SR was to 
“produce a 
model for 
organization of 
multidisciplinary 
team clinics that 
could be 
developed in 
every 
healthcare 
system” 
(Welbourne et 
al., 2018)  
populations 
with obesity.  
 Diabetes, 
included: 
diet, 
exercise, 
bariatric, 
dietetics/pha
rmacotherapi
es,  
included in 
the SR.  
Included in 
the SR: 
guidelines 
published 
between 
2011 and 
2016. 
Inclusion:  
Published 
guidelines, 
systematic 
reviews, 
RCTs 
published 
from 2011 
to 2016. 
Exclusions: 
revision 
(bariatric) 
surgery.  
specialist referral 
criteria, diabetic 
management and 
referrals for bariatric 
surgery; in specialist 
clinic/ adult weight 
assessment and 
management: 
interdisciplinary 
teams including 
bariatric physician, 
dietician, nurse 
specialist, 
psychologist/psychia
try & physical 
therapist and access 
for patients with 
special disabilities; 
Diabetic/ DMII care 
HbA1c <6.9, referral 
for bariatric 
specialist, 
assessment of CV 
risk; Psychological 
and lifestyle issues: 
referrals to 
specialist, 
medication history 
and evaluation of 
psychotropic drugs; 
Post bariatric 
surgical care: 
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interdisciplinary 
care.  
 
The evidence 
provided guidelines 
for standard of 
treatment on a 4 
level scale initiating 
with primary/general 
practice: universal 
interventions routine 
anthropometric 
measurements thus 
reducing stigma, 
and diet, exercise 
and healthy lifestyle 
counseling. Tier 2 
multicomponent 
weight management 
that includes tier 1 
components plus 
pharmacotherapies. 
Tier 3 includes tier 1 
and 2 as well as a 
multidisciplinary 
team and specialist 
assessment. The 4th 
tier includes bariatric 
specialist 
assessment as well 
as the first 3 tiers.  
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• Note: Appraisal tool utilized in this evidence appraisal was the Johns Hopkins Nursing Research Evidence 
Appraisal Tools, ©The Johns Hopkins Hospital/ Johns Hopkins University School of Nursing (Dang & Dearholt, 
2017).  
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Construction of Evidence-Based Practice 
Synthesis of Critically Appraised Literature 
 According to the WHO (2018) the global incidence of obesity has nearly tripled 
since 1975. In 2016, approximately 13% of the global adult population was obese, and 
39% were overweight (WHO, 2018). Given the overwhelming and growing prevalence 
of obesity, and the significant impact of obesity on morbidity and mortality, managing 
obesity is of paramount importance in the primary care setting. This EBP Project strove 
to address whether the use of an evidenced based multicomponent protocol for the 
assessment and treatment of obese patients assist adult patients with obesity to 
achieve better weight loss outcomes compared to usual care including: a reduction in 
BMI, waist circumference and waist to-hip ratio, as well as improve secondary outcomes 
measures of BP, HbA1c, total cholesterol, HDL, LDL, triglycerides and the PHQ-9 and 
the GAD-7 scores.  
The current literature supports the use of a tailored multicomponent approach to 
weight loss that is unique to each patient with obesity. Furthermore, high-quality 
evidence demonstrates that the following interventions can effectively reduce weight, 
BMI, waist circumference, and other obesity indicators: 
• Anthropometric measurement (eg. height, weight, BMI, waist 
circumference, and waist-to-hip ratio) (Tapsell et al., 2017; Welbourn et 
al., 2018) 
• Nutritional assessment (Hageman et al., 2017; Thabault et al., 2016; 
Wellbourn et al., 2018) 
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• Individualization or tailoring of interventions (Eaton et al., 2016; Cheatham 
et al., 2018; Tang et al., 2016) 
• Diet and exercise counseling that included: caloric reduction from between 
500 -1000kcal per day and use of a healthful diet( lean protein, fresh fruits 
and vegetables, whole grains and low fat; portion control); increased 
exercise to at least 150 minutes per week, on most days that included 
aerobic activity (eg. brisk walking) (Batsis et al., 2016; Cheatham et al., 
2018; Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; Rodriguez-
Cristobal et al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et 
al., 2016; Welbourn et al., 2018).  
• Behavioral and lifestyle counseling and modification (eg. face-to-face, or 
telephone, printed tools; not eating in front of the television, social eating, 
stress, goal setting) (Batsis et al., 2016; Beeken et al., 2017; Cheatham et 
al., 2018; Eaton et al., 2016; Hageman et al., 2017; Harrigan et al., 2016; 
Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; Rodriguez-
Cristobal et al., 2017; Samdal et al., 2017; Tang et al., 2016; Tapsell et al., 
2017; Welbourn et al., 2018) 
• Motivational counseling (Rodriguez-Cristobal et al., 2017; Samdal et al., 
2017, Thabault et al., 2016; Welbourn et al., 2018 
• The 5A’s (ask, assess, advise, agree, and assist) counseling and 
intervention (Thabault et al., 2016) 
• Self-guided weight loss plan (eg. Ten Top Tips/10TT, online diet plans) 
(Beeken et al., 2017; Hageman et al., 2017; Tang et al., 2016) 
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• Self-monitoring of diet and activity log, goals using a diary, or tracking 
device (eg. Fitbit®, Smartphone application, pedometer, or online tracker) 
(Cheatham et al., 2018; Ma et al., 2019; Rolls et al., 2017; Tang et al., 
2016) 
• Peer groups, discussion boards and weekly meetings (Hageman et al., 
2017) 
• Psychosocial (eg. PHQ-9, GAD-7, SF-12, SF-36, SCL-20, IWQoL) (Kroes 
et al., 2016; Ma et al., 2019; Tapsell et al., 2017) and readiness evaluation 
(eg. AAQ-W) (Tapsell et al., 2017) with referral and treatment for 
depression and anxiety  
• Specialist collaboration (eg. dietician, psychologist, bariatric) (Kroes et al., 
2016; Tapsell et al., 2017; Wellbourn et al., 2018) 
• Pharmacotherapies, use of weight loss medications (Kroes et al., 2016; 
Wellbourn et al., 2018) 
In addition, the following interventions appear to significantly improve 
cardiovascular risk, cardiovascular and or metabolic biomarkers, quality of life, or 
physical function: 
• Nutritional assessment (Hageman et al., 2017; Thabault et al., 2016; 
Wellbourn et al., 2018) 
• Individualization or tailoring of interventions (Eaton et al., 2016; Cheatham 
et al., 2018; Tang et al., 2016) 
• Diet and exercise counseling that included: caloric reduction from between 
500 -1000kcal per day and use of a healthful diet (lean protein, fresh fruits 
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and vegetables, whole grains and low fat; portion control); increased 
exercise to at least 150 minutes per week, on most days that included 
aerobic activity (eg. brisk walking) (Batsis et al., 2016; Cheatham et al., 
2018; Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; Rodriguez-
Cristobal et al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et 
al., 2016; Welbourn et al., 2018).  
• Behavioral and lifestyle counseling and modification on regularly 
scheduled bases (eg. face-to-face, telephone, text messages, or printed 
tools; not eating in front of the television, social eating, stress, goal setting) 
(Batsis et al., 2016; Beeken et al., 2017; Cheatham et al., 2018; Eaton et 
al., 2016; Hageman et al., 2017; Harrigan et al., 2016; Kozica et al., 2015; 
Kroes et al., 2016; Ma et al., 2019; Rodriguez-Cristobal et al., 2017; 
Samdal et al., 2017; Tang et al., 2016; Tapsell et al., 2017; Welbourn et 
al., 2018) 
• Motivational counseling (Rodriguez-Cristobal et al., 2017; Samdal et al., 
2017, Thabault et al., 2016; Welbourn et al., 2018 
• The 5A’s (ask, assess, advise, agree, and assist) counseling and 
intervention (Thabault et al., 2016) 
• Self-guided weight loss plan (eg. Ten Top Tips/10TT, online diet plans) 
(Beeken et al., 2017; Hageman et al., 2017; Tang et al., 2016) 
• Self-monitoring of diet and activity log, goals using a diary, or tracking 
device (eg. Fitbit®, Smartphone application, pedometer, or online tracker) 
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(Cheatham et al., 2018; Ma et al., 2019; Rolls et al., 2017; Tang et al., 
2016) 
• Peer groups, discussion boards and weekly meetings (Hageman et al., 
2017) 
• Psychosocial (eg. PHQ-9, GAD-7, SF-12, SF-36, SCL-20, IWQoL) (Kroes 
et al., 2016; Ma et al., 2019; Tapsell et al., 2017) and readiness evaluation 
(eg. AAQ-W) (Tapsell et al., 2017) with referral and treatment for 
depression and anxiety  
• Specialist collaboration (eg. dietician, psychologist, bariatric) (Kroes et al., 
2016; Tapsell et al., 2017; Wellbourn et al., 2018) 
• Pharmacotherapies, use of weight loss medications (Kroes et al., 2016; 
Wellbourn et al., 2018) 
 Evidence presented suggested that prior to initiating any form of intervention, 
patients should be screened for obesity. This would involve measurements of height, 
weight and calculating BMI. BMI > 30 is consistent with obesity, however, this 
measurement can be deceiving in a patient with large muscle mass. Therefore, waist 
circumference and waist-to-hip ratio should also be measured. Since obesity carries 
known health risks, screening for comorbidities such as: hypertension, diabetes, 
hyperlipidemia, depression and or anxiety should also be completed when possible 
(Batsis  et al., 2016; Beeken  et al., 2017; Cheatham  et al., 2018; Eaton  et al., 2016; 
Harrigan  et al., 2016; Tapsell  et al., 2017; Thabault et al., 2016; Wellbourn et al., 
2018).  
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Provider use of the 5A’s (ask, assess, advise, agree, and assist) (Thabault et al., 
2016) counseling and intervention technique as well as motivational interviewing or 
counseling techniques (Rodriguez-Cristobal et al., 2017; Samdal et al., 2017; Thabault 
et al., 2016; Welbourn et al., 2018) were interventions shown in Level I and Level II 
evidence to illicit open conversation, aid in assessment and treatment, and develop 
relationships that improve successful weight loss. Determining participant weight loss 
history, readiness to lose weight, bias(es), physical as well as psychosocial barriers and 
limitations can produce better outcomes (Kroes et al., 2016; Ma et al., 2019; Tapsell et 
al., 2017)  
Obesity is a multifactorial chronic disease often accompanied by comorbidities. 
Therefore no one specific intervention can consistently meet each individual’s needs. 
Multiple individualized interventions may be necessary to produce weight reduction 
(Cheatham et al., 2018; Eaton et al., 2016; Ma et al., 2019; Sambal et al., 2017; Tapsell 
et al., 2017; Thabault Burke & Ades, 2016). These interventions may have included 
collaboration with one or more specialists when necessary (eg. dietician, 
endocrinologist, psychologist, bariatric) (Kroes et al., 2016; Tapsell et al., 2017; 
Wellbourn et al., 2018). 
The evidence compiled for this EBP project offered a multitude of potential 
interventions, however at this clinical site many were unrealistic for this patient 
population. Those that had merit in this setting are discussed further.  
On the surface, the treatment of obesity would appear to be simple, however 
obesity and its’ treatment is complex. For these reasons evidence supports a 
multicomponent approach. Multiple studies (Batsis et al., 2016; Cheatham et al., 2018; 
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Kozica et al., 2015; Kroes et al., 2016; Kushner & Ryan,2014; Ma et al., 2019; 
Rodriguez-Cristobal et al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et al., 
2016; Welbourn et al., 2018) and the Guidelines (2013) for Managing Overweight and 
Obesity in Adults from the NIH (Jensen et al., 2014), advocate for a reduced caloric 
intake with use of healthy use of a healthful diet (eg. lean protein, fresh fruits and 
vegetables, whole grains and low fat) as well as portion control. This diet includes: a 
700kcal/day reduction or use of a 1200 to 1500kcal/day plan for adult females and 1500 
to 1800kcal/day for males, along with increased physical activity. However, a 
standardized program may not work for all patients (eg. diabetes or a personal with 
physical limitations). In these cases, individualization is necessary (Batsis et al., 2016; 
Harrigan et al., 2016; Kroes et al., 2016; Rodriguez-Cristobal et al., 2017; Ma et al., 
2019; Rolls et al., 2017; Tapsell et al., 2017; Thabault Burke & Ades, 2016).  
Increased physical activity for weight loss is supported by Level I and Level II 
evidence. Recommended activity consists of at least 150 minutes per week, on most 
days that included aerobic activity (eg. brisk walking) (Batsis et al., 2016; Cheatham et 
al., 2018; Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; Rodriguez-Cristobal et 
al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et al., 2016; Welbourn et al., 
2018) has been shown to increased caloric expenditure, increase physical functionality 
and mobility and aid in weight reduction. Again, this will need to be modified to the 
individual as patients have circumstances that may be prohibitive to exercise such as: 
physical limitations, climate, comorbidities, responsibilities, and personal desire. 
Motivation and enjoyment are a key to increased exercise (Batsis et al., 2016; Beeken 
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et al., 2017; Eaton et al., 2016; Harrigan et al., 2016; Kroes et al., 2016; Samabal et al., 
2017; Tapsell et al., 2017; Thabault Burke & Ades, 2016).  
Weight loss behavioral and motivational counseling is considered to be the gold 
standard in weight loss (Harrigan et al., 2016) and is supported by Level I and Level II 
evidence. Counseling can be presented in various forms such as motivational 
counseling, behavioral counseling or psychotherapy. It can be implemented using 
various methods (eg. face-to-face, texting, or telephone) and through different media 
(eg. verbal, video or print materials). The best results come from frequent and continued 
behavioral and motivational counseling encounters, however the goal is to help the 
patient to be autonomous and self-monitoring (Hageman  et al., 2017; Harrigan et al., 
2016; Hartman et al., 2014; Kozica et al., 2015; Ma et al., 2019; Pollak et al., 2016; 
Rodriguez-Cristobal et al., 2017; Samdal et al., 2017; Tapsell et al., 2017; Thabault 
Burke & Ades, 2016). Peer groups, online discussion boards and weekly meetings have 
also been supported by high level evidence to be effective interventions when used 
alone or as part of a multicomponent weight loss program (Hageman et al., 2017) 
There are many potential barriers to weight loss. Despite these barriers, 
motivation can be achieved via a multitude of interventions. High levels of evidence 
support the use of validated tools to assess readiness to lose weight (eg. the 
Acceptance and Action Questionnaire for Weight/AAQ-W). Readiness has a direct 
correlation to successful weight loss (Tapsell et al., 2017; Thalbault et al., 2016; 
Welbourn et al., 2018). Therefore, a patient must be emotionally ready regardless of 
physical need. Additionally, weight loss success is greater in patients who have a sense 
of autonomy and self-efficacy, as well as those who set goals for themselves and who 
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hold themselves accountable for those goals (Hageman et al., 2017; Harrigan et al., 
2016; Hartman et al., 2014; Kushner & Ryan, 2014; Kozica et al., 2015; Ma et al., 2019; 
Rodriguez-Cristobal et al., 2017; Samdal et al., 2017; Tapsell et al., 2017).  
Autonomy, self-efficacy and weight loss may have improved through self-guided 
weight loss plans (eg. Ten Top Tips/10TT, online diet plans) (Beeken et al., 2017; 
Hageman et al., 2017; Tang et al., 2016) as well as goal setting and self-monitoring 
through the use of diet and activity log, goals using a diary, or tracking device (eg. 
Fitbit®, Smartphone application, pedometer, or online tracker) (Cheatham et al., 2018; 
Ma et al., 2019; Rolls et al., 2017; Tang et al., 2016).  
There is high level support for the use of tracking technology such as: FitBit® or 
AppleWatch® or smart phone applications such as MyFitnessPal®, along with weight 
loss, behavioral and motivational counseling, have been shown to increase physical 
activity and weight loss within the young and middle aged population (Beeken et al., 
2017; Cheatham et al., 2018; Tang et al., 2016). Several studies offered group or peer 
led activities in an on-line format to increased autonomy, stimulate self-monitoring and 
provide access to those in remote or limited access communities in an effort to promote 
weight loss (Beeken et al., 2017; Cheatham et al., 2018; Hageman et al., 2017; 
Hartman et al., 2014; Kozica et al., 2015; Tang et al., 2016). In order to self-monitor and 
achieve set goals, various methods have been supported in the literature such as the 
use of a food and exercise journal (Hartman et al., 2014) or tracking technology such 
as: MyFitnessPal® (Tang et al., 2016) that can be used to track caloric intake, activity 
and search menu items and nutrition information. It also sends the user reminders to log 
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in. These have been shown to be effective mechanisms and enhance both short-term 
and long-term weight loss success.  
In addition to treating comorbidities that can affect weight (eg. depression) (Ma et 
al., 2019) high level evidence supports the use of pharmacotherapies to enhance weight 
loss when accompanied by diet, exercise and lifestyle modifications (Kroes et al., 2016; 
Wellbourn et al., 2018). There are many drug classes that assist with weight loss, 
among them are: gastrointestinal lipase inhibitors (eg. Orlistat/ Xenical), serotonin 2C 
receptor agonists (eg. Locaserin/ Belviq), phentermine-topiramate combinations (eg. 
Bontril), and noradrenergic/ dopaminergic antidepressants (eg. Buproprion). Off label 
use of serotonic agents (eg. Fluoxetine) have not been approved by the FDA for weight 
loss, but have been used to treat depression, panic disorder, obsessive compulsive 
disorder and bulimic eating disorder (Sheehan, Chen, Yanovski & Calis, 2014; Tek, 
2016) 
Best Practice Model Recommendation 
 The clinical site for this EBP project was in an underserved community free clinic. 
All the patient population had limited financial resources, and had difficulty with keeping 
follow-up appointments, thus limiting possible weight loss interventions. This was taken 
into consideration when designing this EBP project.  
Obesity is a multifactorial chronic disease and no one intervention will work for 
each individual with consistency (Cheatham et al., 2018; Eaton et al., 2016; Kushner & 
Ryan, 2014; Ma et al., 2019; McLaughlin et al., 2017; Sambal et al., 2017; Tapsell et al., 
2017). The literature review identified an individualized multicomponent intervention as 
the best practice in the treatment of obesity in adults. This multicomponent intervention 
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should include identifying patients who are obese by measuring weight and BMI at each 
visit. For those with a BMI > 30, a waist circumference measurement and waist to hip 
ratio should be obtained as well as an obesity history and health assessment for risks 
associated with obesity (Batsis et al., 2016; Beeken et al., 2017; Cheatham et al., 2018; 
Eaton et al., 2016; Harrigan et al., 2016; Tapsell et al., 2017). Prior to starting any 
intervention, and after determining the need for weight reduction, a weight loss 
readiness assessment should be completed as there is a direct correlation with 
readiness and weight loss success (Rolls et al., 2017). Because obesity is often 
associated with comorbidities, screening for hypertension, diabetes, hyperlipidemia, 
depression and or anxiety should also be completed when possible (Kroes et al., 2016; 
Rodriguez-Cristobal et al., 2017; Ma et al., 2019; Rolls et al., 2017; Tapsell et al., 2017). 
Anthropometric assessment of height, weight, BMI, was completed at baseline and at 
each visit. Waist circumference and waist to hip ratio should be completed at baseline 
and week 12. Validated and simple assessment tools, specifically the PHQ-9, as well as 
the GAD-7 should be incorporated to complete depression and anxiety screening at 
baseline and at three months. Laboratory studies should be completed at baseline and 
if necessary, at three months provided the patient is able to complete the studies.  
Obese patients had a personalized intervention that includes weight loss with a 
healthy diet with caloric reduction to 1200 to 1500 kcal per day for women and 1500 to 
1800 kcal per day for men, or a caloric reduction of 500 kcal to 700 kcal per day, or use 
of an evidence based diet. It also involves increased activity, ideally at least 150 
minutes per week spanning over at least four days per week. Additionally, lifestyle and 
weight loss behavioral counseling should be implemented for a period of at least six 
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months. For this project the first three months of the weight loss counseling would take 
place during the intervention phase after which clinic staff would provide the remaining 
follow-up. This behavioral counseling may include motivational counseling, autonomy 
and self-efficacy building, and goal setting. Additionally, possible individualized use of 
internet resources such as the National Heart Lung and Blood institute (NIH) Aim for 
Healthy Weight page and www.choosemyplate.gov may be recommended. Printed 
educational tools obtained from validated web sites such as: NIH, American Diabetes 
Association (ADA) or the American Heart Association (AHA) may be provided (Batsis et 
al., 2016; Harrigan et al., 2016; Kroes et al., 2016; Rodriguez-Cristobal et al., 2017; Ma 
et al., 2019; Rolls et al., 2017; Tapsell et al., 2017). Medication adjustment utilizing 
pharmacotherapies that do not have side effects of weight gain and or use of anti-
obesity medications may be helpful for some patients (Kroes et al., 2016; Ma et al., 
2019). For a select group of adults with BMI > 40 or > 35 with obesity-related 
comorbidities, bariatric surgery may be beneficial and a referral would be provided in 
the primary care setting if the patient does not respond to multicomponent interventions 
(Batsis  et al., 2016; Harrigan  et al., 2016;; Kroes  et al., 2016; Tapsell  et al., 2017) .  
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
Evidence showed that tailored multicomponent interventions were an effective 
way to promote weight loss in adults with obesity. Many facilities, including the clinic 
used for this EBP Project do not use a standard protocol to promote weight loss. 
Instead, patients may receive basic education regarding the benefit of caloric reduction 
and increased activity to promote weight loss but lack individualized attention to the 
patient’s resources and personal needs. At this site, obesity management is a challenge 
despite both staff and patients placing weight loss as a high priority for the population 
being served.  
This project included the EBP project manager’s collaboration with: a family 
practice physician, nurse practitioners (NP), registered nurses (RN), medical assistants 
(MA), dietician, as well as the office manager, all of whom appreciated the significance 
of the practice change for the treatment of obesity within this clinical setting. A great 
many barriers exist when treating obesity including: the stigma associated with obesity, 
propensity of providers to ignore this chronic disease and provider personal bias, lack of 
use of affordable and effective treatment options, lack of understanding and knowledge 
related to obesity and treatment, inappropriate prescribing of medications including 
those that contribute to weight gain or underuse of anti-obesity pharmacotherapies, all 
of which contribute to the aversion to provision of best practice recommendations in the 
management of obesity.  
The aim of this project was to help patients and providers to overcome barriers 
that prevent weight loss in adults with obesity through the implementation of theory-
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driven and Evidence-Based best practices. The purpose of this project was to improve 
selected obesity indicators, including weight, body mass index (BMI), waist 
circumference, and waist-to-hip ratio, through the implementation of an Evidence-Based 
multicomponent intervention tailored to individual patient strengths, barriers, and 
resources. In addition, a secondary aim was to determine if the weight loss intervention 
resulted in improvement in health outcomes related to obesity, including BP, HbA1c, 
lipids, as well as depression and anxiety symptoms. The intervention components 
varied by patient, but in general, options included diet and exercise education, tracking 
of caloric intake and exercise, lifestyle and behavioral counseling, pharmacotherapies, 
and referrals when appropriate.  
Participants and Setting 
  This EBP project was conducted in a free family practice clinic in Northeast 
Indiana that provides primary care to the underserved population across the lifespan. 
This was the only site utilized for this practice implementation. This site was staffed by 
two Masters-prepared NPs and a Medical Doctor who also functions as the Medical 
Director, volunteers who function in various clinical and non-clinical capacities, and a 
small group of non-clinical and administrative staff. The Medical Doctor had been a 
physician since 2007 and is Board Certified in Family Medicine. He is an accomplished 
Family Medicine physician and an Associate Professor at Indiana University School of 
Medicine. The EBP project manager had never been a member of staff within this 
facility, thus eliminating the chance of recruiting her own patients into the project sample 
and, therefore, potential selection bias. Permission for the project’s implementation was 
provided on August 29, 2019 by the Medical Director who approved the project, agreed 
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with the benefit of the project to the clinic and patient population, identified the project 
as feasible at this primary location, as well as promoted interest for the project among 
the clinic’s staff. 
 Eligible participants were recruited during their appointments at the clinic and 
through in-house advertisement of the program from September 20 to December 10, 
2019. Patients who expressed interest were initially interviewed by the project manager 
to evaluate eligibility. The project manager, the Medical Director and the NPs reviewed 
the patient charts to determine eligibility based on diagnosis and health risks. Patients 
who were at least 18 years of age with a BMI of at least 30kg/m2; could understand, 
speak, read and write in English or communicate through a translator; and were able to 
commit to the three-month study timeline were eligible. Patients were excluded from the 
project if they were pregnant or lactating, had cognitive impairment, were not ready to 
lose weight, or were already in an organized weight loss program. Though patients were 
asked to commit to the entire three-month length of the project, they were free to drop 
out at any time. Patients who reasonably could have been harmed by the weight loss 
interventions were excluded from the study.  
 Weight loss in the adult population is challenging due to a wide variety of 
personal factors, including environmental influences and demands, biological and 
behavioral factors, sociocultural factors, socioeconomics, prior history with weight loss 
programs, and self-efficacy (Bomberg et al., 2017; Ceccarini et al., 2015; Hageman et 
al., 2017; Kozica et al., 2015; Pender, 2011; Samdal et al., 2017; Thabault et al., 2016). 
Research shows that obesity is often the result of lifelong dietary and inactivity habits 
that are heavily ingrained within the obese individual and changing these habits can be 
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exquisitely difficult. Thus, it was believed that the merit of this project was to empower 
patients with obesity to use individualized weight loss interventions that would be most 
appropriate given their unique personal factors.  
Outcomes 
Multiple anthropometric, clinical, and laboratory outcomes were measured at 
baseline and monitored over time, in accordance with the literature. The primary 
outcome measures were weight and body mass index. Additional weight-related 
outcomes included waist circumference and waist-to-hip ratio. All of these additional 
measures are important predictors of morbidity and mortality and associated diseases 
of the cardiovascular system, metabolic disorders, diabetes, musculoskeletal 
dysfunction and various cancers (Batsis et al., 2016; Eaton et al., 2016; Hageman et al., 
2017; Harrigan et al., 2016; Ma et al., 2019; Tang et al., 2016; Tran et al., 2018). 
Anthropometric measures of weight and BMI were collected at baseline and at follow-up 
visits (each week for 4 weeks, then monthly for 2 months). Waist circumference and 
waist-to-hip ratio were collected at baseline but not at week 12. Anthropometric 
measurements were collected using standardized procedures and equipment at the 
practice site are included in Appendix J.  
  Secondary outcomes included depression, anxiety, blood pressure, glycosylated 
hemoglobin (HbA1c), and a fasting lipid panel (total cholesterol, low-density lipoprotein, 
high-density lipoprotein, and triglycerides). Each of these secondary outcomes is 
considered either a predictive factor or consequence of obesity, or both (Beeken et al., 
2017; Grossman et al., 2017; Kushner & Ryan, 2014; Rodriguez-Cristobal et al., 2017; 
Tapsell et al., 2017; Thabault et al., 2016).  
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Obesity is often associated with chronic mental illnesses including depression 
and anxiety. Both of these conditions can contribute to obesity (Kushner & Ryan, 2014; 
Ma et al., 2019; Tapsell et al., 2017; Thabault et al., 2016) as well as predict the failure 
of obesity treatment (Kushner & Ryan, 2014; Ma et al., 2019; Tapsell et al., 2017; 
Thabault et al., 2016). Both depression and anxiety were measured at baseline and 
depression was measured at 3 months afterwards using the Patient Health 
Questionnaire -9 (PHQ-9) and Generalized Anxiety Disorder-7 Questionnaire (GAD-7). 
These questionnaires are included in Appendices G and H respectively.  
Blood pressure, chronic hyperglycemia, and dyslipidemia are strong predictors of 
cardiovascular disease, and they are often present along with obesity in adults (ADA, 
2019b; AHA, 2018; Curry et al., 2018; NIH, 2019). Because blood pressure is generally 
measured at each clinic visit as part of standard care, it was measured according to the 
same schedule as the anthropometric measures. Laboratory data (HbA1c and lipid 
panel) were obtained at baseline in patients that qualified for the test and were 
financially able to cover the cost if any. However, no participants completed follow up 
studies 3 months afterwards. Laboratory results are included in Appendix K.  
  Intervention 
  Because singular interventions are generally ineffective at managing obesity, the 
“intervention” for this EBP project consisted of a set of activities that were tailored to 
each participant’s strengths, resources, and challenges. The tailored multicomponent 
weight loss program featured the following categories, organized along the mnemonic, 
“NEWER ME”: Nutrition, Exercise, Weight loss support, Emotional support, Referrals, 
Medications, and Expanded accountability. This section will describe the intervention 
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options within each of these categories and how patients will be matched to weight loss 
options based on their strengths, resources, and challenges.  
Choosing the “Right” Components 
All patients were asked to complete a HPM questionnaire (Pender, 2011) about 
their individual strengths, resources, and challenges when they were enrolled into the 
project. In addition, the patient was screened upon enrollment for weight loss readiness, 
depression, and anxiety to determine the appropriateness and scope of certain program 
components (e.g. emotional support). Those participants who were deemed unready for 
the intervention based upon their answers were to be excluded at that time. No 
participant was excluded. In addition, participants who screened positive for either 
depression or anxiety at the enrollment visit were referred to a Behavioral Health 
Specialist. The project leader worked with the participant to select specific weight loss 
strategies based on the patient’s responses to the questionnaire and screening tools, 
thus promoting autonomy, self-efficacy and accountability. Based upon how well the 
participant was doing at each subsequent visit, modifications to the plan were made, 
including addition and or subtraction of interventions.  
Nutrition 
Since a calorie deficit is paramount for all weight loss programs, all participants 
were instructed to follow a calorie-restricted diet. Depending on their weight loss goals 
and the participant’s personal preference, the patient was prescribed one of three types 
of diets. The three types of diets for participants without comorbidities based upon 
National Guidelines (2013) for Managing Overweight and Obesity in Adults (Jensen et 
al., 2014; Kushner & Ryan, 2014) include eating diets that contain low unsaturated fats, 
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vegetables and fruits, lean proteins, whole grains and low-fat dairy, as well as 
increasing water and fiber intake. Caloric restriction components include one of the 
three following plans:  
• Caloric intake of 1200-1500kcal/day for women or 1500-1800kcal/day for men 
• 500kcal/day or 750kcal/day caloric deficit 
• Use of an evidence–based diets that restricts certain foods such as high fat, 
high carbohydrate, low fiber foods to create caloric deficit such 0as 
www.choosemyplate.gov or Weight Watchers ® (Madigan, 2014) 
In addition, participants with specific dietary needs (e.g. iron, calcium, stable 
vitamin K) or restrictions (e.g. sugar, sodium, saturated fat) according to their medical 
history were prescribed these along with their calorie restriction. Based upon the 
participants personal learning style, nutritional education was provided to all patients in 
visual, verbal and written form as well as through use of hands on examples such as 
product nutrition labels, plates, a deck of cards, measuring cups and spoons for 
participants who are kinesthetic learners. (Appendix M). Participants were asked to 
track their caloric intake in their food and exercise log, either via paper journal 
(Appendix R) or a technology-based application of their choice.  
Exercise 
The primary way in which calories are expended to produce a calorie deficit is 
through physical exercise. While there is a wide variety of exercise modalities available, 
the four main types this intervention will focus on are aerobic, resistance, stretching, 
and water based. Based on national guidelines for obesity management, all patients 
were prescribed a minimum exercise plan of moderate intensity exercise for 150 
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minutes per week, exercising on at least four days per week (Kushner & Ryan, 2014). 
Though walking was the most recommended and chosen form of exercise, participants 
could choose what type of exercise they wanted to use. This could be through a formal 
gym membership and use of equipment and facilities, swimming, bicycling, walking or 
aerobic activity as desired and tolerated. Education about physical exercise was 
provided to all patients in both verbal and written form or demonstrated through a 
professional trainer or instructor at a gym of their preference, such as an aerobics 
instructor at a class at their personal gym or YMCA (Appendix N). Participants were 
asked to track their activity in their food and exercise log.  
Weight Loss Support 
Participants could choose to utilize commercial weight loss programs such as 
Weight Watchers ® and or the use of community exercise facilities if they felt they 
needed the extra weight loss support. Per participant preference they may have chosen 
to utilize their personal gym or YMCA or work out with family or friends. The participants 
had a choice of how they elected to increase physical activity to meet the guidelines as 
tolerated and physically capable.  
Emotional Support 
Each participant was screened for the presence of depression and anxiety at 
baseline and for depression at the three-month mark using the Patient Health 
Questionnaire-9 (PHQ-9) as well as the Generalized Anxiety Disorder-7 (GAD-7) 
respectively. These screening tools were available at the clinical site in multiple 
languages. The PHQ-9 questions the frequency of depressed mood during the past two 
weeks. (Appendix E). Participants who screened positive using the PHQ-9, indicated by 
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a global cut-off score of 10 or more, received a referral to a behavioral health provider to 
determine if they should be treated for depressive disorder (American Psychology 
Association, 2019; Wang et al., 2015; Williams & Nieuwsma, 2019). The GAD-7 
required the participant to answer seven specific questions related to anxiety-related 
symptoms using a Likert-type scale (Appendix F). Global scores at or above 5 would 
receive a referral to a behavioral health provider to determine if they should be treated 
for generalized anxiety disorder (Ahmad et al., 2017; Plummer et al., 2016). 
Emotional support included: motivational counseling; teaching the participant to 
adopt positive rather than negative self-talk or placing blame; recognizing the misuse of 
the terminal words always and never when describing behaviors; developing problem 
solving strategies to manage food intake and situations; learning assertiveness and that 
they were allowed to say no; identifying stressors and food triggers and the techniques 
to reduce stressors and emotional eating; or asking for help and enlisting the assistance 
of family and friends in weight loss efforts. Additional emotional supportive measures 
included meditation and practicing mindfulness (Perreault, 2019b; Rodriguez-Cristobal 
et al., 2017; Samdal et al., 2017; Szczekala et al., 2018; Thalbault et al., 2016; 
Welbourn et al., 2018).  
Referrals 
Referrals to a bariatric surgeon should be provided for participants with a BMI of 
or greater than 40kg/m2 or BMI of or greater than 35kg/m2 with comorbidities, who are 
highly motivated to lose weight and have not responded to non-surgical medically 
supervised interventions (Kroes et al., 2016; Jensen et al., 2014; Kushner & Ryan, 
2014; Welbourn et al., 2018). This includes behavioral treatment with or without 
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pharmacotherapies and lost enough weight or maintained weight loss to meet target 
goals for health risk reduction. These participants should have been referred to a board 
certified and qualified bariatric surgeon. Unfortunately, in the current clinical setting, with 
this patient population, bariatric surgery was not a possibility as the participants did not 
have health insurance or financial resources to cover the costs. During the time frame of 
this EBP Project there were no pro bono bariatric surgery options. Therefore, patients 
who expressed an interest in receiving bariatric surgery for weight loss were provided 
with information about local physicians who could offer this service, but this referral 
would not be made unless patients requested information.  
Referrals were also provided as needed for: mental health counseling and or 
psychotherapies; physical therapist and or orthopedic referral for participants with 
musculoskeletal dysfunction; dietitian for specific dietary needs not met by this program; 
and specialist providers for management of comorbidities such as cardiologist, 
endocrinologist or pain management (Kushner & Ryan, 2014; Ma et al., 2019; Tapsell et 
al., 2017; Welbourn et al., 2018) as these providers were available at or accessible 
through the clinic.  
Medications 
 Medication interventions included: a review of each participant’s current 
medications and discussion of potential drugs that could cause weight gain as well as 
possible alternatives to their use; starting or switching to antidepressant with the least 
potential for weight gain; starting weight loss medications; and medication education.  
 Specific drugs that are known to cause weight gain include some of the following: 
tricyclic anti-depressants (TCA), monoamine oxidase inhibitors (MAOI’s), selective 
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serotonin reuptake inhibitors (SSRI’s), insulin, sulfonylureas, beta blockers, 
contraceptives, and steroid hormones. Alternative choices include: bupropion 
(norepinephrine-dopamine reuptake inhibitor, NDRI), protriptyline (TCA), fluoxetine 
(SSRI), or sertraline (SSRI), metformin (bioguanide), liraglutide (GLP-1 receptor 
agonist), orlistat (lipase inhibitor), angiotensin-converting-enzyme inhibitor (ACE-I), 
calcium channel blockers (CCB), barrier methods of contraception, and nonsteroidal 
anti-inflammatory agents. Changes in medication regimens were made in collaboration 
with the provider, as appropriate, and within the limitations of this free clinic’s formulary. 
Use of pharmacotherapies for weight loss for participants with a BMI of 30kg/m2 or 
higher, or a BMI of 27 kg/m2 or higher with comorbidities is indicated (Jensen et al., 
2014; Kushner & Ryan, 2014). Recommended pharmacotherapies include orlistat, 
lorcaserin or phentermine/topiramate XR. Lorcaserin is newer and has shown positive 
results as it affects appetite due to its high affinity for the 5-hydroxytryptamine 2C 
receptor, a subtype of 5-HT receptor that binds the endogenous serotonin (Jensen et 
al., 2014; Kushner & Ryan, 2014). However, due to site limitations, phentermine and 
topiramate are the drugs usually prescribed and are provided at no charge to the 
patients when pharmacotherapies are indicated. Other options may have been 
prescribed if the patient chose but would have needed to be obtained from an outside 
pharmacy and would not be free of charge. During this project no participant chose to 
use any weight loss specific pharmacotherapies.  
Expanded Accountability  
 Participants tracked caloric intake and physical activity through either a paper 
journal or electronic technology/app (eg. FitBit®, MyFitnessPal®, SmartWatch®) 
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immediately after each meal and activity for weekly and monthly review with the 
program manager. Participants were asked to keep a daily journal and track mood and 
challenges, use of weight loss interventions and progression of goals and were offered 
simple journaling tools to use if they chose (Appendix R) or they purchased a journal or 
created their own document. Behavioral and lifestyle education and counseling was 
provided and reinforced at each appointment to enhance autonomy and accountability.  
  To expand autonomy and accountability, diet and exercise journals were 
reviewed for use and content, usually completed via verbal self-reporting. Along with 
reinforcement of weight loss education, observation of caloric intake and food 
substance was discussed with the participant. Encouragement and motivational 
counseling were provided, and modifications were addressed at each appointment as 
needed. Daily journals were reviewed with each participant via verbal interaction and 
self-reporting, looking for behavioral concerns and use of interventions and potential 
need for modifications. Additionally, review of realistic goals and progression toward 
successful attainment through lifestyle and behavioral modification was discussed with 
the participant at each visit to provide for further autonomy and self-efficacy.  
Comparison  
  The comparison data for this project were obtained through a retrospective 
review of electronic medical records (EMR) prior to project implementation on 
September 20, 2019. The review consisted of a sample (n=25) of patients from the 
Matthew 25 Health and Dental Clinic who met the eligibility criteria for this project and 
who were seen in that clinic approximately 3 to 5 months apart. The goal of this 
retrospective review was to determine if standard care at the clinic resulted in 
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statistically significant weight loss over the period with this type of patient population. 
The standard care weight loss intervention at that time consisted of advice to lose 
weight with a healthy diet, to increase physical activity to at least 150 minutes per week 
with exercise on most days of the week.  
Characteristics of this comparison sample (n =25) are provided in Table 4.2. As 
described in Chapter 2, this standard care intervention did not result in statistically 
significant weight loss. In fact, the mean baseline BMI was the same as the mean BMI 3 
to 5 months after their baseline visit (38.60 kg/m2 [SD 7.17] vs. 38.58 kg/m2 [SD 7.31]) 
respectively.  
Planning 
A great deal of time and commitment was dedicated to the planning phase of this 
EBP Project in order to safeguard quality, provide evidentiary support for content, as 
well as increase the likelihood of a successful outcome. This project was originally 
planned and slated to begin at a federally qualified health clinic in Northwest Indiana. 
However, after a change in clinic leadership, the project was relocated to the current 
site. This change in clinical location and client population resulted in significant 
alterations in the timeline, stakeholder support, and design of the project, and delayed 
commencement of the project by approximately 2 months.  
After discussion with key stakeholders at the current project site, as well as 
reflecting on prior clinical experience as a staff nurse, the need for practice change 
became apparent. Upon the completion of a comprehensive and exhaustive literature 
search for the best and current evidence practice recommendations were determined 
and were incorporated within this EBP Project. The project manager planned the project 
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with close collaboration from key stakeholders including patients, physician, NPs, RNs, 
MAs, volunteers, and the office manager. The intended project was reviewed and 
discussed. Based on stakeholder input, the EBP Project was revised to meet the needs 
and resources at the clinical site. Support for the project and permission for 
implementation was granted by the Medical Director on August 29, 2019. Project 
planning and modification continued with the contributions from the project manager, 
project faculty advisor, key stakeholders, and through additional research as well as 
feasibility of EBP interventions within this specific clinical setting.  
Data 
For this project, a combination of anthropometric, clinical, and laboratory data 
was to be collected using standardized procedures used by providers at the practice 
site.  
Anthropometric Data. The anthropometric measures in this study were height, 
weight, BMI, waist circumference, and waist-to-hip ratio. Height in inches and 
centimeters and weight in pounds and kilograms were both measured using the digital 
scale that is normally used at the clinical site (Health-O-Meter Model 600KL). The scale 
was zeroed before each patient use according to the manufacturer’s instructions. The 
BMI was automatically calculated in the clinic’s EMR system when height and weight 
data were entered. Weight and BMI were measured at each visit. Waist and hip 
circumferences were measured in centimeters using a standard tape measure. The 
waist circumference was measured at the level of the right iliac crest, and hip 
circumference was measured at the level of the right greater trochanter. Waist 
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circumference and waist-to-hip measures were completed at baseline but due to clinical 
resources and protocol, it was not completed at the week 12 visit. 
Clinical Data. The clinical measures used in this study were blood pressure, 
weight loss readiness, depression symptoms, and anxiety symptoms. Blood pressure 
will be measured in mmHg using the portable digital blood pressure device in the clinic 
(Welch Allyn Model 901058). This device had an accuracy +5 mmHg. Blood pressure 
was measured at each visit to screen for hypertension and to determine change with 
weight loss.  
Weight loss readiness was measured using two tools. The Acceptance and 
Action Questionnaire for Weight-Related Difficulties (AAQ-W) (Appendix G) and the 
Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF) Tool (Appendix H). The 
AAQ-W, used with permission (Appendix T), measures pragmatic avoidance and 
psychological rigidity that play a part in health problems including weight control. This 
tool targets weight control interventions (e.g. acceptance of tough or unpleasant 
emotions) (Lillis & Hayes, 2008). The AAQ-W tool correlates with the common levels of 
avoidance and rigidity as measured by the AAQ (r-0.58, p<0.001), obesity-related 
quality of life using ORWELL (r=0.64, p,0.001), psychological distress using GHQ 
(r=0.40, p<0.01) and BMI (r=0.39, p<0.001). There was also a correlation with self-
reported binge eating (r=0.36, p<0.01) and exercise sessions per week (r= -0.30, 
p<0.01) as well as making healthy food choices while dining out (r= -0.40, p<0.01) 
(Palmeria, Cunha, Gouveia, Carvalho & Lillis, 2016). This tool was administered via 
written format and is considered an effective and validated tool to measure weight loss 
readiness.  
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Additionally, weight loss readiness was measured with the WEL-SF tool. The 
WEL-SF measures eating self-efficacy or one’s belief in their ability to perform in a 
given situation. Low self-efficacy is correlated to lower weight loss success and high 
self-efficacy is correlated to greater weight loss success. Self-efficacy for eating is a 
predictor of acquired weight loss behaviors. This tool asks the participant to reflect on 
how confident they feel in relation to situations in which overeating may become a 
problem. In its original form the Weight Efficacy Lifestyle Questionnaire (WEL) is a 
routinely utilized measure of eating self-efficacy that comprises 20-efficacy and five 
circumstance related elements. The short-form WEL (WEL-SF) is a much shorter form 
of the tool that still addresses key aspects. There is a significant correlation between 
total scoring of the WEL-SF and WEL: Pearson's r value of 0.968 and parallel r2 value of 
0.937. The WEL-SF is a valid measure of eating self-efficacy with 94% of the variability 
of the WEL (Ames, Heckman, Grothe & Clark, 2012). This tool was administered via 
written format and is considered an effective and validated tool to measure weight loss 
readiness. These tools were administered to patients only upon enrollment in the 
project.   
Because weight, depression and anxiety have a correlation (Kushner et al., 2014; 
Ma et al., 2019) screening of depression and anxiety was also to be completed. The 
Patient Health Questionnaire-9 (PHQ-9) (Appendix E) questions the frequency of 
depressed mood during the past two weeks. Participants who screened positive using 
the PHQ-9, indicated by a cut-off score of 10 or more, received further evaluation and 
referral to a behavioral health provider to determine if they should be treated for 
depressive disorder. PHQ-9 scores greater than 10 provides the most ideal balance 
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between sensitivity at between 0.871 to 0.88 and specificity at between 0.835 to 0.88 
and a Cronbach’s alpha of test-retest reliability of 0.809 and 0.882, respectively 
(American Psychology Association, 2019; Kroenke, Spitzer, & Williams, 2004; Wang  et 
al., 2015). For this project, the administration of the PHQ-9 was twofold. It was 
administered via written format at baseline and at 12 weeks to screen for depression 
and to determine change in depression symptoms when accompanied by weight loss. 
The PHQ-9 is recognized as an effective validated tool useful when diagnosing and 
planning treatment for depression and providing continuity of care.  
The Generalized Anxiety Disorder (GAD-7) (Appendix F) tool was used to screen 
for anxiety disorders, again the purpose of which was twofold. It was to be administered 
via written format at baseline and at week 12 to screen for anxiety and to determine 
change in anxiety symptoms when accompanied by weight loss. This tool involves 
DSM-5 criteria and requires the participant to answer seven specific questions related to 
anxiety-related symptoms using a Likert-type scale. A score at or below four indicates 
no or minimal anxiety; between five and nine indicates mild anxiety; between ten and 
fourteen indicates moderate anxiety; and fifteen or greater indicates severe anxiety. The 
GAD-7 has a Cronbach's alpha of 0.92 (Ahmad et al., 2017). Plummer and colleagues 
determined as a cut-off a score of eight to detect GAD during a systematic review and 
meta-analysis in a population of n=5223, and at this score, the GAD-7 had a pooled 
sensitivity of 0.83 (95% CI 0.71-0.91) and specificity of 0.83 (95% CI 0.71-0.91). 
Additionally, they found that scores between 7 and 10 had similar results. However, a 
cutoff score of 10 was identified as the optimal point for sensitivity 0.89 and specificity 
0.82. At that score the GAD-7 had a test–retest reliability of p = 0.85 (Rutter & Brown, 
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2017). For this project, the GAD-7 was administered at baseline but after reevaluation of 
clinical resources and protocol, it was not completed at the week 12 visit. The GAD-7 is 
recognized as an effective validated tool useful when diagnosing and planning 
treatment and continuity of care.  
Laboratory Data. Laboratory outcomes in this project included the hemoglobin 
A1c and a fasting lipid panel, consisting of the HDL, LDL, and total cholesterol. Blood 
samples were collected and analyzed using normal clinic procedures (at an off-site 
laboratory), and results were recorded from the electronic medical record.  
At a cut-off value of 6.5%, hemoglobin A1c has a sensitivity of 0.852 and a  
specificity of 0.823 to detect clinically significant diabetes mellitus (Yap et al., 2017) – a 
potentially disastrous consequence of chronic obesity. Hemoglobin A1c will be 
measured upon enrollment and at the 3-month follow-up visit if clinically appropriate.  
Hypercholesterolemia is associated with cardiovascular diseases such as 
atherosclerosis and coronary heart disease. Adipose tissue is an active endocrine and 
metabolic site, linked to the development of these chronic diseases. Much of the 
metabolism of cholesterol takes place within adipose tissue. Hypercholesterolemia has 
been proven toxic to smooth muscle cells, hepatocytes, and cardiomyocytes, and to 
induce cholesterol excess causing adipocytes hypertrophy thus leading to 
cardiovascular diseases (Aguilar & Fernandez, 2014). Hypercholesterolemia, 
specifically LDL cholesterol is associated with a 20% higher risk of cardiovascular 
disease and total cholesterol is associated with a 10 to 20% higher risk of premature 
cardiovascular morbidity and mortality (Upadhyay, 2015). For lipid panels, with a total 
cholesterol end point of 210, the sensitivity is 0.70 and specificity is 0.925 for detection 
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of LDL cholesterol greater than or equal to 130 and a sensitivity of 0.967 and specificity 
of 0.856 for detection of non-HDL cholesterol greater than or equal to 160. At a total end 
point of 230, the sensitivity is 0.749 and the specificity is 0.920 for identifying LDL 
cholesterol greater than or equal to 160 and a sensitivity of 0.986 and specificity of 
0.898 for non-HDL cholesterol greater than or equal to190 (Aguilar & Fernandez, 2014; 
Kim et al., 2019; Nantsupawat et al., 2018). Obese population have a higher hazard 
ratio than non-obese population with BMI below 30kg/m2, specifically an all-cause 
mortality of 1.94 (95%CI:1.11-3.42) and those with CVD have a hazard ratio of 1.84 
(95%CI:1.15-2.93) compared to non-obese population. An adjusted hazard ratio for 
death due to CVD at a 95% CI for obese patients with hypercholesterolemia is 1.04 
(0.77-1.41; p=0.780). The adjusted hazard risk for death/overall mortality at a 95%CI for 
obese patients with hypercholesterolemia is 0.86 (0.60-1.22; p=0.388) (Ponce-Garcia et 
al., 2015). 
Time 
  The baseline visit occurred when the participant came to the clinic for a primary 
care visit during the enrollment period (September 20 through December 10, 2019). 
Participants were to return to the clinic every seven days for the next 3 weeks to check 
weight and BMI, as well as to reinforce their weight loss plan. After their third weekly 
follow-up visit, they were to return to the clinic once per month to collect data and 
reinforce their weight loss plan. On their final visit (3 months after enrollment), a final set 
of anthropometric, clinical, and laboratory data were to be collected, and participation in 
the project was finished. Participants were encouraged to continue their weight loss 
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plan or make modifications at the recommendation of their primary care team. The EBP 
Project timeline can be found in Appendix I.  
Collection. Data collection took place during in person face-to-face encounters 
with the project manager and clinical providers and staff from September 20, 2019 
through March 3, 2020. This recruitment process was continuous through December 10, 
2019, with starting and completion dates varying among participants, but ending at the 
12-week mark after initial visit for each participant. It began at the initial baseline patient 
appointment when the patient was provided with the description of the EBP Project and 
interventions. Once the participant agreed to participate in the project, they were given 
the initial weight loss packet containing the PHQ-9, GAD-7, AAQ-W, and WEL-SF 
assessment tools. Based on these results, the patient was given individualized weight 
loss instructions using the NEWER-ME framework. Along with the PHQ-9, GAD-7, 
AAQ-W, WEL-SF, the participant’s anthropometric and blood pressure measurements 
were completed and recorded, using the safeguards that were in place to protect health 
information. When indicated, secondary outcome measures data: HbA1C and lipids 
(total cholesterol, HDL, LDL and triglycerides), were also recorded with the identical 
safeguards.  
All data was collected under HIPPA and CITI guidelines. To maintain anonymity 
participants were provided with a four-digit numeric code upon enrollment in the project 
that was their identifier for data collection. This code consisted of two letters and two 
numbers: AA01, AA02, AA03 and so on for those participants evaluated on the first day, 
and AB01, AB02, AB03 and so on for those participants evaluated on the second day of 
the first week of the project. Those participants who enter during the second week of the 
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project will be given a code BA01, BA02, BA03 and so on as above. A list of participants 
and their corresponding codes was kept in a password protected Microsoft Excel® 
spreadsheet as well as a paper copy kept in a locked filing cabinet. The code was 
recorded on all assessment tools in the upper margin including demographics, 
anthropometric measurements, AAQ-W, WEL-SF, PHQ-9, GAD-7 and spreadsheets. 
The code served as the method to identify each participant and compare 
comprehensive data. Data collected using paper-and-pencil forms encoded with the 
participant’s four-digit numeric code, was then entered into a password-protected Excel 
spreadsheet within 8 hours of collection. All paper forms were retained in a locked filing 
cabinet in the EBP Project Manager’s locked office. Upon completion of the project, all 
paper forms were shredded and only the electronic data were retained.  
Management and analysis. In order to perform statistical analysis and 
comparisons of data, the project manager had access to the specified folder kept in the 
locked cabinet. Participant data and codes remained safely stored when not in use by 
the project manager. No identifying information was disclosed, and participants were 
only referenced by code during communication regarding the EBP Project. Upon project 
completion, all participant information including code list and all paper forms were 
shredded and only the electronic data were retained.  
The retrospective (comparison) and the prospective (intervention) samples were 
described using appropriate measures of central tendency and dispersion. Continuous 
descriptive variables (age, weight, height, waist and hip circumference, waist-to-hip 
ratio, BMI, SBP, DBP, HbA1c, total cholesterol, LDL, HDL, triglycerides, PHQ-9, GAD-7) 
were summarized using means and standard deviations. Categorical descriptive 
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variables (ethnicity, sex, age) were summarized using frequencies and proportions 
(Figures 4.2, 4.3, 4.4). All data analyses were completed using the Statistical Package 
for Social Sciences (SPSS) Version 25. The reference for SPSS was Cronk (2017). The 
code book used in this project is included in Appendix S. Descriptive analysis included 
means and standard deviations for continuous variables. Due to sample size, 
continuous dichotomous outcome variables were analyzed using Wilcoxon signed rank 
tests and assigned a level of significance equal to .05. Whether continuous or 
categorical, descriptive variables that were significantly different between the 
retrospective and prospective samples were identified as potential confounders.  
To determine if the NEWER-ME tailored weight loss intervention resulted in 
statistically significant weight loss in the prospective sample, the means for the 
continuous anthropometric measures (weight and BMI) along with blood pressure were 
compared from baseline to the final study visit using Wilcoxon signed rank tests. 
Differences with a p-value less than .05 were considered statistically significant. 
However, no week 12 comparison data were available for waist circumference, waist-to-
hip ratio, laboratory measures (hemoglobin A1c, lipid levels) or GAD-7 global scores.  
The number of patients with clinically significant weight loss (i.e. greater than 3% 
of their baseline BMI) was compared between the retrospective sample (comparison 
group) and the prospective sample (intervention group) using Wilcoxon signed rank 
tests. A difference with a p-value less than .05 was considered statistically significant.  
Protection of Human Subjects 
The protection of human subjects was sustained throughout this EBP Project. 
The project manager was educated regarding all ethical aspects via graduate ethics 
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coursework as well as through the completion of the NIH Protection of Human Research 
Participants course in April 2018 and all precautions to protect participants and preserve 
their anonymity were taken. The course certificate can be found in the appendices 
(Appendix A). The project manager applied for and ultimately gained approval and 
exempt status for this EBP Project from the Valparaiso University Institutional Review 
Board (IRB) on September 12, 2019.  
Confidentiality was maintained through use of a private space when meeting with 
participants. Prior to beginning any interventions, all potential participants were provided 
with the description of the EBP Project and interventions and a list of patient rights. No 
patient was coerced, pressured or threatened to participate. All potential participants 
were informed that their involvement was voluntary, and that they could withdraw from 
the project at any time without retribution or penalty. They were advised that the project 
would not result in additional cost beyond what they would normally pay for primary care 
at the clinic. They were informed that this was a DNP EBP project and standard of care 
and were told about the need for data collection and safeguards in place to maintain 
privacy. All potential participant questions were answered to their satisfaction. Only 
pertinent demographic and clinical data were collected. All collected data remained in 
secure location and patient confidentiality would be maintained via safeguards, 
participant four-digit coding, passwords and locks. Upon completion of the project, all 
paper forms and participant codes were shredded and only the electronic data were 
retained. Because this project did not fall under the purview of “Human Subjects 
Research,” the requirement for informed consent was waived.  
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Chapter 4 
FINDINGS 
 The purpose of this project was to implement an Evidence-Based protocol 
incorporating a multicomponent intervention tailored to individual patient strengths, 
barriers, and resources. The primary purpose of this EBP project was to improve 
selected obesity indicators, including anthropometric measures of weight, BMI, and the 
achievement of 3% weight loss from baseline. The secondary purpose was to determine 
if the weight loss intervention resulted in improvement in BP as well as depression 
symptoms measured with the PHQ-9. Analyses consisted of participant demographics 
and primary and secondary outcomes.  
 Findings. Findings indicated that participants had statistically significant weight 
loss in pounds from baseline to week 4. This weight loss was not sustained at week 8 
but was significant among those who finished the program beyond week 8. Changes in 
BMI were statistically significant from baseline to weeks 4 and 12, but not from baseline 
to week 8. Neither SBP nor DBP were significantly improved from baseline for weeks 4, 
8 or 12. Depression as measured by PHQ-9 scores decreased from baseline to week 
12, and results were statistically significant.  
Participants 
Size. In total 26 participants started the program with staggering start dates and 
were followed for twelve weeks. There was moderate attrition (38.5%) with 16 
participants completing at least one follow-up visit during the 12-week project period 
(see Figure 4.1). Participants cited one or more reasons for program discontinuation, 
including: outside commitments or disinterest (n=12), weather (n=2), transportation 
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difficulties (n=2), illness or exacerbation of disease (n=1), pregnancy (n=1), obtained 
insurance (n=1), and eleven participants cited ‘other’ as the reason or were unable to be 
contacted. 
Figure 4.1. Attrition percentages of project group 
 
Characteristics. The prospective sample is described in Table 4.1 and Figures 
4.2, 4.3, 4.4 and 4.5. Most participants identified as white and Hispanic/Latino (77%), 
female (81%), and able to speak some English (77%). All clinic patients were at or 
below 200% of poverty level, and none had health insurance. The mean age of the 
sample was approximately 40 years.  
Table 4.1. Demographic variables for prospective group 
Variable Frequency 
Number of Participants 26 
Age, mean (SD) 39.73 (11.09) 
Age, min-max 18 – 57  
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Sex 
Female, n (%) 
Male, n (%) 
 
21 (80.8) 
5 (19.2) 
Race 
White, n (%) 
 
26 (100) 
Ethnicity 
Hispanic / Latino, n (%) 
Non-Hispanic / Latino, n (%) 
 
20 (77) 
6 (23) 
Able to Speak English 
Yes, n (%) 
No, n (%) 
 
20 (77) 
6 (23) 
Income 
Below poverty level, n (%) 
Above poverty level, n (%) 
 
26 (100) 
0 (0) 
Insurance Coverage 
No third-party payer, n (%) 
Any third-party payer, n (%) 
 
26 (100) 
0 (0) 
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Figure 4.2. Race and ethnicity: prospective group 
 
 
 
 
Figure 4.3. Gender 
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Figure 4.4. Age 
 
 
 
 
Figure 4.5. Primary Language  
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Changes in outcomes 
Statistical testing. For most of the variables in this project, participants served 
as their own controls. Due to the small number of matched observations (n = 26), 
differences in continuous outcome variables between baseline and follow-up visits (i.e. 
2 to 4 weeks after baseline and 5 to 12 weeks after baseline) were tested for statistical 
significance using the nonparametric equivalent of the paired t-test – the Wilcoxon 
signed-rank test.  
To analyze whether the intervention resulted in achievement of at least 3% body 
weight loss, compared to no intervention, the target weight loss for each participant was 
calculated by multiplying their weight in pounds at baseline by a factor of 0.03. If the 
difference between their final follow-up weight and their baseline weight was equal to or 
larger than their 3% goal, they were identified as having “Met” their 3% goal. If this 
difference was less than their 3% goal, they were identified as having “Not Met” their 
goal.  
The comparison group for this analysis consisted of a retrospective convenience 
sample of patients who were seen at the project site prior to beginning this project. 
Participants were included in this retrospective sample if they were seen at the clinic 
within the last year, had at least 2 documented weights within 5 months apart, and 
otherwise met the project’s eligibility criteria. Race and ethnicity data were not available 
for comparison. Characteristics of this comparison group are provided in Table 4.2. 
Briefly, participants in the comparison group tended to be older than those in the project 
group, but there was a similar tendency for participants in the comparison group to be 
female, have no insurance, and live in poverty.  
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Table 4.2. Retrospective comparison group demographic characteristics 
Variable Frequency 
Number of Participants 25 
Age in years, mean (SD) 46.96 (13.81) 
Age, min-max 19 – 71  
Sex 
Female, n (%) 
Male, n (%) 
 
18 (72) 
7 (28) 
Income 
Below poverty level, n (%) 
Above poverty level, n (%) 
 
25 (100) 
0 (0) 
Insurance Coverage 
No third-party payer, n (%) 
Any third-party payer, n (%) 
 
25 (100) 
0 (0) 
 
The difference between achievement of at least 3% weight loss between 
baseline and the latest follow-up visit for the prospective group was tested for statistical 
significance using the chi-square test of independence. For all inferential analyses, 
differences were considered statistically significant if their p-value was below .05. All 
analyses were completed using the Statistical Package for Social Sciences (SPSS) 
Version 25.  
Weight. The mean weight in pounds at baseline was compared to the mean 
weight at Week 4 (i.e. from any follow-up visit between weeks 2 and week 4), Week 8 
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(i.e. from any follow-up visit between weeks 5 and 8), and at Week 12 (i.e. from any 
follow-up visit between weeks 9 and 12). A decrease in mean weight was seen between 
week 1 and week 4 (228.96 lbs [SD 47.16] vs 214.87 lbs [SD 44.68], respectively), 
which was statistically significant (p = .026). However, weight loss from baseline to 
Week 8 (228.96 [SD 47.16] vs 221.73 [SD 37.01], respectively; p = .686) and from 
baseline to Week 12 (228.96 [SD 47.16] vs 221.57 [SD 52.20], respectively; p = .088) 
was not statistically significant (Table 4.3) (Figure 4.8).  
Body mass index. The mean BMI at baseline was compared to the mean BMI at 
Week 4, (i.e. from any follow-up visit between weeks 2 and week 4) and at Week 12 
(i.e. from any follow-up visit between weeks 9 and 12). A statistically significant 
decrease in mean BMI was seen from baseline to week 4 (39.87 kg/m2 [SD 6.19] vs 
38.27 kg/m2 [SD 6.57], respectively; p = .028) and from baseline to week 12 (39.88 
kg/m2 [SD 6.19] vs 38.64 kg/m2 [SD 6.93], respectively; p = .023), but not from baseline 
to week 8 (i.e. from any follow-up visit between weeks 5 and 8), (39.87kg/m2 [SD 6.19] 
vs 40.58 kg/m2 [SD 6.45], respectively; p = .180) (Table 4.3). 
Met 3% weight loss goal. In the prospective group, ten participants out of 26 lost 
weight however, only 27% of all participants met the goal of a 3% total body weight loss 
at twelve weeks (Table 4.3) (Figure 4.7). In comparison with the retrospective group 
who had only four participants out of twenty-five, or 16%, reach the 3% total weight loss 
goal (p=.034) (Figure 4.6).  
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Figure 4.6. Retrospective group who met 3% total weight loss goal 
 
Figure 4.7. Prospective group who met 3% total weight loss goal 
 
Waist circumference and waist-to-hip ratio. These variables were not measured 
at follow-up due to staff and clinical time limitations. Therefore, a comparison of neither 
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waist circumference nor waist-to-hip ratio between baseline and follow-up could be 
calculated. Baseline means were 117.26 cm (SD 12.72) and 0.96 (SD 0.10) respectively 
(Table 4.3).  
Blood pressure. The mean SBP at baseline (127.96 mmHg) was compared to the 
mean SBP at weeks 4 (123.75 mmHg, SD 15.03), 8 (134.6 mmHg), and 12 (132.33 
mmHg, SD 19.79). There were no statistically significant differences in mean SBP 
between baseline and any follow-up time frame, although there was a tendency for SBP 
to be higher at the week 12 follow-up visits compared to baseline (Table 4.3) (Figure 
4.9). (Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data 
includes last recorded measure weeks 9, 10, 11, 12) 
The mean DBP at baseline (77.96 mmHg) was similarly compared to mean DBP 
at weeks 4 (70.08 mmHg, SD 8.03), 8 (74.8 mmHg), and 12 (78.50 mmHg, SD 8.03). 
The DBP at week 4 was not significantly lower than baseline (p = .814), nor at weeks 8 
(p = .273) or 12 (p = .754) (Table 4.3) (Figure 4.9). (Week 4 data includes last recorded 
measure weeks 2, 3 or 4 and week 12 data includes last recorded measure weeks 9, 
10, 11, 12) 
Depression. The mean PHQ-9 score at baseline (10.25) was compared to the 
mean PHQ-9 score at week 12 only (5.87). There was a statistically significant reduction 
in depression severity during this time frame (p = 0.14) (Table 4.3) (Figure 4.9). 
Anxiety. The GAD-7 was not measured at the week 12 follow-up visit because of 
staffing and clinical time constraints and current clinical practice policy. Therefore, a 
statistical comparison of anxiety between baseline and follow-up could not be 
calculated. Mean score at baseline was 8.375 (SD 5.41).  
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Lab Data. Mean glycosylated hemoglobin, total cholesterol, LDL, HDL, and 
triglycerides were only measured at baseline (Table 4.3). Therefore, no statistical 
comparisons between baseline and follow-up could be calculated for any of these 
biomarkers. HbA1c and lipid tests data were only available at baseline. Mean HbA1c 
was 6.28 (SD 1.04), lipid test means included total cholesterol 180.14 (SD 47.15), LDL 
88.83 (SD 31.37), HDL 51.57 (SD 13.35) and triglycerides 207.57 (SD 111.99).  
Secondary outcome data included blood pressure, HbA1c and lipid tests, 
depression and anxiety screening. No data was available for HbA1c or lipid tests for 
week 12. PHQ-9 scores ranged from 0 to 16, with a mean score of 6.3 (SD 5.8) (Figure 
4.9). One GAD-7 score was recorded for week 12, the score was 1 for this participant 
who scored a 3 at baseline.  
Table 4.3. Statistical analyses of outcome variables 
Outcome Baseline Follow-Up Significance 
Weight in pounds, mean (SD) 228.96 
(47.16) 
Wk 4 = 
214.87 
(44.68) 
Wk 8 = 
221.73 
(37.01) 
Wk 12 = 
221.57 
(52.20) 
p = .026 
 
 
p = .753 
 
 
p = .088 
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BMI kg/m2, mean (SD) 39.87 (6.19) Wk 4 = 
38.27 (6.57) 
Wk 12 = 
38.64 (6.93) 
p = .028 
 
p =.023 
Met 3% weight loss goal, n (%) 0 (0) Wk 12 = 7 
(27) 
p =.001 
Waist circumference, mean (SD) 117.26 cm 
(12.72) 
Wk 12= 103 
cm 
 
Waist-to-hip ratio, mean (SD) 0.96 (0.10) Wk 12= 
0.88 
 
SBP, mean (SD) 127.96 
(15.81) 
Wk 4 = 
123.75 
(15.03)  
Wk 8 = 
134.6 
(16.41) 
Wk 12 = 
132.33 
(19.79) 
p = .814 
 
 
p = .686 
 
 
p =.754 
DBP, mean (SD) 77.96 
(12.30) 
Wk 4 = 
70.08 (8.03) 
Wk 8 = 74.8 
(11.69) 
p = .423 
 
p = .273 
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Wk 12 = 
78.50 (9.18) 
p =.798 
Depression, mean (SD) 9.38 (5.66) Wk 12= 
5.87 (5.82) 
p = .014 
Anxiety, mean (SD) 8.0 (5.47)   
Hemoglobin A1c, mean (SD) 6.28 (1.03)   
Total cholesterol, mean (SD) 180.14 
(47.15) 
  
LDL, mean (SD) 88.83 
(31.36) 
  
HDL, mean (SD) 51.57 
(13.35) 
  
Triglycerides, mean (SD) 207.57 
(111.99) 
  
Note: Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data 
includes last recorded measure weeks 9, 10, 11, 12. Standard deviation are in 
parenthesis. A p-value less than or equal to .05 is statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
141 
 
Figure 4.8. Primary outcomes mean (SD) weeks 1, 4 and 12 
 
 
(Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data 
includes last recorded measure weeks 9, 10, 11, 12) 
 
Figure 4.9. Secondary outcome data mean (SD) 
 
 
(Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data 
includes last recorded measure weeks 9, 10, 11, 12) 
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Chapter 5 
DISCUSSION 
This EBP project attempted to answer the PICOT question, “Will the use of a 
tailored multicomponent intervention, compared to standard clinical care, improve 
indicators of obesity in a primary care adult population over a period of 3 months?” 
Indicators of obesity include BMI, waist circumference and waist to-hip ratio. Secondary 
indicators related to obesity include BP, HbA1c, total cholesterol, HDL, LDL, 
triglycerides, depression, and anxiety.  
This project examined the impact of a tailored multicomponent intervention that 
combines the following care activities into the “NEWER ME” protocol: Nutrition 
counseling; Exercise counseling; Weight loss support and motivation; Emotional support 
and use of screening of depression and anxiety, behavioral health referrals and 
medication; Referrals for added support and care; Medications; and Expanded 
accountability and goal setting, for use within the primary care setting of a free clinic. 
The goal was to reduce weight by a 3% total weight loss, reduce BMI, reduce blood 
pressure, reduce depression and anxiety and reduce biometric markers. This chapter 
will describe and interpret project findings; address strengths and limitations of the 
project; evaluate the theoretical framework and EBP model used to guide the project; 
and explore implications for future practice, research and education. 
Explanation of Findings 
 Project findings indicate that an individualized multicomponent approach was 
effective for reduction of weight, BMI and depression symptoms. These results are 
consistent with the literature. Contrary to the literature, however, SBP and DBP did not 
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significantly improve after the intervention. No results were obtained at week 12 for 
waist to hip ratio, anxiety screening, HbA1c or lipids, so the impact of the intervention on 
these variables is uncertain.  
Participant Findings 
The size of this project sample was considerably smaller (n = 26) than that used 
in most empirical studies about weight loss, although it was felt by clinic providers that 
this was a representative cross-section of the clinic’s adult population. The small sample 
size was a limitation caused by various factors and will be discussed further later in this 
chapter. The sample was predominately white and Hispanic or Latino (77%), female 
(81%), and between 38 and 47 years old (57%). This distribution was expected as these 
groups tend to be the most common consumers of free or low-cost primary care 
services (Arvisais-Anhalt et al., 2018; Hunt, Adamson, Hewitt & Nazareth, 2011), and 
this was consistent with the demographic composition of patients at the project site. All 
participants were at or below 200% of the lower federal poverty limit, and no participants 
had health insurance. This rate of uninsured patients was not consistent with the 
literature study that provided rates between 43% to 94%; however, the study included 
clinics that accepted health insurance (Arvisais-Anhalt et al., 2018) and the clinic for this 
project did not accept patients with insurance. Most participants could read, write, and 
speak in English (77%) (Figure 4.5). This was not consistent with the literature that 
reported English as the primary language for 94% (Arvisais-Anhalt et al., 2018).  
Weight loss and BMI. Most participants who continued with project lost a 
significant amount of weight initially (Appendix L) and continued to trend down at week 
12. Others had fluctuations with weight loss and weight gain, re-gaining much of what 
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they had lost within 3 months. This finding is consistent with other weight-loss literature 
as adults tend to have cyclical periods of weight gain and loss (Cheatham et al. 2018; 
Hageman et al., 2017; Kroes et al., 2016; Rolls et al., 2017; Samdal et al., 2017). It is 
unknown if those participants who initially lost weight and continued to trend down 
maintained their weight loss past the twelve weeks.  
Twelve participants completed at least one follow up visit between weeks 2 and 
4. The mean weight decreased from baseline to week 4 (i.e.: the last follow up visit 
week 2, 3 or 4) (228.96 lbs. [47.16] vs 214.87 lbs. [44.67]) respectively, which was 
statistically significant (p = .026). However, the mean decrease in weight was less from 
baseline to Week 8, (i.e. the last follow up visit week 5-8) as weight fluctuated among 
participants with some gaining weight. Mean weight decreased (228.96 [47.16] vs 
221.73 [37.01], respectively; p = .753). From baseline to week 12 (i.e. the last follow up 
visit weeks 9-12) the mean weight mean decreased (228.96 lbs. [47.16] vs 221.57 lbs. 
[52.20], respectively; p = .088); however, the week 12 decrease was not statistically 
significant (Table 4.3) (Figure 4.8). This may have been caused by attrition which may 
have influenced the sample mean. The varied sample size and the specific participants 
measured changed from week to week, thus changing the week’s baseline mean and 
subsequently creating a potential sample or measurement bias.  
At baseline the mean participant (n=26) BMI was 39.87 kg/m2 (6.19). At the week 
12 follow up the group (n=16) mean BMI mean was 38.64 kg/m2 (6.93, p = .046) (Table 
4.3). The comparison of BMI at week 12 to baseline was statistically significant. 
Regardless of statistical significance, most participants who experienced weight loss 
closely met the pound per week guidelines from the AHA (2018) and Guidelines 2013 
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for Managing Overweight and Obesity in Adults (Jensen et al., 2014) with a group mean 
loss of 11.77 (13.95) lbs. over the three months. Additionally, a total body weight 
reduction of 5% to 10% reduction over one year (Perreault, 2019c) is considered to 
lower health risk (Batsis et al., 2016; Eaton et al., 2016; Hageman et al., 2017; Jensen 
et al., 2014; Kroes, Osei-Assibey and Baker-Searle, 2016; Jensen et al., 2014; Kushner 
& Ryan, 2014; Perreault, 2019c).  
Given the length of the program of twelve weeks, a 3% total body weight loss 
was considered significant. Nine of the participants (n=16) that completed the week 12 
visit lost weight, and seven met the 3% total body weight reduction goal to reduce 
health risk. This may have been caused by attrition which may have influenced the 
sample mean; The varied sample size and specific participants measured changed from 
baseline to week 12, thus changing the mean and subsequently creating a potential 
sample or measurement bias. It is unknown if all original participants had completed the 
full program whether the results would have changed.  
Waist-to-hip (W-to-H) ratio. At baseline, consenting participants (n=17) 
completed waist and hip measurements. W:H of greater than 0.95 in males and 0.85 in 
females was indicative of increased risk for cardiovascular disease and diabetes 
(Marshall, 2019). At baseline the mean W:H was 0.97 (SD = 0.10). Only one participant 
provided both baseline and week 12 data; and their W:H ratio did not change 
significantly (0.87 to 0.88, respectively). The lack of W:H measurements may have 
occurred due to a lack of clinical resources, time, staff understanding of the project 
protocol, language barrier or it may have been due to participant preference.  
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HbA1c. Participants (n=11) had a mean baseline HbA1c of 6.28% (SD = 1.04). 
No week 12 data were available for comparison analysis. This may have been due to 
the same reasons that there were no follow-up data for W:H ratio, or that the patients or 
clinicians did not feel that this blood test was clinically necessary. It may have also been 
due to a language barrier, misunderstanding about the relationship between obesity and 
diabetes mellitus, or a fear of having blood drawn. However, literature suggests that 
HbA1c should improve with weight reduction (Beeken et al., 2017; Delahanty, 2020; 
Rolls et al., 2017; Tapsell et al., 2017). Specifically, HbA1c reductions of 0.02 % to 
0.11% could be expected depending upon the amount of weight lost as well as 
adherence to the dietary regimen (Bauman et al., 2019).  
Lipids. Participants (n=7) had a mean total cholesterol, LDL, HDL and triglyceride 
count of 180.14 mg/dL (SD = 47.15), 88.83 mg/dL (SD = 31.37), 51.57 mg/dL (SD = 
13.37) and 207.57 mg/dL(SD = 111.99) respectively. No week 12 data were available 
for comparison analysis. This was likely due to the same factors that led to missing 
HbA1c data at week 12. The literature suggests that lipid values should improve with 
weight reduction (Hageman et al., 2017; Rodriguez-Cristobal et al., 2017; Rolls et al., 
2017; Tapsell et al., 2017). Following a diet of healthy fresh vegetables and fruits, lean 
proteins and legumes, whole grains and unsaturated fats can result in a total cholesterol 
reduction (-7.4 mg/dL) and a reduction of LDL (-3.3mg/dL) and increase HDL and 
improve triglycerides (Tangney & Rosenson, 2019). 
Depression. Depression is often linked to obesity in a cyclical nature (Kroes et 
al., 2016; Rodriguez-Cristobal et al., 2017; Ma et al., 2019; Rolls et al., 2017; Samdal et 
al., 2017; Tapsell et al., 2017). This relationship was demonstrated in this sample 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
147 
 
between baseline and follow up results as global PHQ-9 scores improved (p=.014), 
often coinciding with weight loss.  The direct cause of improved scores is unknown and 
may or may not be related to weight loss; however, when asked about improved scores, 
one participant stated “I just feel better since I lose the weight”. This improvement may 
have been impacted by improved nutrition and activity levels, environmental factors, 
lifestyle, or use of medication. Nine participants in the project sample were referred to 
their primary care provider due to PHQ-9 global scores of ten or greater as 
recommended in the literature (Kroes et al., 2016; Tapsell et al., 2017; Wellbourn et al., 
2018). It is unknown how many of these participants received a prescription for an 
antidepressant or was compliant with antidepressant use, or how this may have affected 
weight loss outcomes.  
Anxiety. Literature suggests that anxiety often accompanies depression and 
weight gain (Kroes et al., 2016; Rodriguez-Cristobal et al., 2017; Ma et al., 2019; Rolls 
et al., 2017; Tapsell et al., 2017; Welbourn et al., 2018). Although 17 participants 
completed the GAD-7 at baseline, only one completed it at Week 12. The participant 
who completed both anxiety assessments had improved anxiety symptoms from 
baseline to Week 12, though it is not possible to estimate the relationship between 
anxiety and weight loss in the overall sample. After further investigation it was found 
that anxiety screening was not routinely performed at this clinic. Unlike depression 
screening, it was only completed if the patient expressed having symptoms. Despite the 
obesity program protocol having been in place, this may have been a systematic error 
that may have been caused by a change in or limited staffing resources, lack of 
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knowledge or understanding of the protocol, staff may have forgotten as it was not part 
of the usual routine, language barrier or simply that the patient may have declined.   
 Blood pressure. Blood pressure was measured at each visit however sample 
sizes varied, and though participants obtained their medications from the clinic, 
participants’ anti-hypertensive medication compliance is unknown. Overall, mean SBP 
and DBP did not change significantly from baseline to any follow-up time. This is 
inconsistent with most of the literature, which suggests that BP should improve with 
weight loss (Hageman et al., 2017; Rodriguez-Cristobal et al., 2017; Rolls et al., 2017; 
Tapsell et al., 2017; Thabault et al., 2016). It was expected that there would be a blood 
pressure decrease of 1 mm/Hg for every pound lost (Basile & Bloch, 2019).  
Blood pressure may have remained unchanged in this sample for a variety of 
reasons, including attrition of patients with better adherence to the NEWER-ME 
intervention (leaving only those with poor adherence in the final sample), participant 
experiences and or feelings just prior to or at the time of measurement, undertreatment 
of hypertension in those who remained in the project, or poor adherence with 
antihypertensive regimens and or sodium restrictions. Clinical technique used when 
measuring blood pressure may have created systematic error or measurement bias. 
Systems were put in place to measure BP with the same Welch Allyn portable digital 
blood pressure device in the clinic using appropriate cuff sizes, however because 
different clinicians completed the measures, it is not possible to know if all followed 
procedures and used correct technique.  
Strengths and Limitations of the DNP Project 
Strengths 
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 This EBP project had several strengths. First, there was a clear need for and 
interest in the project from the provider, staff, and administrative team. This translated 
into sustained enthusiasm about the project, an eagerness to engage patients in the 
intervention, and ability to initiate this new and ambitious weight loss protocol in the 
clinic.  
Second, patients felt emotionally and financially supported in their weight loss 
journey. A significant portion of the time during each clinic visit was spent on promoting 
autonomous decision-making and self-efficacy about their weight loss, which were new 
territory for many of these project participants, all of whom were impoverished and 
disenfranchised. Participants were not paid, but were provided free health care, 
pharmaceuticals, laboratory studies, social services and community resources to aid 
them in their weight loss journey. Providing this kind of support was crucial to their 
sustained involvement in the project. 
Third, participants were provided Evidence-Based educational guidelines about 
weight loss. This education was delivered using individual nutrition and behavioral 
counseling, a voiced Microsoft Power Point ® and written education, as well as a list of 
free EBP on-line resources (Appendices, M, N,O, and P). Participants in this sample 
had limited access to health education content on their own, so the clinic was willing to 
provide these educational resources at no cost so that participants could refer to them 
after their clinic visit. This strategy gave participants the opportunity to remain engaged 
with their tailored weight loss “prescription” between visits to the clinic.  
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Fourth, clinic staff received a thorough orientation to the project (Appendix Q) 
and to the various weight loss interventions before they were shared with patients. This 
ensured that patients would receive consistent messaging from one provider to another 
about the tailored interventions they would be prescribed as part of their weight loss 
program. The project manager created an outline of the weight loss project via a 
narrated Microsoft Power Point ®, (Appendix O) and this resource was then translated 
from English to Spanish. This content served as the topical outline for weight loss 
discussions with clinic patients. These tools were all available to the clinic providers and 
staff to ensure project continuity and continuity of the project. Furthermore, the project 
manager was available at the clinic most days of the week to facilitate the intervention 
and support the clinic staff.  
Finally, this project used the JHNEBP Model (Appendix D) to provide a clear path 
and guidance for the management of the project. It allowed the project manager to 
anticipate and overcome possible barriers to implementation, which was essential for 
the success of this project in this complicated clinical setting.  
Limitations 
 Though this project had many strengths there were also some barriers and 
limitations to this EBP project that affected data collection and patient outcomes. Most 
importantly, the sample size in this project was very small. While demographic 
characteristics of the sample were felt to accurately represent the population served by 
the clinic, the distribution of outcomes data from this sample may not have accurately 
represented how the overall clinic population might have responded to the intervention. 
Therefore, the results from this project, thought promising, may not apply to other 
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patients at the clinic. Continuing this project with a larger sample would likely produce 
results that could be applied to other patients seen at this clinic.  
The clinic setting, which was a free clinic that provided care to patients who were 
uninsured, provided a unique set of challenges. Patients were required to be uninsured 
in order to receive care at the clinic. Without insurance, patients were unable to access 
some of the most effective weight loss interventions – pharmacotherapy and bariatric 
surgery – that patients with insurance would have been able to receive. Of the 26 
participants in this project, 20 qualified for a referral to bariatric surgery based on their 
BMI and comorbidities (Kushner & Ryan, 2014; Jensen et al., 2014). This restriction of 
services required patients to fully maximize lifestyle and behavioral interventions, which 
is notoriously difficult for people with a fixed or unpredictable income.  
This specific EBP Project addressed these issues by providing educational tools 
and resources as well as weight loss counseling and follow up visits free of charge. 
Participants could also be referred for psychological or behavioral health counseling or 
to the dietician when warranted free of charge. They also had access to a limited 
number of free weight loss medications such as phentermine and topiramate are the 
drugs usually prescribed and were available at the clinic pharmacy; however, no 
participant chose to utilized weight loss medications during this project.  
A third limitation was the restricted availability of clinical resources. The included 
clinic’s sources of revenue, staffing, and clinical resources available. Funding largely 
consisted of donations, grants and federal funding, thus limiting capital resources for 
staffing. Therefore, much of the work was completed by volunteers, clinical staff as well 
as physicians who may or may not have treated the participant previously. This created 
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bottlenecks in which project interventions could not be reliably completed from patient to 
patient or from visit to visit. This primarily affected the measurement of project outcomes 
including the GAD-7, weight loss readiness assessments, anthropometric 
measurements, waist and hip measurements, W:H ratio, and routine biometric 
measures (HbA1c and lipid panel). Additionally, with the high turnaround in staffing as 
well as staffing with volunteers, the clinicians needed to be frequently retrained as 
technique varied from person to person (e.g. collecting height and weight data in the 
same way with decimal). These challenges may have resulted in systematic errors in 
protocol adherence and data collection from one patient or visit to another.  
This was mitigated through additional staff education and training, as well as re-
evaluation of clinical resources by the project manager as to intervention importance in 
this clinical setting. This involved prioritizing interventions against available resources 
and trimming what was not essential to the success and sustainability of a weight loss 
program. Essential measures were found to include accurate weight and BMI, 
depression screening and when possible HbA1c and lipid panels, along with follow up 
care when possible. 
Attrition from baseline to Week 12 was another important limitation that affected 
data collection and protocol adherence. Because of the attrition rates it became 
necessary to provide all resource materials at the baseline visit rather than over the first 
four visits. This amount of information may have become overwhelming, creating 
barriers especially with time spent providing behavioral counseling. However, it also 
allowed participants who would likely not have completed follow up care to have the 
necessary information to achieve successful weight loss on their own.  
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Attrition may have skewed weight loss outcomes as the sample sizes varied 
limiting consistency in number and specific participants being measured, thus changing 
the mean and subsequently creating a potential sample or measurement bias. It is 
unknown if all original participants had completed the full twelve weeks whether the 
results would have changed. Attrition in this population was slightly higher than in the 
traditional primary care setting and underserved primary care clinics as represented in 
the literature (Mallow et al., 2014). A variety of factors account for this difference in 
attrition between underserved settings including the distance to travel from their 
residence to the clinic (which was considerable for some patients in this sample); 
employment and financial limitations such as securing time off work, unpaid time from 
work, working capital; attainment of insurance resulting in the patient being refused care 
at the free clinic; impact of comorbidities on functional status; having an inconsistent 
desire to lose weight; and competing obligations such as family obligations, work 
schedule, legal concerns-court appointments (Arvisais-Anhalt et al.,2018; Birs et al., 
2016; Mallow et al., 2014).  
In effect, a free clinic may not necessarily mean totally “free” care. Because of 
the indirect costs of receiving care, which would affect patients in varying ways (e.g. a 
patient with good adherence and substantial weight loss who could not find time off 
work to follow up at the clinic, compared to a patient with poor adherence and weight 
gain who could not come to the clinic due to lack of transportation), the effectiveness of 
this intervention could not be fully evaluated without being able to control for these 
variables. The only controls available at the clinic were the safety net of the Social 
Services department and the free community resources. All clinic patients have access 
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to Social Services. Participants who were deemed in need could be referred to social 
service for further counseling and would be offered these resources. All participants 
were provided with a list of community food pantries as well as a booklet of community 
resources in either English or Spanish at their first visit as well as the community 
resources information available in the clinic lobby that they could access at any time 
during clinic hours Monday through Saturday.  
Because the vast majority of patients who receive care at the free clinic are not 
citizens of the United States, fear of deportation was another possible limitation that 
may have differentially affected follow-up and/or intervention adherence. As a rule, 
providers did not ask if patients were citizens, and if the participant disclosed the 
information, they were reassured that they would be receiving care and that we could 
not divulge any patient information outside of HIPAA guidelines.  
Many of these patients were also unable to speak English, and even though an 
interpreter was used to facilitate communication, they may not have fully understood 
their weight loss prescription or their plan for follow-up. To mitigate this each participant 
scheduled their follow up appointment and received an appointment card with their next 
follow up visit time and date before they left. Participants were also given a routine 
telephone reminder approximately 24 to 72 hours in advance by clinical staff. If 
possible, Spanish speaking staff members completed appointment scheduling and calls 
when needed.  
Because of the limited clinical staff resources, both in terms of number and 
qualifications of staff, as well as time constraints, the project had to be altered many 
times to make it viable and sustainable. This limited interventions that could be used 
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and how they could be used. To alleviate these limitations, the project manager created 
an outline of the weight loss project and a narrated Microsoft Power Point ® describing 
the weight loss program that provided education and counseling. This resource was 
then to be translated from English to Spanish. This was both a limitation and a strength. 
It was a limitation because once it was sent to the clinic’s translator it was not returned 
to the project manager or available for use with Spanish speaking participants. It was a 
strength because the English version, that was available, provided consistency and 
could be advanced at the participant’s own pace and translated at the point of care by 
their on-site translator. Additionally, various tools (eg.: PHQ-9, GAD-7, educational 
materials) needed to be available in Spanish or needed to be translated by the 
participant’s interpreter. To overcome these obstacles, both the PHQ-9 and GAD-7 
were available in both English and Spanish as well as various other languages at the 
clinic. Many of the educational tools used in this project were available or could be 
accessed on-line in multiple languages, and all participants had access to the internet 
either on their mobile phone or through the library or at home. Participants were 
provided a list of web addresses for all referenced materials and resource tools. 
Implications for the Future 
Practice: The need for weight loss protocols within primary care will continue to 
be in demand as obesity has been consistently on the rise since the 1970s (WHO, 
2018). This individualized multicomponent weight loss intervention provided steady 
weight loss for participants at this free clinic who consistently followed the plan; 
however, due to the limitations described in this chapter, it is unclear if implementation 
at other primary care clinics will result in a similar outcome. Furthermore, resource 
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limitations at free clinics such as the project site may prevent patients from being 
referred to weight loss specialists. This is a barrier that patients in other primary care 
clinics may not face, which could dramatically affect weight loss outcomes in that 
population. Utilizing expanded resources such as pharmaceuticals and referrals, when 
available, may increase the participants chance for successful weight loss. The 
intervention tested in this project is best suited for clinics with limited resources or as a 
foundational step for patients in the primary care setting who are unable to safely 
undergo medical or surgical weight loss therapies.  
This EBP project can be easily transferred into any primary care setting using the 
prescribed methods at a low cost, as many of the resource materials used can be found 
on publicly available web sites (e.g. government, professional associations, private 
organizations) and either viewed electronically or printed at a low cost (Appendix P). 
The PowerPoint ® was created at no cost by the project manager. Along with the 
references listed in this project report, an outline for this media can be found in 
Appendix O that can be used to format a presentation applicable to specific clinical 
settings to promote weight loss and reduce health risks. 
Theory: The theory used for this project was The Health Promotion Model 
(Pender,1982; Pender, 2011). As discussed in chapter two, in this theory, Pender states 
that each person has a unique set of experiences, beliefs, and attitudes that affect their 
willingness and ability to change detrimental health behaviors. The initial purpose of the 
model was to “assist nurses in understanding the major determinants of health 
behaviors, as a basis for behavioral counseling to promote healthy lifestyles” (Pender, 
1982, p.2; Pender, 2011, p. 2). This model recognizes that a person’s context – their 
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experiences, feelings, emotions, resources, social barriers, etc. – impacts their health 
behavior.  
Evidence from this project support many assertions of the Health Promotion 
Model. Selection of the tailored weight loss interventions was heavily influenced by the 
culture, lived experiences, resources, limitations, and individual health status of each 
participant. Although this project did not use predictive modeling to test whether or not 
the amount of weight loss depended on individual demographic or cultural factors, it 
was clear through anecdotal evidence gathered during clinic visits that the patient’s age, 
ethnicity, primary language, financial resources, and social support may have played a 
significant role in how much weight the patient was able to lose.  
 The model used to guide the project was the JHNEBP Model. This model was a 
perfect fit for this EBP project, providing a clear path through the P-E-T process and 
guidance for the management of the project. It allowed the project manager to anticipate 
and overcome possible barriers to implementation, which was essential in this 
complicated setting. Anticipating project needs was necessary in this environment as it 
had very limited resources and the time to complete this project was very brief. 
However, re-evaluating the project was also necessary because the clinic was in 
constant flux with changing providers, volunteer staff, and an inconsistent patient 
caseload. Therefore, it was often necessary to alter the project protocols to meet 
changing demands and to ensure that the project would be sustainable into the future.   
Research: Further research could be completed using this program; however, 
the period of intervention and follow up needs to be longer than the limited time frame 
allowed within this EBP project. Evidence suggests a period of at least twelve months is 
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a minimal time frame for implementation of interventions and evaluation (Jensen et al., 
2014; Kushner & Ryan, 2014; Kozica et al., 2016). A longer timeline may have 
produced a larger sample, larger data sets and more conclusive results. This program 
could also be implemented in multiple sites that provide care for the underserved 
population, thus further increasing the sample size and the ability to obtain and analyze 
data.  
  Further research is needed to address the genesis of the high attrition rates 
(Arvisais-Anhalt et al.,2018; Birs et al., 2016; Mallow et al.,2014) among this population 
and what can be done to resolve it. This was a significant barrier in this project and 
despite an exhaustive literature search, little of the research found prior to the project 
implementation addressed this issue. This information would have been useful for 
project design and may have partly eliminated necessary revisions. Many of the 
participants of this program did not complete the full twelve weeks but were able to lose 
weight on their own after the initial visit using the resources provided. This information 
could be translated into future research that could address the use of a dual mechanism 
weight loss program, initiated with their provider, who provides the initial guidance and 
education resources and then is completed at home, with periodic follow up. 
Research is also needed to evaluate the cultural impact of obesity among the 
underserved and how culture drives rising obesity rates and health risk. The white and 
Hispanic or Latino community tend to have a diet that is higher in carbohydrate, fats and 
caloric content. Based upon anecdotal information, this culture tends to enjoy a great 
deal of family socialization in which food is largely incorporated and where eating large 
portions is accepted. This aspect of their culture may impact rising levels of obesity, and 
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health risks among this population (Drieling, Ma & Stafford, 2011). This is opportunity 
for research as well as education through further study.  
Research is needed into the role that genetics and hormones play in obesity. 
Evidence suggests that as much as 21% of overweight and obesity is linked to genetics. 
There are many known genetic or hormone causes of overweight and obesity. Among 
them is a mutation that causes alterations in the gene known as GWAS or FTO gene 
and chromosome 16 that are related to fat mass and obesity. Additionally, the leptin 
gene may contribute to overweight and obesity in some people. Leptin signals the brain 
whether the amount of fat stored is enough for survival. A leptin-deficiency causes loss 
of signaling, leading to hyperplagia, hyperinsulinemia, insulin resistance, decreased 
energy, weight gain and infertility. Another known cause is the congenital deficiency of 
proprotein convertase subtilisin/kexin type 1 gene (PCSK1) which causes early onset 
obesity via a multihormonal disorder (Perreault, 2019a). Further research could be used 
to develop treatment and education to reduce bias associated with overweight and 
obesity. 
Education: Providers need to be taught that weight loss is not a one size fits 
everyone method, but rather that each patient is unique and requires individualized 
attention and interventions specific to them. Interventions need to fit the person, and 
must also address what they have tried in the past, if anything, as well as incorporating 
lifestyle and abilities, culture and goals. Providers must address their own perceptions 
of the overweight obese patient. Weight stigma and bias are seen throughout society, 
even among health care professionals. Many health care providers have strong bias 
and stereotype patients with obesity, thus impacting their behavior, judgement and the 
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treatment prescribed. The stigma of overweight obesity can reduce the quality of care 
received despite provider intentions. People with overweight obesity may have 
experienced poor treatment and have come to anticipate this from a provider. This may 
cause them stress, fear, mistrust and complete avoidance of treatment and it may lead 
to poor compliance (Phelan, et al., 2015). As much as 69% of overweight or obese 
female patients reported that their healthcare provider was biased against them due to 
their weight (Alberga et al., 2017). Anecdotal information obtained during this project 
reiterates these statistics as participants frequently voiced concerns of being afraid of 
being judged by the providers. As healthcare professionals, education is a key to 
reducing bias and providing EBP. There are so many factors that play a role in being 
overweight/obese. A few are obvious such as diet and activity level, but many are not 
such as genetics, comorbidities, psychological barriers, individual cognition and real or 
perceived barriers, self-efficacy, prior life experiences and experiences with weight loss 
attempts, financial or cultural influences, and support systems.  
Conclusion 
 In this EBP project report obesity has been discussed as a multifactorial, 
individualized, chronic disease that increases known risk factors for significant 
comorbidities and mortality. The primary purpose of this Evidence-Based practice 
project was to improve indicators of obesity (weight, BMI) among patients served by a 
free medical clinic, using a tailored multicomponent intervention consisting of the 
NEWER ME protocol that combines Nutrition and Exercise with Weight loss and 
behavioral counseling, motivation, Emotional support, Referrals for added support and 
care, Medications, and Expanded accountability and goal setting. The secondary 
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purpose was to determine if the weight loss intervention was associated with a 
decrease in blood pressure and depression symptoms. The intervention was guided by 
the Health Promotion Model by Nola Pender. The Johns Hopkins Nursing Evidence 
Based Practice Model (JHNEBP) guided implementation of the project. A 
comprehensive literature review was completed in five databases, and strong evidence 
supported the tailored multicomponent intervention used in this project. Eligible 
participants (n=26) took part in the 3-month program. To maintain consistency, a Power 
Point® outline of the weight loss protocol was presented at each baseline visit. Written 
education materials were provided in English and Spanish, and an interpreter was used 
when appropriate. Weight, BMI, and BP were measured weekly, then at weeks 8 and 
12, and depression screening was measured at baseline and at Week 12.  
Mean weight significantly decreased from 228.96 lbs. (47.16) at baseline to 
214.87 lbs (44.67) at week 4 (i.e. including the last visit during weeks 2, 3 and 4). Mean 
BMI also significantly decreased from 39.87kg/m2 at baseline to 38.27 kg/m2 (6.57) at 
week 4 (i.e. including the last visit during weeks 2, 3 and 4) and 38.64kg/m2 (6.93) at 
week 12. Significantly more patients in the intervention group achieved at least 3% 
weight loss between baseline and Week 12, compared to those who did not receive the 
intervention (27% vs 16%, p=.034). Depression improved significantly from baseline to 
Week 12 (p = .014). There were no significant differences in SBP or DBP.  
Based on these results, a tailored multicomponent weight loss program, that 
focuses on individualized and limited interventions such as weight, BMI and BP 
measures; nutrition and exercise education; behavioral interventions and counseling, 
along with basic laboratory screening of lipids and HbA1c when possible, is an effective 
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method for reducing weight, BMI, and depression in this type of primary care setting. 
This type of individualized interventions could be translated and modified to fit into any 
primary care practice, using the JHNEBP Model (Johns Hopkins Medicine, 2017) as 
well as the Health Promotion Model (Pender,1982; Pender, 2011) patients can be 
assessed and interventions can be tailored to the patient and implemented to achieve 
the best weight loss outcomes. Research can lend to EBP and new information can be 
translated into the protocols and interventions. Education can provide knowledge 
informing EBP and reduce overweight obesity stigma and bias in health care. As health 
care providers we need to educate, support and counsel patients, while allowing them 
autonomy that builds self-efficacy and self-esteem. Additionally, we need to promote 
self-esteem and autonomy through decreased weight bias and increased provider 
education in order to work toward reducing health risk in an overweight and obese 
population.  
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Appendix B 
 
Johns Hopkins Nursing Evidence Based Practice Model and Tools Permission  
JHNEBP MODEL AND TOOLS- PERMISSION 
 
Thank you for your submission. We are happy to give you permission to use the 
JHNEBP model and tools in adherence of our legal terms noted below: 
You may not modify the model or the tools without written approval from Johns 
Hopkins.  
All reference to source forms should include “©The Johns Hopkins Hospital/The Johns 
Hopkins University.” 
The tools may not be used for commercial purposes without special permission.  
If interested in commercial use or discussing changes to the tool, please 
email ijhn@jhmi.edu. 
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Appendix C  
 
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal  
 
Tool 
 
Please note that this tool was taken from Dang & Dearholt, (2017, Appendix E, pp. 281-
290) and appears as in text, content has been unaltered.  
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
186 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
187 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
188 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
189 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
190 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
191 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
192 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
193 
 
 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
194 
 
Images: Dang & Dearholt, (2017, Appendix E, pp. 281-290) [Johns Hopkins Nursing 
Evidence-Based Practice Research Evidence Appraisal Tool]  
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Appendix D 
 
Johns Hopkins Nursing Evidence-Based Practice Model 
 
 
 
(Image: The Johns Hopkins Nursing Evidence-Based Practice Model, 2017). 
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Appendix E 
 
PHQ-9: English version 
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Appendix F 
 
GAD-7 
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Appendix G 
 
AAQ-W 
 
AAQ-W: Acceptance and Action Questionnaire- Weight 
Below you will find a list of statements. Please rate the truth of each statement as it 
applies to you.  
Use the following scale to make your choice. 
Never True  1 2 3 4 5 6 7 Always True 
 
1 2 3 4 5 6 7      1. It’s OK to feel fat 
1 2 3 4 5 6 7      2. When I have negative feelings, I use food to make myself feel better 
1 2 3 4 5 6 7      3. I try to suppress thoughts and feelings that I don’t like about my body                   
                              or weight by just not thinking them 
1 2 3 4 5 6 7      4. I am not in control of what I eat 
1 2 3 4 5 6 7      5. I try hard to avoid feeling bad about my weight or how I look 
1 2 3 4 5 6 7      6. I am in control of how much physical activity I do 
1 2 3 4 5 6 7      7. When I evaluate my weight or my appearance negatively, I am able         
 
to recognize that this is just a reaction, not an objective fact. 
 
1 2 3 4 5 6 7      8. In order to eat well and do physical activity, I need to feel like it 
1 2 3 4 5 6 7      9. I need to feel better about how I look in order to live the life I want to 
1 2 3 4 5 6 7      10. Other people make it hard for me to accept myself 
    Please continue to page 2. 
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Imagine that the following thoughts occurred to you right now. 
 How valid or believable would each be? 
 
For each question, please circle a number from 1 through 7. 
Not at all believable 1 2 3 4 5 6 7  Completely believable 
 
1 2 3 4 5 6 7      11. If I’m overweight, I can’t live the life I want to 
1 2 3 4 5 6 7      12. If I feel unattractive, there is no point in trying to be intimate 
1 2 3 4 5 6 7      13. If I gain weight, that means I have failed 
1 2 3 4 5 6 7      14. I’m in control of my eating behavior 
1 2 3 4 5 6 7      15. I don’t have what it takes to be healthy for life 
1 2 3 4 5 6 7      16. My eating urges control me 
1 2 3 4 5 6 7      17. I need to get rid of my eating urges to eat better 
1 2 3 4 5 6 7      18. I am a stable person 
1 2 3 4 5 6 7      19. If I eat something bad, the whole day is a waste 
1 2 3 4 5 6 7      20. I should be ashamed of my body 
1 2 3 4 5 6 7      21. I need to avoid social situations where people might judge me 
1 2 3 4 5 6 7      22. I will always be overweight 
 
Lillis & Hayes (2008)  
Scoring:  
Before a sum score is taken, items 1, 6, 7, 14, and 18 are reversed keyed: Lower 
scores indicate 
less experiential avoidance and more psychological flexibility. The range of possible 
scores is 22 to 154. 
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Because it can be confusing to speak of a lower score reflecting “more psychological 
flexibility” the 
scoring can be changed if the clinician or user is conceptually focused on increasing 
acceptance and 
response flexibility. In this case, items 1, 6, 7, 14, and 18 would be scored as normally 
and all other items would be reverse scored. 
(Note-Permission to use AAQ-W in Appendix T) 
 
Appendix H 
 
Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF) Tool 
 
Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF) 
 
Read each situation below and decide how confident (or certain) you are that you will be able to 
resist overeating in each of the different situations. On a scale of 0 (Not confident) to 10 (very 
confident), choose ONE number that reflects how confident you feel now about being able to 
successfully resist the desire to overeat. Write that number next to each item (in the confidence 
number column).  
 
0 1 2 3 4 5 6 7 8 9 10 
Not at all 
confident 
         Very confident 
I am confident that: Confidence number 
1. I can resist overeating when I am anxious (nervous).  
2. I can resist overeating on the weekend.  
3. I can resist overeating when I am tired.   
4. I can resist overeating when I am watching TV (or using the 
computer).  
 
5. I can resist overeating when I am depressed (feeling down).   
6. I ca resist overeating when I am in a social situation (or at a party).   
7. I can resist overeating when I am angry (or irritable).   
8. I can resist overeating when others are pressuring me to eat.   
Ames, G. E. et al., Eating self-efficacy. Development of a short-form WEL, Eating Behaviors (2012), 
doi: 10.1016/j.eatbeh.2012.03.013 
 
(Ames, Heckman, Grothe & Clark, 2012) 
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Appendix I 
 
EBP Project Timeline 
 
Participation in the project involves a baseline data collection visit as part of the 
initial clinic visit (T0), weekly follow-up visits for the next 3 weeks (T1 – T3), and monthly 
follow-up visits for the next 2 months (T4 and T5). Project data will be measured 
according to the following timeline: 
Variable T0 T1 T2 T3 T4 T5 
Weight X X X X X X 
Body Mass 
Index 
X X X X X X 
Waist 
Circumference 
X     X 
Waist-to-Hip 
Ratio 
X     X 
Readiness for 
Weight Loss 
X      
Personal 
Strengths, 
Barriers, and 
Resources 
Inventory 
X      
Blood 
Pressure 
X X X X X X 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
202 
 
Depression X     X 
Anxiety X     X 
Lipid Panel 
(Total 
Cholesterol, 
LDL, HDL, 
Triglycerides) 
X 
(if 
medically 
indicated) 
    X 
(if 
medically 
indicated) 
Hemoglobin 
A1c 
X 
(if 
medically 
indicated) 
    X 
(if 
medically 
indicated) 
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Appendix J 
 
Anthropometric measures: Baseline 
 
 
 
 
Pt. Baseline 
Weight Lb 
Baseline 
Weight Kg 
Baseline 
BMI 
Height 
inches Height cm 
Waist 
circum. CM Hip circ. CM 
Waist: Hip 
ratio (W:H) 
                 
1 190 86.2 38.4 59 149.86 120.5 123 0.979 
2 295 134 52.3 63 160.02 145 153 0.947 
3 195 88.4 36.8 61 154.94 109 119.5 0.912 
4 259 117.7 38.2 69 175.26 120 122 0.983 
5 328 148.8 51.4 67 170.18 136 152.5 0.891 
6 230 104.3 42.1 62 157.48 117 125 0.936 
7 180.6 81.9 34.1 61 154.94 115 122 0.942 
8 207.2 93.9 35.6 64 162.56 115.5 118.5 0.974 
9 225.6 102.33 38.7 64 162.56 108 125.5 0.86 
10 172.8 78.38 31.6 62 157.48 114 107 1.06 
11 186.6 84.64 35.3 61 154.94       
12 197.2 89.44 38.5 60 152.4 134 109 1.22 
13 197.6 89.62 33.9 64 162.56 102 112.5 0.906 
14 212 96.16 35.3 65 166.37 106 122 0.8688 
15 269.6 122.28 41 68 172.72       
16 227.6 103.23 40.1 63.2 160.52 131.5 124 1.06 
17 172 78.017 32.2 61.3 155.7 114 103 1.106 
18 180.6 81.9 34.1 61 154.94 100 119.5 0.836 
19 324 146.96 52.3 66 167.64       
20 293 132.9 47.3 66 167.64       
21 261.4 118.56 47.5 62.2 157.988       
22 280 127.3 42.6 68 172.72       
23 192.3 87.22 34.1 63 160.02       
24 220.6 100.06 37.9 64 162.56       
25 262 118.9 46.4 63 160.02       
26 193.2 87.63 39 59 149.86 106 121.5 0.8724 
                 
 228.9576923 103.8741154 39.87307692 63.33461538 160.9183846 117.2647059 122.3235294 0.961952941 
 47.16288518 21.4292008 6.186343521 2.73977259 6.994347021 12.721927 13.19557357 0.100733051 
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Appendix K 
 
Prospective Group Laboratory Results Available: Baseline 
 
       *No Week 12 laboratory results were available.  
 
 
 
Participant 
HbA1C 
Total 
cholesterol LDL HDL Triglycerides 
           
1 9.3         
2 6.1 234   77 406 
3 5.7 164 86 56 108 
4           
5           
6           
7 5.6 150 70 56 119 
8 6.2         
9   133 55 47 154 
10 5.6         
11           
12           
13           
14 6.2 203 109 44 250 
15 5.9 245 141 46 290 
16           
17           
18           
19           
20 6 132 72 35 126 
21           
22 6         
23           
24           
25 6.5         
26           
           
 MEAN: 6.281818 180.1429 88.83333 51.57143 207.5714286 
 SD: 1.038093 47.15022 31.36505 13.35237 111.9908585 
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Appendix L 
 
Participants Weight (Lbs.) Trends 
 
Participant Baseline Week 2 Week 3 Week 4 Week 8 Week 12 
1 190.0      
2 295.0 295.0    286.00 
3 195.0 193.2 189.0 188.6  189.00 
4 295.0      
5 328.0     333.00 
6 230.0     220.50 
7 180.6 177.6 174.2 174.0  177.00 
8 207.2     158.00 
9 225.6  228.8  229.00  
10 172.8  173.2 172.6 172.40  
11 186.6  187.0   175.00 
12 197.2  182.0 182.0   
13 197.6     198.00 
14 212.0 211.6 210.8 210.4 205.40 200.80 
15 269.6     276.00 
16 227.6     232.00 
17 172.0     170.00 
18 180.6 172.4    165.40 
19 324.0      
20 293.0 289.0     
21 261.4    267.00 263.00 
22 280.0     280.40 
23 192.3    197.00  
24 220.6  219.0   221.00 
25 262.0 255.0  259.6 259.60  
26 193.2     286.00 
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Appendix M 
 
Nutrition Education 
 
 
Nutrition Plans:  
There are 3 Evidence-Based diet plans that have been proven to work:  
1. Total caloric reduction of between 500-750 calories per day, while also limiting dining 
out and use of fast foods, as well as eliminating or reducing high caloric ‘empty 
calorie’ foods such as pop and chips (Kushner & Ryan, 2014).  
2. Eating a healthy diet of between 1200-1500 calories for women and 1500-1800 
calories for men that includes lean protein, fresh vegetables and fruits, whole grains 
and legumes, low fat dairy and unsaturated fats while limiting sugars and ‘empty 
calories’ (Kushner & Ryan, 2014). 
3. Use of an evidence–based diets that restricts certain foods such as high fat, high 
carbohydrate, low fiber foods to create caloric deficit such as 
www.choosemyplate.gov or Weight Watchers ® (Kushner & Ryan, 2014; Madigan, 
2014). 
 
Healthy Nutrition: 
  A healthy diet should include:  
• Lean protein, fresh vegetables and fruits, whole grains and legumes, low fat 
dairy and unsaturated fats while limiting sugars and ‘empty calories’ (Kushner 
& Ryan, 2014) 
• Recommended daily intake is 3 servings of lean protein per day (3-4 
ounces/serving).  
• Aim for 5 servings of vegetables/ fruits (DM limit fruit intake) per day  
• Use of whole grains and legumes 
• Carbohydrate intake should be 45-65% of daily total calories 
• Low fat dairy (2-3 servings per day) 
• Unsaturated fats- olive oil, avocado 
• 6-8, 8-ounce glasses of zero calorie water per day unless on fluid restriction 
Limit empty calorie such as sweets, snack foods, processed foods and alcohol 
as these add to caloric intake and contain added salt, sugar and fats  
(ADA, 2019; AHA, 2019; Delahanty, 2020; Kushner & Ryan, 2014; Mayo Clinic, 
2019; NIH, 2019; USDA-ChooseMyPlate.gov, 2019) 
Cooking: bake, broil, boil, stream or grill meats and vegetables; eat fresh /raw fruits and 
vegetables. Limit frying or cooking with fat (ADA; AHA).  
 
Track your caloric intake: Learning to read food labels is very important. Weigh and measure 
foods to maintain caloric intake control. Use a food journal such as MyFitnessPal®, 
spreadsheet or a paper journal (Perreault & Apovian, 2019). 
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Appendix N 
 
Exercise Education 
 
 
Exercise and Physical Activity 
 
 
• The National Guidelines and the American Heart Association recommend 
increasing physical activity to at least 150 minutes per week with activity, 
including “moderate-intensity aerobic activity”. (AHA, 2018; Kushner & Ryan, 
2014). This is about 30 minutes per day, 4-5 days per week. 
• OR “75 minutes per week of vigorous aerobic activity (or a combination of 
both)” (AHA, 2018).  
• Some aerobic activities may include: fast walking; running; use of exercise 
machines like the treadmill, exercise bike, or elliptical machine; swimming; 
bicycling; or taking a jazzercise or zumba class or what ever type of safe and 
healthy activity you choose that increases heart rate and breathing without 
causing health risk. Be realistic and safe! 
• Aerobic activity should increase your heart rate; “Your heart will beat faster, 
and you’ll breathe harder than normal” (AHA, 2018).  
• STOP immediately if you experience chest, neck, back or shoulder pain or 
become light-headed or feel or experience fainting or nausea with increased 
activity. Seek emergency medical care or call 911. 
• Move More, Sit Less: “Get up and move throughout the day. Any activity is 
better than none. Even light-intensity activity can offset the serious health risks 
of being sedentary” (AHA, 2018). 
• And check with your healthcare provider before starting any new physical 
exercise plan.  
• Be safe! Try to exercise with a friend. Always carry identification and 
emergency contact when exercising especially outside.  
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Appendix O 
 
EBP Project Power Point Outline 
 
 
A Multicomponent Tailored Intervention Program Protocol for Weight Loss in an 
Underserved Adult Patient Population: A Power Point Outline 
1. Title slide: 
a. A Personalized Weight Loss Program for an Over-weight or Obese 
Population (Author: Rita R. Arnold MBA, BSM, BSN, RN, DNP Student 
Valparaiso University 2020) 
2. Part One: The Program Plan 
a. NEWER ME 
3. According to the WHO (2018)  
a. Since 1975 obesity has nearly tripled worldwide 
b. As of 2016 approximately 39% of the world’s adult population was over-
weight and 13% were obese. 
c. Approximately 340 million children were either overweight or obese 
d. Epidemic levels  
4. Health Risk of Over-weight and Obesity: 
a. Cardiovascular diseases (AHA, 2019; Jensen et al., 2014; Kushner & 
Ryan, 2014) 
b. Diabetes Mellitus type II (ADA, 2019; Jensen et al., 2014; Kushner & 
Ryan, 2014; Triplett et al., 2014) 
c. Fatty liver disease (Harvard Health, 2018; Jensen et al., 2014; Kushner & 
Ryan, 2014) 
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d. High blood pressure/ hypertension (AHA, 2019; Jensen et al., 2014; 
Kushner & Ryan, 2014) 
e. Joint and back pain/injury (Jensen et al., 2014; Kushner & Ryan, 2014) 
f. Infertility and Polycystic Ovarian Syndrome (ACOG, 2014) 
g. Depression and anxiety (Jensen et al., 2014; Kushner & Ryan, 2014; Ma 
et al, 2019; Melton & Kirkwood, 2019) 
h. Certain cancers (Jensen et al., 2014; Kushner & Ryan, 2014) 
i. As well as many others . . . 
5. Understanding Obesity 
a. Chronic disease (ACOG,2014; ADA, 2019; AHA, 2019; Cheatham  et al., 
2018; Eaton  et al., 2016; Jensen et al., 2014; Kushner & Ryan, 2014; Ma  
et al., 2019;; Sambal  et al., 2017; Tapsell  et al., 2017; Thabault Burke & 
Ades, 2016). 
i. ICD-10 code: E66 (.0-.9) 
b. Many factors contribute 
c. Cyclical nature where relapses are common: weight loss and regain 
(Kushner & Ryan, 2014; Rodriguez-Cristobal, 2017; McLauglin et al., 
2017). 
d. Obesity is often associated with: 
i. depression (Ma et al, 2019; Melton & Kirkwood, 2019) 
ii. anxiety (Ma et al, 2019; Melton & Kirkwood, 2019) 
iii. loss of self-esteem (Ma et al, 2019; Melton & Kirkwood, 2019) 
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iv. reduced quality of life (Kroes, Osei-Assibey and Baker-Searle, 
2016; Tapsell et al., 2017) 
v. risk of weight related comorbidities/ health risk (Jensen et al., 2014; 
Kushner & Ryan, 2014) 
vi. psychosocial isolation (Eaton et al., 2016; Kushner & Ryan, 2014; 
Samdal et al., 2017; Tapsell et al., 2017; Thabault et al., 2016). 
vii. stigma and bias (Phelan, et al., 2015; Welbourn et al., 2015). 
6. There are many factors that contribute to over-weight and obesity. Among them 
are:  
Genetic or hormonal component (21%) (Doig & Huether, 2014; Perreault, 
2019a).  
a. Chemical imbalances or disease states 
b. Depression anxiety 
c. Certain medication side effects 
d. Caloric intake and types of foods 
e. Activity and aerobic exercise 
f. Sedentary lifestyle: work and leisure 
g. Fatigue: poor sleep/sleep apnea/ hours of sleep 
h. Demands and over scheduling: busy lifestyle and commitments 
i. Over working, absent minded eating/ eating alone 
j. Cultural influences 
k. Support systems 
7. The good news is there is help: NEWER ME 
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a. Weight loss is a multicomponent process that includes:  
i. Nutrition: a healthy diet and reduced caloric intake (Jensen et al., 
2014; Kushner & Ryan, 2014; Perreault & Apovian, 2019) 
ii. Exercise: increased physical activity: > 150 minutes per week 
(AHA, 2019) 
iii. Weight loss support (Curry et al., 2018; Jensen et al., 2014; 
Kushner & Ryan, 2014; Perreault, 2019b;) 
iv. Emotional support: behavior and lifestyle changes (Curry et al., 
2018; Ma et al., 2017; Perreault, 2019b; Samdal et al, 2017) 
1. The 5 A’s: Provider use of the 5A’s (ask, assess, advise, 
agree, and assist) (Thabault et al., 2016; Vallis et al., 2013) 
counseling and intervention technique as well as 
motivational interviewing or counseling techniques 
(Rodriguez-Cristobal et al., 2017; Samdal et al., 2017, 
Thabault et al., 2016; Welbourn et al., 2018) 
v. Referrals for added support and care or counseling  
vi. Medication: review, change, additions 
vii. Expanded accountability: motivation and goals (and) 
viii. Autonomy and decision making (and) 
ix. Belief in one’s abilities-self-efficacy (Batsis et al., 2016; Beeken et 
al., 2017; Curry et al., 2018; Eaton et al., 2016; Grossman et al., 
2017; Hageman et al., 2017; Hartman et al., 2014; Kozica et al., 
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2015; Kroes, Osei-Assibey, Baker-Searle & Huang, 2016; Jensen 
et al., 2014; Kushner & Ryan, 2014; Samdal et al., 2017) 
8. Weight change is achieved by:  
a. Choice! 
b. The balance between caloric intake and calories utilized through bodily 
functions and physical activity (like a two-sided scale) 
c. Each pound of body fat results from 3500 calories taken in that are not 
utilized and stored as fat  
d. It’s simple math!  
i. Calories eaten minus calories burned = weight gain or loss 
9. A Healthy Diet and Reduced caloric intake 
a. According to the 2013 AHA/ACC/TOS Guideline for the Management of 
Overweight and Obesity in Adults: A Report of the American College of 
Cardiology/American Heart Association (2019) Task Force on Practice 
Guidelines and The Obesity Society (Jensen et al., 2014). 
b. There are 3 Evidence-Based diet plans that have been proven to work:  
i. Total caloric reduction of between 500-750 calories per day, 
while also limiting dining out and use of fast foods, as well as 
eliminating or reducing high caloric ‘empty calorie’ foods such as 
pop and chips (Jensen, et al., 2014; Kushner & Ryan, 2014) 
ii. Eating a healthy diet of between 1200-1500 calories for women 
and 1500-1800 calories for men that includes lean protein, fresh 
vegetables and fruits, whole grains and legumes, low fat dairy and 
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unsaturated fats while limiting sugars and ‘empty calories’ (Jensen, 
et al., 2014; Kushner & Ryan, 2014) 
iii. Use of an evidence–based diets that restricts certain foods such 
as high fat, high carbohydrate, low fiber foods to create caloric 
deficit such as www.choosemyplate.gov or Weight Watchers ®      
(Jensen, et al., 2014; Kushner & Ryan, 2014; Madigan, 2014; 
USDA) 
10.  Increased Physical Activity 
a. Check with your healthcare provider before starting any new physical 
exercise plan.  
b. Stop immediately if you experience chest, neck, back or shoulder pain or 
light-headedness/dizziness or fainting, or nausea with increased activity 
and seek emergency medical care or call 911.  
c. Stay hydrated, drink plenty of water! 
d. Avoid exercising in extreme conditions of heat or cold.  
e. Having a support system, family member or friend to exercise with can 
help keep you on track.  
11. Increased Physical Activity 
a. The National Guidelines and the American Heart Association recommend 
increasing physical activity to at least 150 minutes per week with activity, 
including “moderate-intensity aerobic activity”. (AHA, 2018; Kushner & 
Ryan, 2014) 
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b. OR “75 minutes per week of vigorous aerobic activity (or a combination of 
both)” (AHA, 2018).  
12. Increased Physical Activity 
a. Add Intensity; “Moderate to vigorous aerobic exercise is best” (AHA, 
2018).  
b. Aerobic activity should increase your heart rate; “Your heart will beat 
faster, and you’ll breathe harder than normal” (AHA, 2018).  
c. Some aerobic activities may include fast walking, running, use of exercise 
machines, swimming, bicycling, or taking a jazzercise, dancing or zumba 
class 
13.  Increased Physical Activity 
a. Move More, Sit Less! 
b. “Get up and move throughout the day. Any activity is better than none. 
Even light-intensity activity can offset the serious health risks of being 
sedentary” (AHA, 2018). 
14. Choosing and making behavioral and lifestyle changes 
a. Meal planning and shopping (www.choosemyplate.gov) 
b. Making meals ahead, use your freezer 
c. Packing your lunch instead of dining out or getting take-out 
d. Taking a lunch or dinner break instead of eating at your desk, on the go or 
skipping meals 
e. Don’t eat and drive, watch TV or multi-task 
i. Mindfulness-be in the moment  
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
215 
 
ii. Enjoy your food (Perreault, 2019b; Rodriguez-Cristobal et al., 2017; 
Samdal et al., 2017; Szczekala et al., 2018 
f. Don’t use food as an emotional support 
i. Food is fuel (Perreault, 2019b; Rodriguez-Cristobal et al., 2017; 
Samdal et al., 2017; Szczekala et al., 2018; Thalbault et al., 2016; 
Welbourn et al., 2018).  
g. You can say ‘No Thank You’  
i. when pressured to over-eat  
ii. or to eat unhealthy foods   
h. Look for healthy choices at social gatherings or bring your own  
i. Limit alcohol 
i. Empty calories: Low calorie to nutrition ratio 
j. Plan ahead 
15.  Cooking TIPS 
a. Bake, broil, grill, steam or boil.  
b. Avoid deep frying!  
c. Cooking in oil adds calories and fat to food. 
d. Use a sprayer bottle with olive oil if necessary 
e. Use a nonstick pan instead of adding oils. 
f. Eat fruits and vegetables, washed and raw! 
16. Track your food and exercise 
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a. The best way to have weight loss success and maintain weight loss long-
term is to keep a food and exercise diary of daily caloric intake and 
activity.  
i. Paper journal 
ii. Technology based  
iii. Phone applications (Cheatham et al., 2017; Tang et al., 2016). 
17. Motivation and Goals 
a. Ask yourself: 
i. What are my personal reasons or motivation for losing weight?  
ii. What are my weight loss goals?  Set daily, weekly, short and long-
term goals. Keep them realistic and attainable! 
iii. Revisit and reassess them often.  Why are these goals important to 
me? 
iv. How can I achieve weight loss? What realistic changes can I 
make? (Kozica et al., 2015; Rodrguez-Cristobal et al., 2017; 
Szczekala et al., 2018; Thabault et al., 2016; Wellbourn  et al., 
2018), 
b. Make your own choices and take ownership of choices made. Be 
accountable!  
c. Use positive self-talk. 
d. Keep a food and exercise diary/journal.  
e. Stay motivated: Each food and exercise choice bring you one step closer 
to your weight loss goal! 
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18. Autonomy and making your own decisions 
a. EBP information 
b. Making informed choices 
c. Taking ownership of choices made (Samdal et al., 2017) 
19. Positive self-talk 
a. Accept that over-weight and obesity are a chronic disease (Cheatham et 
al., 2018; Eaton et al., 2016; Ma et al., 2019; Sambal et al., 2017; Tapsell 
et al., 2017; Thabault Burke & Ades, 2016)  
b. Autonomy allows us to make our own choices  
c. Don’t get caught in the negative self-talk trap! 
d. Human’s are fallible beings- we make mistakes 
e. Owning our choices 
f. Make better choices next time 
g. Patterns developing 
h. Be Realistic-Aim for a 90:10 ratio! 
i. 90% stay vigilant  
ii. 10% enjoy a treat/rest 
i. Moving forward in a positive way- You can do this! 
20. Belief in yourself-self-efficacy 
a. Weight loss can be overwhelming 
b. There can be a lot of obstacles, influences or pressures 
c. Weight loss may have been hard to achieve or maintain in the past 
d. Maybe you haven’t been ready  
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e. One of life’s biggest hurdles is belief that you can do something 
f. You can lose weight. 
21. Part Two 
a. NEWER ME 
b. THE DIET PLANS 
22. Beginning a weight loss plan 
a. Learning to read food labels 
b. Tracking calories 
c. Choosing the right plan for me 
d. A healthy diet 
e. Portion distortion 
f. Shopping for health 
g. Party time! Planning ahead  
h. When I slip, I dust myself off and start a new 
i. Specific weight loss plans 
j. Resources 
23. Reviewing a food nutrition label: making calories count 
a. Is eating it worth it? 
b. Servings per container 
c. Serving size 
d. Caloric intake per serving 
e. Carbohydrates/sugar 
f. Fats/cholesterol 
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g. Protein 
h. Sodium 
i. Vitamins 
j. Minerals 
24. Track food and caloric intake 
a. The best way to have weight loss success and maintain weight loss long-
term is to keep a food diary of daily caloric intake.  
b. Paper journal 
c. Technology based  
d. Phone applications 
e. If it goes into your mouth…COUNT IT! 
25. A healthy diet includes 
a. Lean protein 
b. Fresh or frozen vegetables and fruits 
c. Whole grains 
d. No-fat or low-fat dairy 
e. Unsaturated fats 
f. Water 
26.  Incorporate Portion Control 
a. Check package labeling for serving size  
b. Use a smaller salad plate instead of dinner plate 
c. No second helpings 
d. Order small size- don’t Super-Size! 
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e. Share servings 
27.  Shopping for health! 
a. ChooseMyPlate.gov  
b. Shop the perimeter  
i. Fresh foods 
c. Limit or eliminate processed foods 
d. Limit or eliminate empty calories/snack foods 
28. Party time! Planning ahead 
a. Plan for special events 
b. Reserve some of your weekly caloric intake so that you can enjoy special 
meals 
c. Exercise extra throughout the week 
d. Watch out for hidden calories 
e. Bring your own treats 
f. It’s OK to say no thank you 
29. When I slip, I dust myself off and start a new 
a. Weight loss is difficult for some people 
b. A misstep is not the end of your weight loss journey 
c. Take ownership of your eating and exercise 
d. Forgive yourself, use positive self-talk 
i. Avoid words like always, and never 
e. Choose to get back on track 
f. Have a positive support person 
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30. The three Evidence- based diet plans that have been proven to work:  
a. Total caloric reduction of between 500-750 calories per day, while also 
limiting dining out and use of fast foods, as well as eliminating or reducing 
high caloric ‘empty calorie’ foods such as pop and chips (Jensen et al., 
2014; Kushner & Ryan, 2014) 
b. Eating a healthy diet of between 1200-1500 calories for women and 1500-
1800 calories for men that includes lean protein, fresh vegetables and 
fruits, whole grains and legumes, low fat dairy and unsaturated fats while 
limiting sugars and ‘empty calories’ (Jensen et al., 2014; Kushner & Ryan, 
2014) 
c. Use of an evidence–based diets that restricts certain foods such as high 
fat, high carbohydrate, low fiber foods to create caloric deficit (Jensen et 
al., 2014; Kushner & Ryan, 2014)  
i. Such as the USDA www.choosemyplate.gov or Weight Watchers ® 
(Madigan, 2014; USDA) 
31. Total caloric reduction of between 500-750 calories per day 
a. Reduce portion sizes 
i. Smaller plates 
ii. No second helpings 
iii. Order small not super-size 
iv. Share  
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b. Incorporating healthy food choices: lean protein, fresh or frozen 
vegetables and fruits, whole grains, non-fat or low-fat dairy, and 
unsaturated fats such as olive oil. 
c. Limiting dining out and use of fast foods/drive throughs 
i. Higher caloric content 
ii. Added ingredients 
iii. Mindfulness 
d. Eliminating or reducing high caloric ‘empty calorie’ foods such as pop and 
chips 
e. Reducing or eliminating processed foods 
f. Keep a food diary to track calories 
g. Weigh in weekly 
h. Increase activity 
i. The goal is to burn more calories in a day through bodily function and 
aerobic activity, then are taken in through foods consumed.  
32. Eating a healthy diet of between 1200-1500 calories for women and 1500-1800 
calories for men 
a. Stay within caloric daily limits 
b. Includes lean protein, fresh vegetables and fruits, whole grains and 
legumes, low fat dairy and unsaturated fats (Jensen et al., 2014; Kushner 
& Ryan, 2014) 
c. Limiting dining out and use of fast foods/drive throughs 
i. Higher caloric content 
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ii. Added ingredients 
iii. Mindfulness (Perreault, 2019b; Rodriguez-Cristobal et al., 2017; 
Samdal et al., 2017; Szczekala et al., 2018 
d. Eliminating or reducing high caloric ‘empty calorie’ foods such as pop and 
chips 
e. Reducing or eliminating processed foods 
i. Additives sugars, salts and fats 
f. Keep a food diary to track calories 
g. Weigh in weekly 
h. Increase activity 
33. Use an Evidence-Based commercial diet 
a. Restrict certain foods such as: high fat, high carbohydrate, low fiber foods 
to create caloric deficit (Jensen et al., 2014; Kushner & Ryan, 2014) 
b. www.choosemyplate.gov or Weight Watchers ®       
(Madigan, 2014; USDA, 20) 
34. On-line Resources 
a. American Heart Association 
i. https://www.heart.org/en/healthy-living/healthy-eating/losing-
weight?uid=1966 
b. American Diabetes Association 
i. https://www.diabetes.org/fitness/weight-loss 
ii. And https://www.diabetes.org/nutrition 
c. National Institutes of Health: Aim for a Healthy Weight 
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i. https://www.nhlbi.nih.gov/health/educational/lose_wt/index.htm 
d. USDA: ChooseMyPlate  
i. English and Spanish 
ii. www.ChooseMyPlate.gov 
e. Cornerstones4Care 
i. Diabetes Mellitus II control resources 
ii. English and Spanish 
iii. Free resource booklets and tracking tools 
iv. www.cornerstones4care.com 
35. References 
a. Provided in this DNP EBP Project report reference section 
 
Appendix P 
 
On-line Participant Resource Tools 
 
Weight Loss Web Sites and Tools 
Herramientas y sitios web para bajar de peso 
 
English: 
 
Cornerstone4Care:Nutrition and Diabetes: It’s all on the label (accessed: 2019).  
 
• https://www.cornerstones4care.com/healthy-eating/what-to-do/nutrition-and-
diabetes.html 
 
Novomedlink Resources: professional and patient (accessed: 2019) 
 
• https://www.novomedlink.com/content/dam/novonordisk/novomedlink/resources/
generaldocuments/CountingCarbandMeal_EG.pdf 
 
ChooseMyPlate.gov: Nutrition resources (accessed: 2019) 
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• https://choosemyplate-
prod.azureedge.net/sites/default/files/tentips/MPMW_tipsheet_14_FINAL.pdf 
 
• https://www.choosemyplate.gov/myplate-tip-sheets 
 
National Institutes of Health/NIH : Healthy Eating- Tips (accessed: 2019) 
 
• https://www.nhlbi.nih.gov/health/educational/lose_wt/eat/tips.htm 
 
• https://www.nhlbi.nih.gov/health/educational/lose_wt/eat/calories.htm 
 
• https://www.nhlbi.nih.gov/health/educational/lose_wt/eat/fd_exch.htm 
 
American Diabetes Association: What to eat with diabetes or pre-diabetes 
(accessed: 2019) 
 
• https://diatribe.org/what-eat-diabetes-or-prediabetes-adas-new-nutrition-
guidelines 
 
• https://www.diabetes.org/nutrition 
 
• https://www.diabetes.org/a1c 
 
American Diabetes Association: fitness and weight loss (accessed: 2019) 
 
• https://www.diabetes.org/fitness 
 
• https://www.diabetes.org/fitness/weight-loss 
 
American Heart Association: Healthy living, eating and weight loss resources 
(accessed 2019) 
 
• https://www.heart.org/en/healthy-living/healthy-eating/losing-weight 
 
• https://www.heart.org/en/healthy-living/healthy-eating/losing-weight/5-steps-to-
lose-weight-and-keep-it-off 
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• https://www.heart.org/en/health-topics/cholesterol/cholesterol-tools-and-
resources 
 
• https://www.heart.org/en/healthy-living/healthy-eating/losing-weight 
 
Cleveland Clinic: exercise and calories burned chart (accessed:2019) 
 
• https://health.clevelandclinic.org/burn-off-calories-boost-heart-health-infographic/ 
 
Spanish/Espanol resources: 
 
Novomedlink: Cornerstone4Care: weight loss, diabetic and prediabetic free 
printed and online resources for clinicians and patients in Espanol (accessed 
2019) 
• https://www.novomedlink.com/content/dam/novonordisk/novomedlink/resources/
generaldocuments/CountingCarbandMeal_SP.pdf 
 
American Heart Association: Healthy living, eating and weight loss resources 
(accessed 2019) 
• https://www.heart.org/en/health-topics/consumer-healthcare/order-american-
heart-association-educational-brochures/losing-weight-the-healthy-way-spanish-
brochure 
 
• https://www.heart.org/en/health-topics/cholesterol/cholesterol-tools-and-
resources 
 
• https://www.heart.org/-/media/files/health-topics/cholesterol/question-for-your-
doctor_spanish_2-12-
19_form.pdf?la=en&hash=CCCDB417A7D7BDD2ED415A49DF0C6FB1C62E26
1E 
 
ChooseMyPlate.gov: Nutrition Spanish/ Espanol language resources (accessed: 
2019) 
• https://choosemyplate-
prod.azureedge.net/sites/default/files/printablematerials/Mini-
Poster_Spanish_508.pdf 
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Appendix Q 
 
Matthew 25 Health and Dental Clinic Obesity Project Program Protocol 
 
Project Protocol 
 
A Multicomponent Tailored Intervention Program Protocol for Weight Loss in an 
Underserved Adult Patient Population with Obesity 
Week One: 
Complete the following screenings and measures as time allows: 
• Weight and height in stocking feet. 
o  Encourage patient to wear same type of clothing each weigh in.  
o Calculate BMI:  
▪ 18-24.9= normal 
▪ 25-29.9= overweight 
▪ 30.0-39.9= obese 
▪ > 40 = morbidly obese 
▪ If the EMR does not automatically calculate this or paper 
charts are used, the NIH @ nhlbi.nih.gov has an online 
calculator for BMI 
• Need height in feet and inches and weight in lbs. 
• Blood pressure 
o Complete accurately with location 1” above antecubital space, 
correct cuff size, sitting with feet flat, after resting for 5 minutes, 
with measuring arm held at heart height 
o Monitor and refer for follow up assessment if BP above ACC/AHA 
2018 guidelines on 2 or more visits.  
▪ A BP of 120-129/>80 is class I elevated according to new 
guidelines 
• 130-139/80-89 is Stage I HTN 
• > 140/90 is Stage II HTN 
• Laboratory testing when possible: HbA1c and lipid panel; other 
warranted assessments may include EKG, TSH, AST, ALT 
                              (Jensen et al., 2014; Kushner & Ryan, 2014; Perreault, 2020) 
• PHQ-9 and GAD-7 
o Assess for depression and anxiety as these often accompany 
overweight/obesity in a reciprocal nature 
o Refer for further evaluation if PHQ-9 score is > 10 or if GAD-7 
score is > 5, or if patient requests intervention.  
• AAQ-W: Acceptance and action questionnaire  
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o The AAQ-W is used to assess weight loss readiness; it measures 
pragmatic avoidance and psychological rigidity that play a part in 
health problems including weight control (Lillis & Hayes, 2008).  
o The AAQ-W tool correlates with the common levels of avoidance 
and rigidity, obesity-related quality of life, psychological distress 
and BMI. Also there is a correlation with self-reported binge 
eating and exercise sessions per week as well as making healthy 
food choices while dining out (Palmeria, Cunha, Gouveia, 
Carvalho & Lillis, 2016).  This considered an effective and 
validated tool to measure weight loss readiness.  
o Scoring may range from 22 to 154 with lower scores indicating 
“less experimental avoidance and more psychological flexibility” 
(Lillis & Hayes, 2008, p. 34). 
• WEL-SF: Weight Efficacy Lifestyle Questionnaire Short-Form Tool 
o The WEL-SF measures eating self-efficacy or one’s belief in their 
ability to perform in a given situation. Low self-efficacy is 
correlated to lower weight loss success and high self-efficacy is 
correlated to greater weight loss success. Self-efficacy for eating 
is a predictor of acquired weight loss behaviors. This tool asks 
the participant to reflect on how confident they feel in relation to 
situations in which overeating may become a problem. 
o Likert format with scores that range between 0 to 10 with higher 
scores representing higher confidence levels for each question. 
(Ames, Heckman, Grothe & Clark, 2012; Flolo, Andersen, 
Neilsen, & Natvig, 2014). 
o Used to measure weight-loss readiness.  
• The 5 A’s: ask, assess, advise, agree, and assist (Thabault et al., 2016; 
Vallis et al., 2013) counseling and intervention technique: 
▪ Ask would it be alright if we talk about your weight or how 
do you feel about your weight? (Do not judge-unbiased) 
▪ Assess health status, weight, BMI, BP etc. 
▪ Advise: collaborate- say now that we know your current 
health and risks, can we work together to help improve 
things/ or what can I help you with to improve your health 
and lose weight? 
• This is a great time for weight loss education. 
▪ Agree- the patient needs to understand the treatment and 
agree that it’s a good choice creating ‘buy in’ to set goals. 
▪ Assist-identify barriers and facilitators to success with the 
patient, talk about ways to overcome or promote these. 
o  Use motivational interviewing or counseling techniques 
(Rodriguez-Cristobal et al., 2017; Samdal et al., 2017, Thabault 
et al., 2016; Welbourn et al., 2018) 
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• View program instruction via: A Personalized Weight Loss Program for 
an Over-weight or Obese Population -Power Point presentation  
o 2-part series in 1 presentation 
o  voiced over 
o  lasts about 30 minutes  
• Review weight loss plan  
o There are 3 plans: the first works by decreasing calories by 500-
750 calories per day and works if they are already below @2500-
3000 calories per day otherwise it won’t work. The third plan- use 
of Weight Watchers ® type that costs $$ but will work.  
o Generally, allow them to choose but explain as written above. Try 
to put patients on the second plan either the 1200-1500 calories 
for women or the 1500-1800 calories for men because it provides 
structured limits and guidelines. Also, this one works well for 
diabetes (Jensen et al., 2014; Kushner & Ryan, 2014) 
▪ Within the 1200-1500 /1500-1800 calories they need to 
get: 
• Carbohydrates/ Grains: 45-65% of daily total 
calories (< 125-150 grams) carbohydrate from all 
sources, including grains, fruit, dairy, sugars. 
• Fruit /veg: 5 servings (limit to 2 servings fruit if DM) 
o Corn, peas, carrots, plantains, potato, yam, 
squash limit 1/2c per serving; all other veg 
generally unlimited and doesn’t need to be 
counted in calories due to nutrition, fiber and 
low calories.  
o Fresh or frozen are best due to sodium, 
sugar and additives in canned.  
• Protein: try to get 3 servings or between 55-75 
grams of lean protein per day  
o Lean beef, poultry, fish, legumes/beans, 
nuts, eggs, dairy 
o (limit processed meats; no pork, ground 
meats or sausages) 
• Fat: < 45 grams per day: Unsaturated fats such as 
olive oil, avocado, banana, cooking spray 
o Avoid solid fats such as white shortening 
(Crisco type) 
o Use banana, avocado, apple sauce for 
baking, or low saturated oil. 
 A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL           
   
 
230 
 
o Dairy: 2 servings per day, or supplement 
calcium with green leafy veg/ mineral 
supplement 
• Water: 6-8, 8-ounce glasses of no calorie water per 
day unless restricted.  
• No food are off limits but, tell patients if it goes in 
their mouth they must count it and stop eating when 
they have reached their daily calorie limits.  
o Bake, broil, boil, grill foods with minimal sprayed oil or fats.  
o DO NOT DEEP or fat fry.  
o AVOID Processed foods and empty calories in general.  
o Shop the perimeter of the grocery where healthy choices are.  
o Read food labels for servings/size and content 
o Weight and measure foods 
o Keep a food and exercise journal after EVERY Meal 
• Discuss healthy BMI and were patient is currently: Set 3% total body 
weight loss as initial 12-week goal; then 5% from baseline at 6-month 
mark and 10% from baseline by month 12. Do not overwhelm them. Let 
them know this is a long-term process with no quick fix, but each day 
they will weigh less.  
• Weigh in weekly to promote accountability 
o Remind them the scale does not lie; calories in versus calories 
burned makes the scale go up, down or stay the same. It is their 
choice.  
o Unless there is a cardiac issue/edema-then refer.  
• Exercise at least 150 minutes per week on most days (about 20-30 
minutes per day)- moderate intensity aerobic activity of their choice: 
walking, bicycling, swimming or use of exercise machines 
• Review S/S of CVA MI-STOP Call 911 
• Provide handouts: 
o Food and exercise journal 
o Personal daily Journal Diary: Goal setting and motivation 
o What’s on your plate? (www.choosemyplate.gov) (English and 
Spanish) 
o Planning Healthy Meals (www.Cornerstone4Care.com) 
o 5 Steps to Lose Weight and Keep It Off (www.heart.org) 
o Changing Habits for Better Health (www.niddk.nih.go)v 
o Make a Difference with Positive Self-Talk (www.diabetes.org) 
o Conquer Cravings with These Healthy Substitutions 
(www.heart.org) 
o Why Do I Eat When I’m Not Hungry?  
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o Websites for Healthy Recipes (www.cookinglight.com; 
www.bbcgoodfood.com) 
o Recipe card Healthy Stuffed Chicken Breast 
(www.bbcgoodfood.com) 
o Weight loss websites and tools list (ADA; AHA; www.heart.org; 
www.choosemyplate.gov; www.cornerstone4care.com; 
www.nhlbi.nih.gov; www.diabetes.org; https://diatribe.org) 
o Provide Cornerstone4Care diabetes education booklets in 
English or Spanish (www.cornerstones4care.com)  
o Provide community resource booklet and food pantry list- contact 
Social Services 
• This is a lot of information for patients, but because of the high ‘no show’ 
rate for follow up appointments at this clinical site,  it provides the 
necessary resource tools for them should they choose to lose weight on 
their own.  
o Have them bring any questions to their second visit, and monitor 
progress. 
o Evaluate food and exercise journal- verbal discussion. 
o Evaluate and reinforce weight loss education and need for 
journaling and goal setting as necessary.  
Follow up. Follow up weekly for at least 4- 8 weeks; then every 2-4 weeks until at 
goal; then monthly for 6 months; then every 6 months for 2 years; then if weight loss 
goal is maintained meet yearly.  
• Schedule next visit while the patient in clinic and provide appointment 
card. Call to remind patient of appointment 24-72 hours in advance. 
Each visit. Reassess Weight, BMI and BP at each visit. Reinforce education, goal 
setting, behavioral interventions, food and exercise tracking, accountability and 
autonomy. Do not allow bias to influence treatment. Provide EBP counsel and 
support.  
 
Re-assess for depression and anxiety. Reassess for depression and anxiety as 
these often accompany overweight/obesity in a reciprocal nature 
o Complete PHQ-9 and GAD-7 at baseline, week 12, 6 months, 
then at each visit. 
o Refer for further evaluation if PHQ-9 score is > 10 or if GAD-7 
score is > 5, or if patient requests intervention. 
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Appendix R 
Daily Food and Exercise Journal 
Daily Food and Exercise Journal/ Diario de Alimentos y Ejercicios 
Meal/ 
Comida 
Foods eaten/  
Alimentos consumidos 
Protein/ proteina 
grams 
Carbohydrates
/carbo-hidrato 
grams 
Fats/ 
grasas 
grams 
 Total Calories / 
Total de calorias 
Minutes 
of  
exercise/ 
Ejercicios 
Breakfast 
Desayuno 
    =  
Lunch/  
Almuerzo 
 
 
 + + + +/=  
Dinner/  
Cena 
 
 + + + +/=  
Snack/  
Bocadillo 
 
 
 + + + +/=  
Snack/ 
Bocadillo 
 
 
 + + + +/=  
 
Add up the total caloric 
intake for today from the 
above totals / Sumar la 
ingesta calorica total para 
hoy de los totals 
anteriores. Review your 
limits /revise sus limites.  
= = = = = 
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Appendix S 
 
SPSS Code Book 
 
Demographics 
 Measure  Value 
 
Code 
 
1 Sex Male 
Female 
Other 
1 
2 
3 
2 Age True age Number  
 
3 Race American Indian or 
Alaska Native 
Asian 
Black or African 
American 
Native Hawaiian or 
Other Pacific 
Islander 
White 
More than one race 
Unknown or not 
reported 
 
 
1         
 
 
    2 
 
3 
 
 
4 
 
     
 
 
    5 
 
6 
 
 
7 
 Ethnicity Hispanic or Latino 1 
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Not Hispanic or 
Latino 
Unknown or not 
reported 
 
2 
 
3 
4 English speaking Yes 
No 
1 
2 
Measures 
5 (Height in Inches) 
HtInW1 
50 - 75 Number 
6 (Weight in pounds) 
WtLbs1 
WtLbs2 
WtLbs3 
WtLbs4  
WtLbs8 
WtLbs12 
100 - 500 Number 
7 (Weight In Kg) 
WtKg1 
WtKg2 
WtKg3 
WtKg4 
WtKg8 
WtKg12 
50 - 400 Number 
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8 (BMI) 
BMIW1 
BMIW2 
BMIW3 
BMIW4 
BMIW5 
BMIW6 
20 - 50 Number 
9 WaistCircCMW1 
WaistCircCMW12 
75-150CM Number 
10 HipCircCMW1 
HipCircCMW12 
75-150CM  Number 
11 WHRW1 
WHRW12 
0.5-1.9 Number 
12 (Systolic BP) 
SBPW1 
SBPW2 
SBPW3 
SBPW4 
SBPW8 
SBPW12 
75-200 Number 
13 (Diastolic BP) 
DBPW1 
DBPW2 
50-125 Number 
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DBPW3 
DBPW8 
DBPW12 
14 HbA1cW1 
HbA1c:W12 
5.5-13.9 Number 
15 (Chol & Lipids) 
TCW1 
TCW12 
100-300 Number 
16 LDLW1 
LDLW12 
0-300 Number 
17 HDLW1 
HDLW12 
0-100 Number 
18 TrigW1 
TrigW12 
40-500 Number 
19 GAD-7: 
GAD7Q1W1, GAD7Q2W1, GAD7Q3W1, . . . 
GAD7Q7W1 
 GAD7Q1W12, GAD7Q2W12, GAD7Q3W12, . . .  
GAD7Q7W12 
 
0 – 3 for each item 
 
 
Number 
 
20 PHQ-9: 
PHQ9Q1W1, PHQ9Q2W1, PHQ9Q3W1 … PHQ9Q9W1 
PHQ9Q1W12, PHQ9Q2W12 … PHQ9Q9W12 
 
 
0 – 3 for each item 
 
Number 
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21 AAQW: 
AAQWQ1, AAQWQ2, AAQWQ3, …, AAQWQ22 
 
0-6 for each item Number 
22 WELSF: 
WELSFQ1, WELSFQ2, WELSFQ3, …, QELSFQ8 
 
 
1-10 for each item Number 
23 WksComp 
 
1, 2, 3, 4, 8, or 12 
 
number 
24 WtLoss Yes 
No 
1 
2 
25 WtLossMaint Yes 
No 
1 
2 
26 WtChange  
-100 – 100 
Number 
Enter as 
plus or 
minus  
27 MetWtLossGoal Yes 
No 
1 
2 
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Appendix T 
Permission to use AAQW tool as published in 2008 
Via email reply Sun., July 21, 2019, 8:07PM  
Yes of course, you have my permission (though it is not needed). Best of luck with your 
research! 
 
Jason 
______________ 
 
Jason Lillis, Ph.D. 
Associate Editor, Journal of Contextual Behavioral Science 
Assistant Professor (Research) 
Brown Medical School/ The Miriam Hospital  
 
 
 
